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ABSTRACT OF THE DISSERTATION 
 
 
The Effect of Dietary Fat on Obesity, Gene Expression, and DNA Methylation in Two 
Generations of Mice 
 
by 
 
Madeline Rose Keleher 
 
Doctor of Philosophy in Evolution, Ecology, and Population Biology 
 
Washington University in St. Louis, 2017 
 
Professor James Cheverud, Chairperson 
 
 
 
 As obesity rates continue rising nationally and globally, it is crucial to understand how a 
high-fat diet disrupts the regulation of the genome and leads to adverse health effects. 
Uncovering the underlying gene expression and DNA methylation changes induced by an 
individual’s high-fat diet and a maternal high-fat diet can pinpoint new targets for epigenetic 
therapies and reveal the physiological and behavioral changes in obesity. The goal of this 
dissertation is to gain deeper insight into the DNA methylation and gene expression changes that 
occur in response to a high-fat diet. 
 I studied the response to dietary fat within two generations of the inbred SM/J mouse 
strain by feeding them either a low-fat diet or a high-fat diet that was nearly isocaloric but had 
approximately three times as many calories from fat. I measured their weights weekly for 17 
weeks, tested their glucose and insulin tolerance, assessed serum biomarkers, and weighed their 
organs at necropsy. Diet strongly affected all of these traits. I isolated RNA from the liver tissue 
and used RNA-sequencing to uncover 4,356 genes that were differentially expressed due to diet. 
Nearly 200 of these genes had a significant sex-by-diet interaction, highlighting the importance 
 xiii
of sex differences in the response to a high-fat diet. The dysregulated genes were enriched for 
pathways involved in cytokine-cytokine receptor interaction, chemokine signaling, and oxidative 
phosphorylation. I extracted DNA from the liver tissue and identified differentially methylated 
regions across the genome using MeDIP and MRE sequencing. More than 7,000 genes in the 
liver had differentially methylated regions at the FDR-adjusted q < 0.05 level. The differentially 
methylated regions occurred in differentially expressed genes significantly more often than 
expected by chance alone. These findings underscore the major effect that dietary fat has on gene 
expression and DNA methylation patterns in the liver, and illustrate how different this effect is 
depending on sex.  
 I then mated low-fat-fed males with females on either diet, and cross-fostered all 
offspring to low-fat-fed SM/J nurses in order to study the effect of prenatal maternal diet on adult 
offspring metabolic traits, behavior, gene expression, and DNA methylation. I weaned the 
offspring onto a high fat or low-fat diet at 3 weeks of age. I then measured the same traits in the 
offspring as I measured in the parental generation, as well as additional morphological and 
behavioral traits. I measured the long-bone lengths and weights, anxiety with the Open Field 
Test, behavior with instantaneous scan sampling, and nest quality with the Deacon Scale. 
Compared to low-fat-fed offspring, high-fat-fed offspring had longer, heavier bones, had 
increased anxiety levels, built lower-quality nests, and had reduced activity levels in adulthood, 
including exploratory and self-maintenance behaviors. Maternal diet did not have much of an 
impact on offspring bones or behavior, only affecting whether or not the offspring built their 
nests inside a hut.  
 Although maternal diet did not widely affect offspring behavior, it had major effects on 
the obesity and diabetes-related traits in the adult daughters. Compared to high-fat-fed daughters 
 xiv 
of low fat mothers, high-fat-fed daughters of high-fat mothers weighed more, had heavier livers 
and reproductive fat pads, and had higher leptin levels in their serum. These physiological 
changes were accompanied by 46 differentially expressed genes and 1,700 differentially 
methylated genomic regions in liver cells, as well as 45 differentially expressed genes and 4,103 
differentially methylated genomic regions in heart cells. Although the obesity traits were only 
altered by maternal diet only in the daughters, all offspring experienced changes in the 
expression of dozens of genes in the liver, particularly genes involved in RNA processing, 
immune response, and cellular respiration in mitochondria. Maternal obesity also altered DNA 
methylation in thousands of regions in the genome. Over 7,300 genes contained at least one 
differentially methylated region due to maternal diet in high-fat-fed offspring, and over 9,300 
genes did in low-fat-fed offspring. Regardless of maternal diet, an offspring high-fat diet reduced 
overall variation in methylation, increased body size—as measured by the weights of the organs 
and body, and the weights and lengths of the long bones—decreased insulin sensitivity, and 
altered the expression of 3,908 genes. While the mice were more affected by their own 
individual diets, their maternal diet impacted their DNA methylation and gene expression into 
adulthood. The findings of this dissertation improve our understanding of the epigenetic 
architecture of obesity and identify new targets for therapies in the future.  
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 The human obesity rate has been climbing over the last several decades. While it was 
14% in the United States in the 1980s (Bray and Popkin 2014), it had passed 37% by 2014 
(Flegal et al. 2016), and it is predicted to reach 42% by 2030 (Finkelstein et al. 2012). The 
prevalence of obesity may be higher than estimated, since many studies are based on self-
reported weights, which people tend to underestimate (Cawley et al. 2015). The increasing 
prevalence of obesity is a major public health concern, because obesity raises the risk of 
developing hypertension by 5 times (Haslam and James 2005), it elevates the risk for many 
cancers (Lauby-Secretan et al. 2016), it predisposes people to diabetes (Haslam and James 
2005), it raises the risk of stroke and heart attack (Cawley and Meyerhoefer 2011), and it 
decreases life expectancy by a decade on average (Buchwald 2005).  
 Obesity is a complex condition with a myriad of causes. A major factor leading to obesity 
is the environment, particularly an individual’s diet and physical activity level (Hill and Peters 
1998). Diet has been changing considerably in the United States, both in terms of macronutrient 
composition and total calorie intake. From the 1970s to 2000, the average energy intake 
increased by 168 kcal/day for men and 335 kcal/day for women (CDC 2004). Sugar partially 
accounts for the higher energy intake; while the average American consumed 4 lbs of sugar 
annually in 1776, it had increased to 20 lbs per year by 1850 and 120 lbs per year by 1994 (Bray 
and Popkin 2014).  
 In addition to environmental factors such as diet and physical activity, another factor 
leading to obesity is genetic. Obesity is highly heritable (BMI has a heritability of 64-84%), and 
genes such as MC4R, POMC, and LEP are known to be involved in monogenic obesity 
syndromes (O’Rahilly and Farooqi 2006). A study of more than 2,000 first-degree relatives 
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revealed that having a parent or sibling with a BMI of at least 40 increases a person’s risk of 
being obese by 5 times (Lee et al. 1997). A study of more than 3,000 children in Germany 
revealed that offspring BMI was significantly correlated with maternal BMI (r = 0.254) and 
paternal BMI (r = 0.159) (Danielzik et al. 2002). The authors found that the odds ratio for being 
overweight in children was higher for those with at least one overweight parent, and was highest 
for children with two obese parents (an odds ratio of 7.6 in sons and 6.3 in daughters). A 
longitudinal study that followed girls from the ages of 5 to 13 showed that daughters with two 
overweight parents had higher levels of disinhibited eating and had an 8 times higher risk of 
being overweight at age 13 than daughters of lean parents (Francis et al. 2007). The health risks 
that come with having two overweight parents are important to consider, because researchers 
have identified assortative mating in terms of weight, with a strong association between maternal 
and paternal obesity prior to conception (Soubry et al. 2015).  
 Childhood weight has a strong genetic component, as illustrated by a study of 177 pairs 
of twins where genes accounted for 90% of body weight variance at 5 months of age and 87% of 
variance at 5 years of age (Dubois et al. 2007). Mutations in 5 genes account for at least 5% of 
severe childhood obesity cases: MC4R, POMC, PCSK1, LEP, and LEPR (Bouchard 2009). 
However, obesity disorders are more commonly caused by many genes of small effect rather 
than a single gene of large effect (Bouchard 2009). More than 75 genomic loci linked to obesity 
have been identified through genome-wide association studies (Gorkin and Ren 2014). 
Interestingly, many of these loci are in non-protein coding regions of genes, as is the case with 
FTO (Gorkin and Ren 2014). Although GWAS studies have consistently identified an 
association between obesity and SNPs in FTO, the expression of FTO itself does not impact 
obesity. Rather, an intron of FTO regulates the expression of the homeobox gene IRX3 (Smemo 
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et al. 2014). 
 Modern increases in obesity are not due to genetic changes but to the changes in 
environment as discussed above. Nevertheless, there is genetic variation in response to 
obesogenic environments. For instance, the FTO gene participates in gene-by-environment 
interactions. The effects of physical activity on obesity change depending on the FTO genotype 
in humans. Compared to TT homozygotes, AA homozygotes have 1.95 kg/m2 higher BMIs, but 
only if they are physically inactive (Andreasen et al. 2008). A gene-by-environment interaction 
has also been identified in the response to caloric excess. When Bouchard et al. (1990) assigned 
12 pairs of identical male twins to a diet with an excess of 1,000-kcal/day for 100 days, each of 
the men gained weight, but there was 3 times more variance between pairs of twins than within 
pairs. Numerous gene-by-diet interactions have also been discovered in mice, and most of the 
genes affecting obesity in a cross of LG/J and SM/J mice (the latter strain is the focus of this 
dissertation) are involved in gene-by-diet interactions (Ehrich et al. 2000, Cheverud et al. 2011). 
 Many less-studied causes of obesity have been identified as well. Sleep deprivation has 
been shown to cause impaired glucose and insulin sensitivity (Knutson et al. 2007), and lower 
rates of obesity have been linked to urbanization and living at a higher elevation in the United 
States (Voss et al. 2013). Recently, the gut microbiome has also been implicated in obesity 
(Parekh et al. 2015, Barlow et al. 2015), and researchers have shown that transferring gut 
microbiota from obese people to mice causes the mice to gain significantly more adipose tissue 
than if they receive microbiota from a lean person (Ridaura et al. 2013). Additionally, several 
studies have suggested a relationship between obesity and infection with certain viruses. Obesity 
has resulted in mice after they were infected with canine distemper virus, and in chickens after 
being infected with Rous-associated virus-7 (RAV-7) (McAllister et al. 2009). Marmosets 
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infected with adenovirus-36 (Ad-36) gained 4 times as much weight as uninfected marmosets. In 
a study of 502 people in the United States, 30% of obese individuals were found to have been 
naturally infected by Ad-36, compared to only 11% of non-obese individuals (Atkinson et al. 
2005).   
 Parental effects also contribute to obesity risk through environmental and genetic 
mechanisms. Paternal obesity has been shown to impact offspring in numerous ways. Children 
have an increased risk of developing early-onset obesity if they inherit a paternal allele of the 
INS gene that carries a class I variable nucleotide tandem repeat polymorphism (Le Stunff et al. 
2001). Epigenetic changes associated with paternal obesity can also impact offspring. High-fat-
fed male mice had 25% less DNA methylation in their sperm and altered gene expression in their 
testes, which affected their progeny by increasing adiposity in their daughters by 67% and in 
their grandsons by 24% (Fullston et al. 2013). In addition to methylation, the tRNA in sperm is 
also susceptible to diet. When the tRNA from high-fat-fed male mice was inserted into eggs 
fertilized by the sperm of lean males, the offspring went on to develop insulin resistance (Chen et 
al. 2016).  
 Maternal high-fat diet also has substantial effects on offspring, although our 
understanding of this has only begun to develop only in the last few decades. The prevailing 
view in the mid-1900s was that the fetus was a “perfect parasite,” shielded by the placenta from 
any dangerous substances in the mother’s body, including alcohol and cigarette smoke (Almond 
and Currie 2011). In the 1960s and 1970s, nearly half of pregnant women smoked (Abel 1980, 
Fertig 2010, CDC 2001), and in the 1980s, a third of women consumed alcohol during pregnancy 
(Serdula et al. 1991). Since the emergence of the fetal origins of adult disease hypothesis, the 
prevalence of smoking and drinking has dropped drastically: by the 2000s only 8.4% of pregnant 
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women smoked (Curtin and Matthews 2016), and alcohol consumption had dropped to 8-14% 
(Zhao et al. 2012). Now that we have a better understanding of the relationship between the 
mother, fetus, and environmental inputs, the next step is to reduce maternal obesity during 
pregnancy. 
 The fetal origins of adult disease hypothesis originated from research that Dr. David 
Barker published in the 1980s. Barker and colleagues compiled the birth weights of 5,654 men 
born in Hertfordshire, England between 1911-1930 and catalogued the cause of death in the over 
1,000 men who had died by 1987 (Barker et al. 1989). They found that men with the lowest 
weights at birth and one year of age had the highest death rates of ischemic heart disease (those 
weighing 18 lbs or less at one year had a 3 times higher rate of death from heart disease than 
those weighing at least 27 lbs), leading the authors to conclude that risk of heart disease is 
affected by processes influencing prenatal and early postnatal growth. Subsequent research 
extended the fetal origins hypothesis to include type 2 diabetes and hypertension (Hales et al. 
1991, Barker et al. 2002). 
 To specify the underlying mechanism, Barker proposed the thrifty phenotype hypothesis. 
This hypothesis states that exposure to poor nutrition in the prenatal and early postnatal 
environment permanently changes glucose and insulin metabolism, resulting in 
metabolic syndrome later in life (Hales and Barker 2001). While Barker’s thrifty phenotype 
hypothesis originally focused on the connection between low birth weight and adult 
cardiovascular disease, high birth weight has now been added to it. Many studies noted a U-
shaped curve, with both low and high birth weight infants having an increased risk of metabolic 
syndrome as adults (Pettitt and Jovanovic 2001, Harder et al. 2007). Compared to infants with 
intermediate birth weights, large for gestational age infants have higher BMIs as children, 
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adolescents, and adults (Skelton et al. 2014) 
 Maternal obesity during pregnancy is harmful to both a mother and her offspring. 
Negative effects to the mother include increasing the risk of: preeclampsia by 10-15% (Barton 
and Sibai 2008), gestational diabetes (while 2.3% of lean women develop gestational diabetes, 
the incidence is 4.8% in overweight women, 5.5% in obese women, and 11.5% in 
extremely obese women) (Kim et al. 2010), miscarriage (10.7% of lean women have at least one 
miscarriage, compared to 11.8% of overweight and 13.6% of obese women) (Boots and 
Stephenson 2011), gestational hypertension (affecting 5% of lean women, 10% of obese women, 
and 12% of morbidly obese women) (Weiss et al. 2004), C-section (21% of lean women have C-
sections, compared to 34% of obese and 47% of morbidly obese women) (Weiss et al. 2004), 
and longer time to dilate from 4 to 10 cm (6.2 hours for lean women compared to 7.5 for 
overweight and 7.9 hours for obese women) (Vahratian et al. 2004). 
 The risks to the offspring include stillbirth (the risk is 2-5 times higher with an obese 
mother, and 25% of stillbirths after 36 weeks of gestation are associated with obesity) (Yao et al. 
2014, Chu et al. 2007), neural tube defects (the odds ratios is 1.22 with an overweight mother, 
1.70 with an obese mother, and 3.11 with a severely obese mother) (Rasmussen et al. 2008), and 
being born large for gestational age (Weiss et al. 2004, Gaudet et al. 2014, Wang et al. 2015), 
which comes with an elevated risk of hypoglycemia and hypomagnesemia in utero, and 
cardiovascular disease and obesity later in life (Stirrat and Reynolds 2014). The effects of 
maternal obesity last through childhood, increasing the risk of childhood obesity (9% of 4-year-
olds with lean mothers were found to be obese, compared to 24% of those whose mothers were 
obese during pregnancy) (Whitaker 2004), increasing the levels of insulin, cholesterol, and blood 
pressure (Gaillard et al. 2014), and raising the risk of anxiety, attention deficit hyperactivity 
 8
disorder, and autism (Sullivan et al. 2014). As adults, people whose mothers were obese during 
pregnancy have a higher risk of cancer, cardiovascular disease, hypertension, and type 2 diabetes 
(Hochner et al. 2012, Eriksson et al. 2014, Stirrat and Reynolds 2014, Galliard 2015). 
 Maternal obesity can affect offspring development through a variety of mechanisms, 
including by altering the glucose consumption of oocytes (Jungheim et al. 2010, Leary et al. 
2015), causing the placenta to be inflamed and transport more glucose to the fetus (Bar et al. 
2012, Sferruzzi-Perri et al. 2013), and causing mitochondrial dysfunction (Igosheva et al. 2010, 
Luzzo et al. 2012, Grindler and Moley 2013). Saben et al. (2016) showed that feeding female 
mice a diet high in fat and sugar induced mitochondrial dysfunction in 3 generations of offspring, 
which appeared to be transmitted through mitochondrial abnormalities observed in the F1 and F2 
germ cells. Postnatally, one way that maternal obesity affects offspring is through lactation. 
Mouse dams fed a high-fat diet have higher levels of leptin and fat in their milk (Sun et al. 
2012), and maternal obesity delays the onset of lactogenesis II in women. This may be because 
obese women have a higher risk of edema, prolonged labor, dysfunctional labor, insulin 
imbalance, and C-sections, which are all associated with a delayed onset of lactogenesis 
(Babendure et al. 2015).  
 The present study is an investigation of a subset of non-genetic maternal effects. In 
Chapters 2 and 4, I studied the maternal effects a high-fat diet on offspring behavior and obesity. 
When maternal effects are present, the offspring’s phenotype is determined not only by its own 
environment and genetics, but by its mother’s environment and genetics as well. In some cases, 
the maternal environment that an individual experiences during development can have effects 
lasting throughout life. This is an important evolutionary strategy that helps some organisms 
cope with environmental heterogeneity. For instance, when seed beetle mothers are forced to lay 
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eggs on thick-coated seeds, they lay larger eggs to give the offspring enough energy provisions 
to bore through the seed (Fox et al. 1999). Females of many species can also manipulate the 
number of eggs they lay in a clutch, and female parasitic wasps, alligators, and collared 
flycatchers can manipulate offspring sex ratio to increase fitness based on environmental cues 
(Mousseau and Fox 1998). Maternal effects are not always adaptive, however, as in the case of 
prenatal metabolic programming of obesity in humans. Children of obese mothers have a higher 
future risk of insulin resistance, obesity, and cardiometabolic disease (Tam et al. 2014). One 
mechanism through which maternal effects can persist in offspring is via epigenetics. 
 When Conrad Waddington first coined the term ‘epigenetics,’ he used it to describe the 
developmental processes connecting genotype to phenotype (Waddington 1942). The meaning of 
the term has developed over the decades, and now usually specifically refers to factors other than 
DNA sequence that control gene expression, such as histone modifications, RNA interference, 
and DNA methylation. A textbook example of maternal diet affecting the methylation of 
offspring DNA involves the Avy allele of the agouti gene in mice. Normally agouti is expressed 
only in the skin and only during early development, but mice carrying the genetically dominant 
Avy allele continuously express agouti throughout the body and throughout development due to a 
cryptic promoter inserted by a transposable element, causing obesity and diabetes in adulthood 
(Miltenberger et al. 1997, Morgan et al. 1999). Expression of the agouti locus is directly 
correlated with the level of methylation at the cryptic promoter, which can be modulated by 
maternal diet. When an Avy/a dam is fed a diet rich in methyl-donors during pregnancy, her 
offspring are born with increased agouti methylation, reduced agouti expression, and they do not 
become obese as adults (Wolff et al. 1998, Waterland and Jirtle 2003, Waterland et al. 2004). It 
appears that genes with cryptic promoters are not the only ones affected epigenetically by 
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maternal diet. In humans, DNA sampled from cord blood reveals differences in methylation at 
several imprinted genes between newborns with obese parents versus those whose parents are 
not obese (Soubry et al. 2015), and children born after their mothers had gastric bypass surgery 
had methylation differences in over 5,000 genes compared to their siblings born before the 
weight-loss surgery, as well as lower BMIs (Guénard et al. 2013).  
 Many unanswered questions remain in the field of obesity epigenetics. Which genes 
become dysregulated by a high-fat diet? How are changes in DNA methylation associated with 
dysregulated gene expression? Which type of genomic regions do these diet-responsive 
methylated regions reside in? How are these factors affected by a prenatal maternal high-fat diet? 
How are the effects different in different tissues? How does a different genetic background 
influence the development of obesity? My dissertation attempts to answer some of these 
questions in the context of the inbred SM/J mouse strain, which is known to have an extensive 
obesogenic response to a high-fat diet (Cheverud et al. 1999, Ehrich et al. 2003, Partridge et al. 
2014). 
 Dietary fat has substantial, wide-ranging effects on the body. Some of these effects—
such as insulin resistance and weight gain—are better understood than others, such as anxiety 
and altered activity patterns. Chapter 2 of this dissertation investigates the effect that a maternal 
high-fat diet and an individual’s high-fat diet have on behavior. To determine whether dietary fat 
increased anxiety, I performed Open Field Testing on 98 high-fat-fed and low-fat-fed mice. I 
used an ethogram to measure behavior with instantaneous scan sampling, and rated the quality of 
the nests the mice built according to the Deacon Scale (Deacon 2006). Chapter 3 addresses the 
direct effect that an individual’s diet has on obesity traits, DNA methylation, and gene 
expression in the liver. Although circadian variation in DNA methylation can be an issue in the 
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brain (Azzi et al. 2014), there is little to none in the liver (Vollmers et al. 2012). I identified 
methylated regions, genes, and gene pathways that were dysregulated due to a high-fat diet. 
Chapter 4 takes this a step further by investigating the response of these traits to a maternal high-
fat diet. I discovered thousands of differentially methylated regions due to maternal diet and 
classified each region’s location in the genome, any regulatory elements it contained, the gene 
nearest to it, and whether the nearest gene had been previously associated with diabetes, obesity, 
or cardiovascular disease. I identified dozens of genes that were differentially expressed due to 
maternal diet and found which of these genes contained differentially methylated regions.  
 This dissertation adds to the field of obesity epigenetics in several ways. For financial 
reasons, most studies measure methylation and expression in only one tissue type, even though 
epigenetic changes due to diet differ across tissues. In Chapter 4, I measured methylation and 
expression in both the liver and the heart in the high-fat-fed daughters. And while most obesity 
studies take a candidate-gene approach to investigate methylation, I took a genome-wide 
approach and identified thousands of methylation changes across the genome, not only in genes 
and enhancers but in intergenic regions as well. Most mouse obesity research is conducted in 
C57BL/6 mice, but I used the less-studied SM/J strain, which allowed me to compare my 
findings with those of other studies to get a better picture of how genetic background affects 
gene expression, methylation, and obesity.  
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ABSTRACT 
 Research has shown that obesity alters certain aspects of behavior, and that maternal 
obesity can increase offspring risk of metabolic disease and anxiety. However, the extent to 
which behavior is impacted by both an individual’s diet and that of its mother is not well 
understood. In this study, I fed a high fat (HF) or low fat (LF) diet to genetically identical female 
SM/J mice and mated them with LF-fed males. I cross-fostered all offspring to LF-fed SM/J 
nurses and weaned them onto an HF or LF diet at 3 weeks of age. I then measured offspring 
anxiety with the Open Field Test, behavior with instantaneous scan sampling, and nest quality 
with the Deacon Scale. The offspring’s own diet had major behavioral effects. HF-fed mice had 
increased anxiety levels (they produced more fecal boli and urinations in the Open Field Test), 
built lower quality nests, and had lower activity levels in adulthood than LF-fed mice. The only 
trait that prenatal maternal diet affected was whether the offspring built their nests inside or 
outside a hut. Offspring diet, but not prenatal maternal diet, affected a wide range of behaviors in 
these mice.  
INTRODUCTION 
 Obesity is a systemic inflammatory condition that can induce extensive behavioral 
changes, in part due to its effect on the brain. Obesity is tightly linked to Alzheimer’s disease and 
other types of cognitive dysfunction in humans (Beydoun et al. 2008), and is associated with 
lower cognitive performance in men based on tests of learning and memory (Elias et al. 2003). 
Obesity’s effects in mice include increased anxiety (Sharma and Fulton 2013, André et al. 2014), 
diminished spatial memory (André et al. 2014), reduced object-location memory (Heyward et al. 
2012), impaired learning of contextual fear conditioning and passive avoidance (Hwang et al. 
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2010), and increased depressive-like behavior (Sharma and Fulton 2013). André et al. (2014) 
found that obese C57BL/6 mice had impaired spatial working memory and increased anxiety 
behavior in the Elevated Plus Maze. High-fat-fed C57BL/6J mice also showed increased 
depressive-like behavior in the Forced Swim Test in addition to increased anxiety in the Elevated 
Plus Maze and Open Field Test (Sharma and Fulton 2013). Even when lean male C57BL/6J mice 
were given gut microbiota from obese mice, they had reduced exploratory behavior and 
increased anxiety (Bruce-Keller et al. 2015). Certain behaviors can lead to obesity, but these 
studies illustrate that obesity can also alter behavior.  
 Compounding its consequences for public health, the effects of obesity are not limited to 
one generation. Children of obese mothers have a higher future risk of insulin resistance, obesity, 
and cardiometabolic disease (Tam et al. 2014). But while much attention has been paid to how 
maternal obesity affects offspring risk of metabolic disease, its impact on offspring behavior is 
only recently beginning to be understood.  
 From rodents to humans, maternal obesity during pregnancy fundamentally alters the 
neurological programming that regulates behavior. In humans, this results in an increased risk of 
offspring anxiety, attention deficit hyperactivity disorder, and autism (Sullivan et al. 2014). In 
rodents, offspring of obese dams exhibit significant deficits in reversal learning accompanied by 
striatal disturbance (Wu et al. 2013), as well as long-term impairments in spatial learning thought 
to be caused by reduced hippocampal production of brain-derived neurotrophic factor (BDNF), 
which is critical for spatial learning and memory (Tozuka et al. 2010).  
 Several mechanisms have been suggested for how maternal obesity impacts offspring 
behavior. One indirect route is through maternal behavior: high-fat-fed rat dams nurse their 
young more, which can lead to over-eating behavior later in life (Bertino 1982). In humans, 
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parental eating habits can influence children’s eating habits (Savage et al. 2007). Evidence for a 
hormonal aspect of transmission is provided by studies such as Rodriguez et al. (2012), where 
pregnant high-fat-fed rat dams had elevated levels of corticosterone during pregnancy and whose 
offspring had learning deficits. Maternal steroids can disrupt fetal development when they pass 
through the placenta, which may account for the impaired learning exhibited by the rat offspring 
in that study. Maternal obesity also affects offspring behavior through inflammation. Obesity is 
associated with chronically elevated levels of inflammatory cytokines, which are known to affect 
the serotonergic and dopaminergic systems (Mehta et al. 2014). Exposure to maternal cytokines 
in the womb has been shown to have a neuroinflammatory effect on offspring. Bilbo and Tsang 
(2010) found that rats born to obese mothers had inflammation of the hippocampus and increased 
anxiety as adults. Similarly, Kang et al. (2014) found that female mice born to mothers on a 
high-fat diet exhibited higher levels of anxiety, brain tissue inflammation, and inflammatory 
cytokines. The researchers concluded that the results supported a link between inflammatory 
cytokines and behavioral changes due to maternal diet. 
 The effects of a maternal high-fat diet on behavior are complex and ambiguous, and its 
impact on offspring anxiety is far from resolved in the field (Table 2.1). In some cases, maternal 
high-fat diet is credited with increasing anxiety in offspring (Kang et al. 2014, Peleg-Raibstein et 
al. 2012, Bilbo and Tsang 2010), while in others it has been shown to have an anxiolytic effect 
(Rodriguez et al. 2012, Sasaki et al. 2014, Bellisario et al. 2014, Wright et al. 2011). This 
discrepancy can be attributed to several causes, including the fact that behavior is a highly 
variable and notoriously difficult trait to measure, the small sample sizes that are often used in 
these types of experiments, the variation in the fat content of high-fat diets (ranging from 16% to 
60% of calories from fat), the multitude of tools being used to measure anxiety, and the lack of 
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standardization in how these tools are used. 
 Common tools for measuring anxiety in rodents are the Elevated Plus Maze, the Open 
Field Test, the Light/Dark Box, and the Water Maze. When researchers use multiple tests in a 
study, oftentimes one test shows no difference in anxiety traits while another does. For instance, 
while not finding an effect of maternal diet in the Open Field Test, Peleg-Raibstein et al. (2012) 
did find increased anxiety behavior as measured by the Elevated Plus Maze and a test of food 
neophobia. This contrasted with Rodriguez et al. (2012), who found no effects of maternal high-
fat diet in the Elevated Plus Maze but did find an effect in the Open Field Test. These 
discrepancies suggest that conclusions drawn about the effect of a maternal high-fat diet on 
anxiety can be highly inconsistent. 
 The results from a timed test like the Open Field Test are difficult to compare across 
studies, because the duration of the test varies. In studies of maternal obesity the test has been 
run for 5 minutes (Wright et al. 2011, Ramírez-López et al. 2016), 10 minutes (Fernandez et al. 
2012, Rodriguez et al. 2012), 15 minutes (Kang et al. 2014, Bellisario et al. 2014, Sasaki et al. 
2014), and one hour (Peleg-Raibstein et al. 2012). Anxiety traits measured in the Open Field 
Test include the number of fecal boli and urination events, the degree of thigmotaxis (wall-
hugging), and the number of rears (standing on hind legs). Higher values for each of these traits 
indicate higher anxiety levels; however, results can be mixed and interpreted in different ways. 
For instance, Fernandes et al. (2012) found that exposure to a maternal high-fat diet resulted in 
adult male C57BL/6J mice (n = 9) traveling further and rearing more in the outer zone of the 
Open Field arena compared to control males (n = 8), but they concluded that there were no 
differences in anxiety in the mice. Kang et al. (2014) found that in C57BL/6J mice, the sons 
traveled further (n = 28), the daughters exhibited more thigmotaxis (n = 29), and both sexes 
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reared more if they had high-fat-fed mothers, concluding that maternal high-fat diet induces 
offspring anxiety. However, researchers found the opposite in Wistar rats with high-fat-fed 
mothers (n = 6), who displayed less thigmotaxis in the Open Field Test than rats with mothers on 
a control diet (Rodriguez et al. 2012), as well as in Long Evans rats with high-fat-fed mothers (n 
= 20), who had more entries into the center arena, indicating lower levels of anxiety (Sasaki et al. 
2014).  
 Even less is understood about the effect of maternal high-fat diet on offspring activity 
levels, as few studies have investigated this. Maternal high-fat diet was found to decrease 
locomotor activity in daughters (with no effect in sons) in Sprague-Dawley rats (Khan et al. 
2003), but it increased locomotor activity in one of three mouse strains in an Open Field Test and 
in all three strains during a swim test (Raygada et al. 1998). More research must be done to 
understand the direction and magnitude of the effect of maternal obesity on offspring activity 
levels, if indeed there is a consistent effect. In humans, it has become clear that children’s diet, 
behavior, and weight are influenced by those of their parents through non-genetic mechanisms 
(Oken 2009, Skouteris et al. 2011). However, it is challenging to determine how much of this is 
due to the prenatal environment versus the postnatal environment, which makes it difficult to 
know the most effective time to target health interventions. It is far more feasible to investigate 
this phenomenon with a cross-fostering design in mice, as I have done in the present experiment. 
Here, I studied the effect of maternal high-fat diet during pregnancy, while controlling for 
postnatal environment by cross-fostering all pups to a low-fat-fed SM/J nurse.  
 In this study I also investigated nest building, since it plays an important role in the 
fitness of mice and has been used to assess their well-being (Jirkof 2014). Carter et al. (2000) 
showed that nest size is correlated with locomotor activity, where mice selected for high levels of 
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voluntary wheel running built smaller nests. Nests are important for thermoregulation, and both 
males and females build them (Deacon 2006). Mouse pups particularly rely on nests, since they 
are born hairless and nests reduce heat loss (Gaskill et al. 2013). Nest quality affects mouse 
fitness, as illustrated by Lynch (1980) who found that mice selected for poor nest building 
became less fertile over 15 generations, whereas mice selected for good nest building became 
more fertile and increased their litter size and body weight. A more recent study revealed that 
mice in cages lacking enrichment materials for hiding and nest building produced pups that 
weighed less and had lower survival rates to weaning age (Whitaker et al. 2009). Several 
quantitative trait loci have been identified that contribute to genetic variation in nest building 
(Sauce et al. 2012). In addition to genetics, nest building is affected by hormones (Lisk et al. 
1969, Bond et al. 2002) and lesions on the hippocampus, which are also both known to be 
disrupted by obesity (Stranahan et al. 2008, Kanoski et al. 2011). In fact, maternal obesity has 
been shown to alter hippocampal gene expression in offspring and to impair their spatial learning 
(Tozuka et al. 2010). Because of this potential connection between obesity and nest building, I 
tested whether a mouse’s diet and mother’s diet affected nest quality. By measuring the 
offspring’s nest building, activity levels, and anxiety, I have generated a fuller picture of the 
effect of dietary fat on behavior.  
METHODS 
Animal Rearing 
 I used the inbred SM/J mouse strain from The Jackson Laboratory (Bar Harbor, Maine) 
which has been shown to be hyper-responsive to a high fat (HF) diet (Cheverud et al. 1999, 
Ehrich et al. 2003, Partridge et al. 2014). Using a strain with maximal response to an HF diet 
increases our power to detect effects. At three weeks of age, 30 male mice and 15 female mice 
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were weaned onto a low fat (LF) diet, and 15 female mice were weaned onto an HF diet to create 
an F0 generation. In the LF diet, 15% of the calories came from fat (Research Diets D12284), 
whereas 42% of the calories came from fat in the HF diet (Harlan Teklad diet TD.88137) (Table 
2.2). An LF diet was used instead of standard mouse chow because it was specifically tailored to 
have nearly the same number of calories per gram as the HF diet. Erich et al. (2003) has shown 
that SM/J mice consume the same amount of food whether they are on the HF diet or the LF diet. 
The F0 mice were raised for 7 weeks on the diet and then mated. To limit paternal effects, sires 
were removed from the cages after abdominal palpation revealed the dam to be pregnant. To 
avoid confounding the prenatal and postnatal maternal obesity effects, all pups were cross-
fostered within 24 hours of birth to an LF-fed SM/J nurse. Pups born to LF mothers were also 
cross-fostered to an LF nurse to control for the effect of cross-fostering. Half of the pups from 
each litter were weaned onto an HF diet and the other half onto an LF diet. This produced four F1 
diet treatment groups: HF-HF, LF-HF, HF-LF, and LF-LF, where the first diet listed is the 
mother’s diet and the second diet listed is the offspring’s diet (Figure 2.1). Ten to 15 offspring of 
each sex were assigned to each diet treatment group, for a total of 98 F1 mice. After weaning, 
each mouse was housed with one other mouse of the same sex and diet in a cage that contained a 
wooden gnawing block (Bio Serve), a red privacy hut (Alt Design), a 2” x 2” cotton nestlet for 
nesting material (Ancare), and food and water ad libitum. Procedures followed an approved 
Institutional Animal Care and Use Committee protocol (Project #1188). 
Open Field Test 
 The Open Field Test was conducted using a 17.5” (L) x 13” (W) x 15” (H) opaque plastic 
box with a grid on the floor that subdivided it into 48 rectangles measuring 2.16” x 2.18” each 
(Figure 2.2). The mice were brought into the testing room at 9:00 am and allowed to acclimate, 
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with testing beginning at 11:30 am. Open Field Tests are short in duration to assess exploratory 
behavior and response to a novel environment rather than baseline activity levels (Gould et al. 
2009). To reduce exposure to other types of novelty, no cage changes were performed within 24 
hours prior to testing, and the entire arena was sanitized with 70% ethanol after each mouse was 
tested. A 10-week old mouse was then placed into a corner of the arena, and the mouse’s 
movements were observed and video recorded for 5 minutes by 1-2 female researchers. I note 
that the researchers were female because Sorge et al. (2014) showed that male experimenters 
induce a stress response in mice and rats, which includes increasing fecal boli production. I 
collected the following measurements in the Open Field Test: the number of times the mouse 
reared, the number of times the mouse crossed any of the 8 squares in the center of the arena, the 
total number of squares the mouse crossed, the number of times the mouse urinated, and the 
number of fecal boli produced. The number of squares crossed was determined by reviewing the 
video of the session, because the mice often moved too quickly to count the squares with the 
unaided eye. The center:total distance ratio was calculated by dividing the number of center 
squares crossed by the total number of squares crossed. A low center:total distance ratio and high 
levels of rearing, urination, and fecal boli production were interpreted as indicators of anxiety.  
Ethogram Data 
 A behavioral ethogram was created by listing all mouse behaviors witnessed during 5 
hours of observation, for a total of 19 behaviors (Table 2.3). The offspring were observed 3-4 
times per week, and the observation times were categorized as a morning session (between 8:00 
and 10:30 am) or an afternoon session (between 2:30 and 5:00 pm). Each session consisted of 20 
observations by instantaneous scan sampling. Specifically, a researcher marked on the ethogram 
checklist which behavior the mouse was performing at the instant it was observed, then moved 
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on to the next mouse, and continued until all of the mice had been observed once. The observer 
then returned to the first mouse and checked off the behavior it was then performing, completing 
this cycle 20 times. The mice were observed for an average of 26 sessions between the ages of 3-
14 weeks. Since some mice were observed more than others, I calculated an average of each 
behavior per age group for analysis (3-5 weeks, 6-8 weeks, 9-11 weeks, and 12-14 weeks). 
Nest Quality 
 At 13 weeks of age, each mouse was housed alone in a fresh cage and given a 2” x 2” 
cotton nestlet. Twenty-four hours later, a photograph was taken of the nest that the mouse had 
built and it was rated for quality using the Deacon Scale, which ranges from 1 to 5 (Deacon 
2006). A Deacon score of 1 indicates a poor quality nest, where over 90% of the nestlet remains 
unused; a score of 2 means that 50-90% of the nestlet is still intact; 3 indicates the nestlet is 
mostly shredded but there is no identifiable nest site; 4 means that more than 90% of the nestlet 
is torn and the nest walls are higher than the mouse’s body; and a score of 5 is a near perfect nest 
(Deacon 2006). Since there was a privacy hut in the cage, I also noted whether the nest was built 
inside of the hut or outside of it.  
Statistical Analysis 
 The behavior data were not normally distributed, as determined by the Shapiro-Wilk test 
of normality. I thus used a non-parametric approach, the Kruskal-Wallis test, for the analysis. I 
also randomized the relevant phenotypes over the factors to obtain a null distribution of ANOVA 
parameters under the hypothesis of no treatment effects on the phenotypes. Using just the 
offspring of HF mothers, I randomized the trait values 9,999 times, then tested the difference 
between the LF- and HF-fed offspring using a 2-sample t-test for each behavior, and compared 
the t-test statistic from the observed values to those of the randomized values. I did another 
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randomization to determine if offspring sex had a significant effect on behavior. I repeated this 
procedure for the offspring of LF mothers. The t-test statistics for each of these tests were 
normally distributed, even though the raw data were not. The p-values from the randomization 
procedure were nearly identical to those resulting from an ANOVA. Since the ANOVA was so 
robust to the non-normally distributed data, I report those p-values. For each set of traits (Open 
Field Test, ethogram, and nest quality) I ran a General Linear Model in SYSTAT (Version 12, 
Systat Software, San Jose, CA) to test the full model, which included the effects of maternal diet, 
offspring diet, offspring sex, nurse ID, parity, and their two- and three-way interactions. For the 
ethogram data I also included age period in the model. I then ran a reduced model for the 
ethogram data that included just nurse, offspring diet, and age period, since those were the only 
three variables with a statistically significant effect.  
RESULTS 
Open Field Test 
  The direct effects of an offspring’s diet had a significant effect on the Open Field Test 
traits. Both urination frequency (p = 0.018) and fecal boli production (p = 0.040) were 
significantly different between the four diet-sex groups based on the Kruskal-Wallis test. A 
general linear model revealed that offspring diet was significant on a multivariate level (p = 
0.028), as well as for the individual traits of urination frequency (p = 0.007) and fecal boli 
production (p = 0.042). The average urination frequency was 3.8 times higher in HF-fed females 
and 1.9 times higher in HF-fed males compared to mice on an LF diet (Figure 2.4A). The 
average fecal boli production was more than 4 times higher in mice on an HF diet than those on 
an LF diet for both sexes (Figure 2.4B). The two diets had equal fiber content, so this was not a 
factor in the difference in fecal boli production.  
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 Prenatal maternal diet did not have much of an effect on anxiety. There were 8 groups of 
offspring based on their sex, their mother’s diet, and their own diet, and the only Open Field Test 
trait that the eight groups differed significantly for was urination frequency (p = 0.039) based on 
the Kruskal-Wallis test. A maternal HF diet did appear to increase urination frequency in HF 
sons (1.2 average urinations) compared to LF sons (0.42 average urinations), but a t-test showed 
only borderline significance (p = 0.058) so this result was interpreted with caution (Figure 2.3). 
A general linear model run on the Open Field Test traits indicated again that maternal diet was 
only borderline significant on the multivariate level (p = 0.054). 
Ethogram Data 
 Testing the full model revealed that offspring diet (p = 4.60 x 10-8), age period (p = 2.08 
x 10-10), and nurse ID (p = 0.01) had statistically significant effects on the offspring ethogram 
traits. Since sex did not have a significant effect, the males and females were analyzed together. 
Maternal diet also did not have significant effect. The fact that nurse ID was significant means 
that even though all pups were cross-fostered to genetically identical LF-fed SM/J nurses, the 
nurses differed in some other way that had a lasting impact on their fostered offspring, no matter 
what diet the offspring or the biological mother had. This random environmental maternal effect 
could be an interesting avenue to explore in a future study, but in the present study I controlled 
for it by including nurse ID in the model.  
 The most commonly observed behaviors in the mice were sleeping (62.5% of the time), 
autogrooming (7.4%), climbing on the ceiling bars (7.4%), walking (5.9%), and eating (3.7%). 
Many of the behaviors were performed too infrequently to detect much of a difference due to 
diet. For example, behaviors observed less than 1% of the time were: motionless but alert, being 
groomed, rearing, drinking, gnawing, digging, carrying, nesting, allogrooming, running, fighting, 
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and mounting. To incorporate these rare behaviors into the analysis in a more meaningful way, in 
addition to analyzing the individual behaviors, I grouped them into four larger behavior 
categories: self maintenance (drinking, eating, and autogrooming), inactive (sleeping, resting, 
motionless but alert, and sitting), exploring (walking, climbing on the ceiling bars, gnawing, 
digging, carrying, nest arrangement, running, and rearing), and social interaction (allogrooming, 
being groomed, fighting, and mounting) (Table 2.3). I calculated the average percent of time a 
mouse spent performing behaviors in these four categories during each of four age periods for 
which each animal was observed (3-5 weeks, 6-8 weeks, 9-11 weeks, and 12-14 weeks). The 
Social Interaction category could be analyzed only for the first three age period groups, because 
the mice were housed in pairs until 12 weeks of age, after which they were housed individually 
to measure nest-building ability. 
 HF-fed offspring spent less time performing self-maintenance behaviors than LF-fed 
mice at all four age periods (Figure 2.5A). Although they differed in self-maintenance early on, 
significant differences in other behaviors did not manifest until later in life. The mice spent an 
equal amount of time exploring the cage until 12-14 weeks of age, when LF mice increased their 
time exploring and HF mice decreased it (p = 0.0001). This change meant that HF mice explored 
only half as often as LF mice in adulthood (Figure 2.5B). Instead of performing self-maintenance 
and exploration behaviors as often, the HF mice spent more time being inactive as adults. Mice 
on an LF diet became more active with age (they were inactive 75.8% of the time at 3-6 weeks 
old, and 66.6% of the time at 12-14 weeks old), whereas mice on an HF diet never increased 
their activity levels (they were inactive 80% of the time at both 3-6 weeks and 12-14 weeks of 
age) (Figure 2.5C). The difference in activity levels between the two diet groups became 
detectable at 9-11 weeks of age (p = 0.026), but weight differences were detectable at 4 weeks, 
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indicating that the reduced activity levels followed the weight gain from an HF diet. Neither 
group of mice performed social interaction behaviors frequently, but at 9-11 weeks of age the HF 
mice performed them significantly more often than the LF mice (1% of the time versus 0.2% of 
the time, p = 0.003) (Figure 2.5D). This was not due to differences in fighting or mounting, but 
rather because the HF mice spent more time grooming each other (p = 0.005) and being groomed 
(p = 0.025) as adults.  
 The differences in the four behavior summary categories appear to be primarily driven by 
a significant difference in the following individual behaviors at 12-14 weeks of age: sleeping, 
climbing on the ceiling, and walking, with HF-fed mice sleeping more and climbing and walking 
less than LF-fed mice (Figure 2.6). 
Nest Quality 
 Mice on an HF diet built poorer quality nests than mice on an LF diet (p = 0.040) (Figure 
2.7B). The difference was driven by the males, where HF-fed males scored an average of 2.8 out 
of 5 on the Deacon scale, compared to 3.8 for LF-fed males. Maternal diet did not affect the 
offspring’s Deacon score, although it did affect where they built their nests. Regardless of their 
own diets, offspring of LF mothers were 2.5 to 3.5 times more likely to build their nests inside 
the hut than offspring of HF diet mothers (p = 0.020) (Figure 2.7A). In other words, having an 
HF-fed mother reduced the offspring’s probability of building a nest inside the hut (11% of 
offspring of HF-fed mothers built their nests inside the hut, compared to 38% of offspring of LF-
fed mothers). Although offspring diet did not significantly affect where the nests were built (p = 
0.075), it is interesting to note that a paired t-test of just the sons shows that HF-fed sons built 
their nests inside the hut less often (p = 0.021) (Figure 2.7C). 
DISCUSSION 
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 A high fat (HF) diet in offspring induced anxiety, reduced levels of activity and 
exploration, and reduced nest quality, indicating that diet influences a wide range of behaviors in 
mice. This is generally similar to findings in previous studies (Sharma and Fulton 2013, André et 
al. 2014, Hwang et al. 2010, Bruce-Keller et al. 2015). 
 In the Open Field Test, the higher levels of urination and fecal boli production in both 
sexes of HF-fed mice support the hypothesis that obesity increases anxiety. However, there was 
no difference in rearing or the center:total squares ratio between the diet treatment groups, 
indicating a limited manifestation of this anxiety. The results of the Open Field Test can be 
difficult to compare across studies, since rodents may show a significant difference in only one 
or two of the multiple anxiety measures, and there is not a standardized way of interpreting the 
collective findings. In the present study, the mice showed increased anxiety for two of the five 
measures. Although I found no effect of an HF diet on the number of squares crossed in the 
center of the arena, Bruce-Keller et al. (2015) found that HF-fed male mice (n = 10) spent less 
time in the inner zone of the Open Field Test than LF-chow-fed mice (n = 10), with the total 
distance traveled unchanged. Similarly, Sharma and Fulton (2013) found that HF-fed mice (n = 
8) entered the inner zone less often and spent less time in it than LF-fed mice (n = 8). Both of 
those studies were conducted with C57BL/6J mice, whereas ours was with SM/J mice, so it is 
possible that the manifestation of anxiety is dependent on genetic background. Nevertheless, 
although different aspects of the Open Field Test came out as significant in these studies, all of 
them detected increased anxiety due to an HF diet.  
 In addition to being more anxious, HF mice performed fewer self-maintenance behaviors 
at all ages, and by 11 weeks of age they explored the cage half as often and were far less active 
than low-fat (LF) mice. In fact, while LF mice became more active as they aged, HF mice 
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became less active. HF mice slept significantly more and spent less time walking and climbing as 
adults. The lower activity levels in HF mice developed several weeks after they began to weigh 
more than the LF mice. This suggests that weight gain can lead to inactivity, and not just the 
other way around. The reduced activity levels in the HF-fed mice may compound the effect of 
the diet to lead to further weight gain.  
 The mice on an HF diet also built poorer quality nests. This could potentially be 
influenced by several factors, such as thermoregulatory changes due to obesity, hormonal 
changes, the observed reduction in activity levels, or alterations in brain regions known both to 
affect nesting behavior and be impaired by obesity, such as the hippocampus.  
 An HF diet has a definitive effect on behavior in SM/J mice, while maternal prenatal HF 
diet has little effect on offspring behavior. However, there was a significant effect of nurse ID on 
offspring behavior, despite the nurses all being genetically identical and LF-fed. This 
environmental maternal effect persisted through adulthood, indicating that the rearing and 
lactation environment has a lasting effect on murine behavior, more so than the prenatal maternal 
diet. 
 Findings on the effect that maternal obesity has on offspring anxiety are varied in 
rodents, ranging from an anxiolytic effect to an anxiety-inducing effect. The present study 
revealed no effect of maternal diet on offspring anxiety in the Open Field Test, other than a 
marginal increase in urination in HF sons. If there is an effect of maternal diet, the effect size 
must be small, as our sample size gave us 80% power to detect differences of 0.4 residual 
standard deviation units. By not detecting an effect of maternal obesity on anxiety, my findings 
suggest that the effect of maternal diet identified in other rodent studies may principally be due 
to postnatal maternal diet, since I only varied prenatal diet. This is supported by an experiment 
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by Kang et al. (2014), who found that the increased anxiety in mice with HF mothers was 
reduced in those whose mothers were transferred to a control diet during lactation. Postnatal 
maternal diet in rodents may thus have a stronger effect on offspring behavior than prenatal diet. 
If this scales up to humans, it would support there being a strong emphasis on postnatal maternal 
dietary interventions for obesity and not just prenatal ones. 
 Maternal diet did not affect the offspring’s behavior patterns as measured by 
instantaneous scan sampling, consistent with the outcome of the Open Field Test. It did, 
however, have an unexpected effect on offspring nesting behavior. Mice with mothers on an HF 
diet were less likely to build their nests inside huts (not a single HF-fed male with a HF mother 
built a nest inside the hut). The connection between maternal HF diet and building nests outside  
huts is unclear. Perhaps thermoregulation plays a role, although maternal diet only affected the 
weight of HF daughters and not of LF daughters or sons (data shown in Chapter 3). 
Alternatively, anxiety could play a role if having a nest separate from the hut provides a second 
hiding place. This has yet to be established, however.  
 While this study did not investigate the effects of an HF diet on parenting behavior, the 
lasting effect of nurse ID as well as the observed changes in behavior due to dietary fat give 
reason to predict that parental HF diet could have major effects on the pups. For instance, pup 
survival could be reduced if the father and mother’s poorer nest building failed to keep the pups 
warm and hidden from predators. Higher levels of inactivity in the mothers could lead to a 
reduction in pup grooming and arch-backed nursing, which would negatively affect offspring 
weight. Higher levels of maternal anxiety could increase offspring stress response into 
adulthood, as seen in rats (Liu et al. 1997). It will be important in the future to study the effect of 
a postnatal maternal HF diet and to determine its underlying mechanisms. In the meantime, it is 
 36
clear that an individual mouse’s own diet affects a vast array of behaviors—including anxiety, 
nest building, and activity patterns—while prenatal maternal diet does not.  
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TABLES AND FIGURES 
Study Species (Strain) 
Maternal Diet 
Conclusion 
Length of Time on 
Maternal Diet Diet attributes 
Offspring sample 
size 
Kang et al. 
(2014) 
Mice  
(C57BL/6J) 
Induces anxiety 
Gestation and 
lactation 
HF (60% cal 
from fat) vs. C 
(10% cal from 
fat) 
22 C ♂, 21 HF ♂, 
7 HF-C (lactation) 
♂, 30 C ♀, 16 HF 
♀, 13 HF-C 
(lactation) ♀ 
Fernandes et 
al. (2012) 
Mice 
(C57BL/6J) 
No effect on 
anxiety (but 
induced 
hyperactivity) 
6 weeks prior to 
pregnancy, through 
lactation 
Western diet 
(16% fat, 33% 
sugar) vs. C 
9 HF ♂, 8 C ♂ (all 
raised on C diet) 
Rodriguez et 
al. (2012) 
Rats (Wistar) Anxiolytic 
Gestation and 
lactation 
HF (25% cal 
from fat) vs. C 
(5% cal from fat) 
6 HF ♂, 6 C ♂ (all 
on C diet) 
Bellisario et 
al. (2014) 
Mice (P66Shc 
WT and KO on 
C57BL/6J 
background) 
Anxiolytic in 
daughters, 
anxiety inducing 
in sons 
10 weeks prior to 
mating until 3 days 
prior to giving birth 
HF (58% cal 
from fat) vs. C 
(10.5 % cal from 
fat) vs. Standard 
Diet (17% cal 
from fat) 
15 HF-wt (10 ♀, 
11 ♂), 16 C-wt (15 
♀, 10 ♂), n=12 for 
the OFT 
Peleg-
Raibstein et 
al. (2012) 
Mice 
(C57BL/6N) 
Induces anxiety 
3 weeks prior to 
mating, through 
lactation 
HF (60% cal 
from fat) vs. 
chow 
12 HF ♂, 9 HF ♀, 
12 C ♂, 10 C ♀ 
Bilbo and 
Tsang (2010) 
Rats (Sprague-
Dawley) 
Induces anxiety 
4 weeks prior to 
mating, through 
lactation 
High-saturated-
fat (60% cal from 
fat) vs. high-
trans-fat (60% 
cal from fat) vs. 
C (10% cal from 
fat) 
8 per group 
Sasaki et al. 
(2014) 
Rats (Long 
Evans) 
Anxiolytic 
4 weeks prior to 
mating, through 
lactation 
HF (60% cal 
from fat) vs. C 
(13.5% fat) 
13 HF ♀, 7 HF ♂, 
13 C ♀, 13 C ♂ 
Wright et al. 
(2011) 
Rats (Wistar) Anxiolytic 
8 weeks prior to 
mating, then some 
switched to chow 
Cafeteria diet, 
different each 
day, % fat not 
reported 
5-12 per group 
Ramírez-
López et al. 
2016 
Rats (Wistar) Induces anxiety 
8 weeks prior to 
mating, then 
throughout 
pregnancy and 
lactation 
Chow vs. free-
choice of chow 
and cafeteria diet 
(chocolate) 
(24.45% cals 
from fat) 
15 from chow 
moms, 17 from 
free-choice moms, 
all weaned on 
chow 
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Study 
Length 
of OFT 
OFT total 
distance 
traveled 
OFT 
Center:total 
ratio 
OFT Time 
in Center 
OFT 
Rearing 
OFT 
boarder 
entries 
Elevated Plus 
Maze 
Kang et al. 
(2014) 
15 min 
Increased in 
♂, NS in ♀ 
NS in ♂, 
lower in ♀ 
NA 
Increased 
in both 
sexes  
NA NA 
Fernandes et 
al. (2012) 
10 min 
Traveled 
more 
NA No diff 
Increased 
(in outer 
part) 
NA NA 
Rodriguez et 
al. (2012) 
10 min 
No diff in ♂, 
♀ not tested 
NA 
No diff in 
♂, ♀ not 
tested 
NA 
Increased 
in HF ♂, 
♀ not 
tested 
No diff 
Bellisario et 
al. (2014) 
Three 5- 
min 
intervals 
HF ♂ and 
daughters 
traveled less 
NA No diff NA NA 
HF ♂ more 
anxious 
(groomed more, 
immobile more), 
♀ less anxious 
(immobile less) 
Peleg-
Raibstein et 
al. (2012) 
1 hr No diff NA NA NA NA 
More anxious 
(spent less time 
in open arms) 
Bilbo and 
Tsang (2010) 
NA NA NA NA NA NA 
SFD and TFD ♂ 
spent less time in 
the open arms 
Sasaki et al. 
(2014) 
15 min NA 
HF offspring 
had a higher 
ratio 
NA NA NA 
HF offspring 
entered the open 
arms more 
Wright et al. 
(2011) 
5 min 
Pregnancy 
diet: no diff 
Lactation 
diet: reduced 
tot distance 
traveled in 
♂ (no diff in 
♀) 
NA 
♂ entered 
center 
sooner (no 
diff in ♀) 
Pregnancy 
diet: ♂ 
increased  
Lactation 
diet: ♂ 
decreased 
(♀ 
decreased 
for both) 
NA 
Reduced 
locomotor 
activity in ♂ and 
♀, reduced 
grooming in ♂ 
Ramírez-
López et al. 
2016 
5 min 
No diff in 
total 
distance 
traveled or 
mean speed 
NA 
Offspring 
from free-
choice 
dams spent 
less time in 
center of 
arena 
NA No diff 
Offspring of 
free-choice dams 
spent less time in 
open arms, 
entered less often 
into the open 
arms, spent more 
time in closed 
arms and entered 
the closed arms 
more 
Table 2.1 Compilation of the literature studying the effect of maternal high-fat diet on anxiety in 
rodent offspring. HF = High-fat diet, C = Control diet, WT = Wild Type, KO = Knock-Out, Cal 
= Calories, OFT = Open Field Test, NS = Not Significant, diff = difference. 
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Table 2.2. Composition of diets. 
 
 
 
 
Figure 2.1. Breeding design.  
 
 
 
Figure 2.2. Diagram of the Open Field Test arena. 
 
Component High-fat diet Low-fat diet 
Energy from fat, % 42 15 
Casein, g/kg 195 197 
Sugars, g/kg 341 307 
Corn starch, g/kg 150 313 
Cellulose, g/kg 50 30 
Corn oil, g/kg 0 58 
Hydrogenated 
coconut oil, g/kg 
0 7 
Anhydrous milk fat, 
g/kg 
210 0 
Cholesterol, g/kg 1.5 0 
Kilojoules per gram 18.95 16.99 
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Table 2.3. This table indicates how the 19 ethogram behaviors were grouped into 4 larger 
behavioral categories. It shows the average percent of time that mice on a high-fat diet and mice 
on a low-fat diet were observed performing behaviors in each of these summary categories at 
each of the four age periods. Since sex did not have a significant effect on the behaviors, males 
and females were analyzed together. The p-values are from an ANOVA showing the effect of 
nurse ID and offspring diet on the summary ethogram categories. Nurse ID affected how often 
the mice performed self-maintenance, inactive, and exploration behaviors throughout their lives. 
Offspring diet affected self-maintenance behaviors throughout life, and inactive, exploration, and 
social interaction behaviors later in adulthood. 
Behavior 
Category 
Factor 
Age  
3-5 weeks 
Age 
6-8 weeks 
Age 
9-11 weeks 
Age 
12-14 weeks 
Self 
maintenance 
(drinking, eating, 
autogrooming) 
High fat avg 7.3% 6.2% 6.7% 10.0% 
Low fat avg 12.1% 10.8% 14.6% 13.4% 
Offspring Diet 0.00864 0.0134 8.00E-04 8.60E-04 
Nurse 0.00178 0.00066 0.36662 0.00126 
Inactive 
(resting, 
motionless but 
alert, sitting, 
sleeping) 
High fat avg 80.6% 81.7% 75.4% 79.8% 
Low fat avg 75.8% 77.3% 67.5% 66.6% 
Offspring Diet 0.10326 0.64236 2.58E-02 0.00001 
Nurse 0.00002 0.02823 0.00897 1.17E-06 
Explore 
(gnawing, 
digging, carrying, 
nest arrangement, 
climbing, 
running, rearing, 
walking) 
High fat avg 11.5% 11.8% 16.9% 10.1% 
Low fat avg 11.7% 11.7% 17.7% 19.8% 
Offspring Diet 0.56773 0.51643 0.17565 0.00012 
Nurse 
 
 
0.00002 
 
 
0.1679 
 
 
0.00005 
 
 
2.96E-09 
 
 
Social 
interaction 
(allogrooming, 
being groomed, 
fighting, 
mounting) 
High fat avg 0.7% 0.3% 1.0% NA 
Low fat avg 0.4% 0.3% 0.2% NA 
Offspring Diet 0.12934 0.50193 0.00333 NA 
Nurse 
 
0.17361 
 
0.57082 
 
0.10353 
 
NA 
 
  Sample size 
n = 36 HF  
41 LF   
n = 35 HF 
40 LF 
n = 36 HF  
35 LF 
n = 35 HF 
38 LF 
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Figure 2.3. In the Open Field Test, high fat male mice born to high fat mothers (HF-HF ♂) had a 
borderline significant elevation in anxiety through increased urination compared to high fat 
males born to low fat mothers (LF-HF ♂) (p = 0.058). The first diet listed is the maternal diet, 
and the second diet listed is the offspring diet. Error bars represent ± a single standard error, HF 
= High-fat diet, LF = Low-fat diet. 
 
 
 
 
A)  B)  
Figure 2.4. (A) In the Open Field Test, high fat mice urinated more than low fat mice (p = 
0.007). (B) High fat mice also produced more fecal boli than low fat mice (p = 0.042). Sample 
size: n = 27 HF diet females, n = 29 LF diet females, n = 22 HF diet males, n = 20 LF diet males. 
Error bars represent ± a single standard error, HF = High-fat diet, LF = Low-fat diet. 
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A)   B)  
 
C)   D)  
 
Figure 2.5. (A) High fat mice performed self-maintenance behaviors significantly less often than 
low fat mice at every age group. (B) By 12-14 weeks of age, high fat mice spent less time 
exploring than low fat mice (p = 0.0001). (C) Low fat mice became less inactive in adulthood, 
whereas high fat mice never decreased their level of inactivity (p = 0.00001). (D) At 9-11 weeks 
of age, high fat mice engaged in more social interaction behaviors than low fat mice (p = 
0.0033). Error bars represent ± a single standard error, HF = High-fat diet, LF = Low-fat diet. 
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A)   B)   C) 
Figure 2.6. These graphs contrast the behavior of the high fat and low fat mice at 12-14 weeks of 
age. (A) High fat mice spent more time sleeping than low fat mice (p = 0.0017). (B) High fat 
mice spent less time climbing on the ceiling bars than LF mice (p = 0.014). (C) High fat mice 
also spent less time walking (p = 0.0031). Error bars represent the standard error, HF = High-fat 
diet, LF = Low-fat diet, and sample size is n = 35 high-fat diet mice and n = 38 low-fat diet mice. 
A)   
B)  C)  
Figure 2.7. (A) Offspring of high fat mothers built their nests inside of a hut less often (p = 
0.020). (B) Offspring diet has a significant effect on nest quality (p = 0.040), with this difference 
being driven by the sons. High fat sons built lower quality nests than low fat sons. (C) High fat 
offspring showed a nonsignificant trend (p = 0.075) of building nests in the hut less often, 
although a paired t-test of just the sons showed a statistically significant difference (p = 0.021). 
Error bars represent the standard error, HF = High-fat diet, LF = Low-fat diet, sample size: n = 
14 HF-HF♀, 11 LF-HF♀, 13 HF-LF♀, 15 LF-LF♀, 10 HF-HF♂, 11 LF-HF♂, 8 HF-LF♂, and 
12 LF-LF♂. 
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CHAPTER 3 
 
A High-Fat Diet Alters Genome-wide DNA Methylation and Gene Expression in SM/J 
Mice 
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ABSTRACT 
 Discovering the gene expression and methylation changes induced by a high-fat diet can 
help to identify new targets for epigenetic therapies and inform about the physiological changes 
in obesity. In this study, I investigated the effects of dietary fat on obesity, gene expression, and 
DNA methylation in an inbred mouse strain (SM/J). I weaned the male and female mice onto a 
high fat or low-fat diet and measured their weights weekly, tested their glucose and insulin 
tolerance as adults, assessed serum biomarkers, and weighed their organs at necropsy. All of 
these traits were strongly affected by diet. Liver gene expression data from RNA sequencing 
revealed 4,356 genes that were differentially expressed due to diet, with 184 genes exhibiting a 
strong sex-by-diet interaction, indicating that expression levels due to diet differed in the two 
sexes. Dietary fat caused the dysregulation of several pathways, including those involved in 
cytokine-cytokine receptor interaction, chemokine signaling, and oxidative phosphorylation. 
MeDIP and MRE sequencing of DNA from the liver identified 7,000 genes with differentially 
methylated regions at the FDR-adjusted q < 0.05 level. At the q < 0.01 level there were 2,356 
differentially methylated regions in the females and 1,539 in the males due to diet. In the 
females, 174 of the differentially methylated regions occurred in genes that were also 
differentially expressed, as did 240 differentially methylated regions in the males. These genes 
highlight potential targets for epigenetic treatments of obesity in the future. This study 
emphasizes the substantial effect that dietary fat has on gene expression and methylation patterns 
in the liver, and shows that this effect is different in males and females.  
INTRODUCTION 
 In the last three decades, the number of obese adults in the United States has more than 
doubled. This rise in obesity is expected to continue: while 35% of adults are obese today, 42% 
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are predicted to be obese by 2030 (Ogden et al. 2014, Yang and Colditz 2015, Finkelstein et al. 
2012). This is a major threat to public health, since obesity is associated with cancer, stroke, 
asthma, type 2 diabetes, hypertension, heart attack, and other serious health conditions (Cawley 
and Meyerhoefer 2011). As a result, the average life expectancy for the morbidly obese is 9 years 
lower for women and 12 years lower for men (Buchwald 2005). The best studied causes of 
obesity are genetics, the environment, and their interaction (Martinez 2000, Cheverud et al. 
2004, Ehrich et al. 2005, Bell et al. 2005, Pérusse et al. 2005, O’Rahilly and Farooqi 2006). The 
environment changes the expression of genes via the epigenome, and thus environmental factors 
causing obesity may do so by inducing epigenetic modifications that change gene expression. 
Epigenetic variation between individuals may hold the key to more accurate predictions of 
obesity risk, and better understanding it could lead to new tools for fighting obesity.  
 Health problems can result from dysregulated gene expression, which can be caused by 
genetics and epigenetics. While much research has focused on the genetic variants underlying 
disrupted gene expression in obesity (Pérusse et al. 2005, Emilsson et al. 2008), far less is known 
about how diet changes gene expression through epigenetics to cause obesity. A high-fat diet has 
been shown to remodel chromatin in C57BL/6J and DBA/2J mouse livers (Leung et al. 2014). 
Differences in H3K9 and H3K4 histone methylation have been linked to cardiac hypertrophy, 
and alterations in DNA methylation have been linked to heart failure, atherosclerosis, and 
diabetes (Khalil 2014). Technological advances have made epigenetic studies more feasible, and 
new journals and scientific meetings have been created to address the explosion of epigenetics 
research (Bird 2007). Epigenetics in this sense is the study of changes in gene expression that 
persist across cell divisions in an individual’s lifetime and are not due to changes in the 
underlying DNA sequence (Russo et al. 1996). The epigenome is a dynamic body that allows the 
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static genome to adjust to the ever-changing environment by regulating gene expression. Diet is 
an example of an environmental factor, and a high-fat diet has been linked to changes in the 
epigenetic profile of many metabolic genes (Strakovsky et al. 2011, Fullston et al. 2013, Yoon et 
al. 2017, Zhang et al. 2017, Zhou et al. 2017, Zwamborn et al. 2017). It is becoming clear that 
epigenetic differences between individuals impact their obesity risk (Campion et al. 2009). We 
need to characterize these epigenetic differences to understand this important aspect of obesity.    
 Gene expression is regulated by many types of epigenetic mechanisms, including DNA 
methylation, non-coding RNA, and histone modifications (where various chemical groups such 
as acetyl, methyl, phosphate, and ubiquitin groups are added to histone tails). The best-
characterized epigenetic mechanism is DNA methylation; however, even this is still not well-
understood. DNA methylation is the addition of a methyl (CH3) group to DNA, usually to a 
cytosine (Parle-McDermott and Ozaki 2011). In animals, DNA methylation occurs at CpG 
doublets, and in plants it occurs at CpNpG triplets. Vertebrate genomes have distinct clusters of 
CpG doublets at the promoters of many genes (Bird 2002), including 60% of human genes 
(Illingworth and Bird 2009). When the majority of the cytosines in promoter regions are 
methylated, gene expression tends to be much lower than when these regions are hypomethylated 
(Razin and Cedar 1991). This is not always the case, however, and methylation at other 
regulatory regions can actually increase expression (Barua et al. 2014). To fill in the gaps of our 
understanding of epigenetics, it is important to explore the methylation profile of not just 
promoter regions in candidate genes but of the entire genome, as I do in this study.  
 Some variation in methylation is heritable. For example, numerous methylation QTLs 
have been discovered (Voisin et al. 2015, Volkov et al. 2016), epistasis can involve genomic 
imprinting (Lawson et al. 2013), and in an analysis of 648 monozygotic and dizygotic twins, 
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Grundberg et al. (2013) found that methylation variation in adipose tissue had a heritability of 
0.34, and 6% of methylation QTLs regulated both methylation and gene expression. Methylation 
levels are also known to change with age, exercise, diet, and BMI. Comparing blood samples 
from obese and lean preschool children revealed that the promoters of 392 genes were 
differentially methylated (Ding et al. 2015). However, changes in DNA methylation do not 
always imply changes in gene expression, or vice versa. Rats fed a diet high in fat and sugar had 
higher expression of the Hadhb gene in the liver, but had no corresponding changes in 
methylation (Lomba et al. 2010). As another example, Rönn et al. (2013) analyzed DNA 
methylation in the adipose tissue of 23 men before and after 6 months of exercise and found 
methylation changes in 7,663 genes. Of those genes, 197 also had differential expression, 61% of 
which had an inverse relationship between DNA methylation and gene expression. That study 
illustrates a common finding in obesity epigenetics studies: while there are methylation 
differences associated with obesity, many changes in DNA methylation do not cause detectable 
changes in the expression of nearby genes, and those that do lack a straightforward directional 
relationship. Much more research needs to be done to characterize the relevant DNA methylation 
changes in obesity.  
 So far, candidate-gene studies have revealed DNA methylation differences between 
obese and lean individuals in a handful of genes in different tissues, such as leptin (Lep) and 
proopiomelanocortin (Pomc) in the blood (van Dijk et al. 2015). In the liver, C57BL/6J mice 
with higher body weights were found to have higher dipeptidyl peptidase 4 (Dpp4) expression 
and lower methylation in four intronic CpG sites flanking exon 2 (Baumeier et al. 2017). DNA 
methylation is thought to play a role in regulating the inflammation response, as demonstrated 
when Malodobra-Mazur et al. (2014) overexpressed stearoyl-CoA desaturase 1 (Scd1) in mouse 
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3T3-L1 adipose cells and found DNA methylation differences in the promoters of 4 of 22 
inflammatory genes that corresponded with expression differences. These studies have been 
informative, but are restricted to only genes that seem like good candidates for obesity, thus 
limiting the identification of other important but unexpected genes.  
 Genome-wide methylation studies have revealed differentially methylated regions not 
only in genes associated with obesity, but in genes involved in cell differentiation, the immune 
system, and transcriptional regulation (van Dijk et al. 2015). More broadly, DNA methylation 
within a tissue is strongly correlated with the developmental age of the tissue (r = 0.96); the rate 
of age-related changes in methylation has been shown to accelerate with increasing Body Mass 
Index (BMI) in human livers (every 10 BMI units added 2.2 years of DNA methylation age, the 
expected developmental age of a tissue inferred from its level of DNA methylation) (Horvath et 
al. 2014). To understand how changes in DNA methylation affect gene expression in obesity, 
however, it is important to consider genetic background. For example, C57BL/6NCrl and BFMI 
(the Berlin Fat Mouse Inbred line, which develops juvenile obesity) mice on a high-fat diet 
showed decreased methylation at the melanocortin-4 receptor (Mc4r) gene in the brain compared 
to mice on a standard diet, but expression increased only in the BMFI mice (Widiker et al. 2010). 
Thus, it is useful to investigate obesity epigenetics in different genetic contexts, as I have done 
here by using a less commonly studied strain of mouse, the SM/J strain. This strain has a strong 
obesogenic response to an HF diet (Cheverud et al. 1999, Ehrich et al. 2003, Partridge et al. 
2014). I took a genome-wide approach to identify genes previously unknown as playing a role in 
obesity as well as to clarify the regulation of known genes. I synthesized genome-wide 
expression data with genome-wide methylation data to investigate changes induced by a high-fat 
diet.  
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METHODS 
Animal Rearing 
 The inbred SM/J mouse strain from The Jackson Laboratory (Bar Harbor, Maine) was 
used in this study. The SM/J strain originated from a selective breeding experiment for small size 
at 60 days of age (MacArthur 1944). Fifteen males and 15 females born in the facility at Loyola 
University Chicago were bred to produce 56 mice for the study population. The offspring were 
either weaned onto a low fat (LF) or high fat (HF) diet at 3 weeks of age (the sample size was 16 
HF females, 12 LF females, 18 HF males, and 10 LF males). The diets were nearly isocaloric; 
however, 15% of the calories came from fat in the LF diet (Research Diets D12284), whereas 
42% of the calories came from fat in the HF diet (Harlan Teklad diet TD.88137) (Table 3.1). 
Previous work in the lab by Erich et al. (2003) demonstrated that SM/J mice consume the same 
amount of food whether they are on the HF diet or the LF diet. The mice were fed ad libitum, 
and after weaning each mouse was housed with one other mouse of the same sex and diet in a 
cage containing a wooden gnawing block (Bio Serve), a red privacy hut (Alt Design), and a 2” x 
2” cotton nestlet (Ancare). Procedures followed an approved Institutional Animal Care and Use 
Committee protocol (Project #1188). 
Obesity Phenotype 
 The mice were weighed weekly from 1-17 weeks of age. They underwent an 
intraperitoneal glucose tolerance test (IPGTT) at 15 weeks of age. All tests started with a 4-hour 
fast at 6:00 am, followed by a tail snip to measure the baseline glucose level, and an 
intraperitoneal injection of glucose (1 mg/g body weight). Glucose measurements were then 
taken from tail blood at 30, 60, and 120 minutes after injection. At 16 weeks of age, the mice 
received an intraperitoneal insulin tolerance test (IPITT). The protocol for the IPITT is the same 
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as for the IPGTT, except that insulin is injected instead of glucose (0.75 mU/g body weight). If 
the blood glucose levels of a mouse fell below 25 mg/dL, the mouse received a 10% glucose 
injection and was not included in the IPITT results. For both the IPGTT and IPITT, the glucose 
values at the 4 different time points were used to calculate the area under the curve (AUC) using 
the trapezoidal summation method. At 17 weeks of age, the mice were fasted for 4 hours and 
sacrificed via carbon dioxide asphyxiation between the hours of 10:00 am and 2:00 pm. Blood 
from a cardiac puncture (0.5 mL) was centrifuged at 4°C, and the serum was sent to Washington 
University in St. Louis’s Core Laboratory for Clinical Studies to measure insulin and leptin, and 
to the Diabetes Models Phenotyping Core to measure triglycerides, glucose, cholesterol, and free 
fatty acids. I performed the necropsies on ice and recorded the weights of the liver, heart, 
reproductive fat pad, kidneys, spleen, brown fat, and skeletal muscle (gastrocnemius). I weighed 
only the reproductive fat pad rather than all of the fat pads, because it is strongly genetically (h2 
= 0.7-0.9) and phenotypically correlated (r = 0.67-0.82) with the other fat pads (Cheverud et al. 
2004, Cheverud et al. 2011). I flash-froze liver tissue in liquid nitrogen for RNA extraction. I ran 
a general linear model in SYSTAT (Version 12, Systat Software, San Jose, CA) to analyze 
differences in obesity phenotypes between the diet treatments. Multivariate tests were performed 
on the following three groups of traits: weekly weights, diabetes-related traits (week 15 and 16 
weight, baseline glucose during the IPGTT, IPGTT AUC, baseline glucose during the IPITT, and 
IPITT AUC), and necropsy traits (week 17 weight, organ weights, and serum biomarkers), as 
well as all the associated univariate tests. Differences were interpreted as significant for p-values 
less than 0.05. 
Gene Expression 
 I extracted RNA from the liver tissue using the Qiagen RNeasy Plus Mini kit and 
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submitted it to Washington University in St. Louis’s GTAC facility for RNA-seq with poly-A 
selection. A total of 21 libraries were sequenced, each with 2 mice of the same sex and diet 
pooled together. There were 6 LF female libraries, and 5 of each of the other sex-diet groups. A 
1x50 single read sequencing run was done on an Illumina HiSeq 2500 machine (Illumina Inc.). 
The FastQ files were aligned to the Ensembl release 76 assembly using STAR version 2.0.4b 
(Dobin et al. 2013). The gene counts were then analyzed with the R package edgeR (Robinson et 
al. 2010); differences in library size were accounted for with a TMM normalization, and genes 
with counts of zero were filtered out. The weighted likelihoods were then calculated using the 
voom function in the R package Limma based on the mean-variance relationship of each gene 
and transcript. Generalized linear models were used to test for differential expression. Any gene 
with a false discovery rate (FDR) adjusted q-value of 0.05 or less was considered differentially 
expressed. I performed a pathway analysis using the R package GAGE (Luo et al. 2009) and 
visualized the pathways with the R package Pathview (Luo and Brouwer 2013).  
 I validated the differential expression for 3 genes in the females (Adam11, Lad1, and 
Galnt10) and 3 in the males (Adam11, Abcg8, and Col1a1), with Gapdh as a normalizer (Table 
3.11). To do this, I extracted total RNA from the livers of 3 HF and 3 LF mice of each sex using 
Tri-Reagent (MRC), following the manufacturer’s instructions. The concentration and quality of 
the RNA from each sample was assessed twice with a NanoDrop Spectrophotometer, and only 
samples with a 260/280 ratio between 1.7-2.1 and a 260/230 ratio between 2.0-2.4 were used. I 
then immediately reverse transcribed the RNA to cDNA using the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems), following the manufacturer’s instructions. Primers were 
selected from the literature, and if none were found I used PrimerBank 
(https://pga.mgh.harvard.edu/primerbank/) to design the primers. All primers were synthesized 
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by Thermo Fisher Scientific (the sequences are listed in Table 3.4). I performed RT-qPCR using 
10 µL of PowerUp™ SYBR® Green Master Mix (Thermo Fisher), 1 µL of the forward primer, 1 
µL of the reverse primer, 4 µL of 20-fold diluted cDNA, and 4 µL of water, with a total volume 
of 20 µL for each reaction. The RT-qPCR was performed with a StepOnePlus Real-Time PCR 
System (Applied Biosystems) at the following conditions: 20 seconds at 95°C, followed by 40 
cycles of 3 seconds at 95°C and 30 seconds at 60°C. For each of the 3 biological replicates, 3 
technical replicates were used, along with a no-template control and a no-reverse-transcriptase 
control. I did a relative quantification of each gene using Gapdh as a reference using the 
comparative ΔΔCt method. 
DNA Methylation 
 I performed a phenol-chloroform extraction to isolate DNA from the liver tissue. 
Genome-wide DNA methylation was then assessed with Methylated DNA Immunoprecipitation 
Sequencing (MeDIP-seq) and Methylation-sensitive Restriction Enzyme Sequencing (MRE-seq), 
as described by Li et al. (2015). MeDIP-seq detects methylated sites while MRE-seq detects 
unmethylated sites, and when used in combination these two techniques provide a single CpG 
resolution methylation map that has high concordance with whole-genome bisulfite sequencing 
at only a fraction of the cost (Stevens et al. 2013). Four mice of the same sex and diet treatment 
were pooled per library, yielding 2 biological replicates per group and a total of 8 methylation 
libraries. The R package methlyMnM was used to analyze the MRE-seq data in conjunction with 
the MeDIP-seq data to identify differentially methylated regions (DMRs). I used methylMnM to 
split the mouse mm9 genome into 500-base-pair windows (for a total of 5,283,825 windows), 
assess the proportion of methylated CpGs in each window, and then to calculate the novel M&M 
test statistic to determine if the methylation level was different between the two diet treatments 
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(Zhang et al. 2013). M&M can only test two groups at a time, which yielded 4 pairwise 
comparisons of the female libraries and 4 of the males. To synthesize the information from all 4 
library comparisons per sex, I used Fisher’s combined probability test (Fisher 1954). To examine 
DMRs due to diet in the females, the p-value from the M&M test comparing the first HF-female 
library with the first LF-female library was combined with the p-value from the M&M test 
comparing the second HF-female library with the second LF-female library according to the 
following equation by Fisher: 
  ~ − 2  ln ()


 
In this case, pi is the p-value from the pairwise M&M test, and k is the number of tests combined 
(which was 2). I calculated a combined p-value for each 500-base-pair window, corrected for 
FDR with the Benjamini-Hochberg method, and calculated how many of these windows were 
differentially methylated based on q-value cutoffs of less than 0.05, 0.01, and 0.001.  
 For each DMR, I then identified the nearest gene to it, if it fell within a gene, if it fell 
within a promoter, if it contained a known regulatory element listed in Ensembl (mouse genome 
assembly GRCm38.p5), and if the gene closest to it was already known to be involved in obesity, 
diabetes mellitus, or cardiovascular diseases based on Phenopedia’s continuously updated list of 
genes uncovered by genetic association studies in humans (downloaded May 7, 2017). I also 
classified the DMR as being either in an intergenic region, exon, intron, or promoter. This was 
done using the full list of introns, exons, and genes downloaded from the NCBI37/mm9 
assembly on the UCSC Genome Browser. If the DMR overlapped both an intron and an exon, it 
was classified as falling within an exon. It was classified as a promoter if it was within 2,000 
base pairs upstream of a transcription start site or 600 base pairs downstream of one. To 
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determine if the DMRs were associated with gene expression, I randomized the DMRs across the 
genome and calculated how many fell within differentially expressed genes due to chance. To 
account for the general underrepresentation of DMRs in intergenic regions during the 
randomization, the percent of DMRs that were allowed to be randomized into intergenic regions 
was equal to the percent that actually exist in those regions. The overall methylation results 
highlighted the wide range of genomic regions that diet-induced DMRs are found in, as well as 
the complex relationship that DMRs have with gene expression.  
RESULTS  
Obesity phenotype 
 A full model testing for the effect of sex, diet, and a sex-by-diet interaction for the 
obesity traits indicated that there was not a significant sex-by-diet effect (p = 0.13); however, 
sex-by-diet was significant on a univariate level for cholesterol, insulin, and glucose AUC during 
the intraperitoneal insulin tolerance test. The reduced model testing for just sex and diet revealed 
that sex significantly affected the weekly weights (p = 8.71x10-8) (Figure 3.1), the diabetes-
related traits (p = 8.99x10-11), and the necropsy traits (p = 1.13x10-6) (Table 3.2). Regardless of 
diet, males weighed more than females and had heavier hearts, kidneys, and livers. Males also 
had higher serum levels of insulin and cholesterol, and had higher area under the curve values for 
the intraperitoneal glucose and insulin tolerance tests.  Sex did not affect the week 1-3 weights, 
leptin, triglycerides, glucose, free fatty acids, or the weights of the fat pad, spleen, brown fat, or 
gastrocnemius. 
 Diet also significantly affected the weekly weights (p = 1.02x10-4), diabetes-related traits 
(p = 2.06x10-3), and necropsy traits (p = 1.78x10-14). After only one week of being on the diet 
treatment (4 weeks of age), HF mice weighed significantly more than LF mice, and the 
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difference became more pronounced with age. The HF mice had reproductive fat pads that were 
more than 8 times larger than the LF mice. There was an overall increase in all organ weights on 
an HF diet, including 2.8 times heavier livers, 1.4 times heavier kidneys, 1.8 times heavier 
spleens, 1.6 times heavier hearts, and 3.5 times more brown fat on average (Figure 3.2). 
 Diet also significantly affected the response to intraperitoneal glucose and insulin 
tolerance testing, with HF mice having higher area under the curve values for the glucose 
tolerance test (1.4 times higher for females and 1.7 times higher for males) as well as for the 
insulin tolerance test (1.7 times higher for females and 2.3 times higher for males), indicating 
impaired glucose and insulin signaling. All serum biomarkers except for free fatty acids had 
higher levels due to an HF diet, particularly in males. HF mice had higher levels of cholesterol 
(2.2 times higher in females, 3 times higher in males), triglycerides (1.3 times higher in females, 
2.1 times higher in males), glucose (1.4 times higher in females, 2 times higher in males), and 
insulin (6.7 times higher in females, 38 times higher in males) (Figure 3.3). Like insulin 
resistance, leptin resistance can occur in obesity. That was the case in this study, where 
compared to LF mice, HF female mice had 20 times more leptin in their serum and HF male 
mice had 42 times more. Despite these drastically elevated levels of leptin, the mice had a 
reduced ability to respond to leptin due to having 7 times lower expression of the leptin receptor 
(Lepr) gene (Figure 3.5).  
Gene Expression 
 The multidimensional scaling (MDS) plot indicated that the gene expression libraries 
clustered primarily by sex (dimension 1) and then by diet (dimension 2) (Figure 3.4). Diet altered 
the expression of 4,356 genes in the liver, or approximately one-fifth of the genome (Table 3.3). 
Compared to Phenopedia’s list of genes from gene association studies in humans, 419 of the 
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differentially expressed genes matched the 1,720 known obesity genes, 807 matched the 3,455 
known diabetes mellitus genes, and 1,017 matched the 4,540 genes known to be involved in 
cardiovascular disease. Considerably more differentially expressed genes were detected in males 
(3,330) than in females (1,750). Of the genes that were differentially expressed, 848 were 
differentially expressed due to diet only in females and 2,428 were unique to males 
(Supplementary Tables 3.12-3.13). There were 184 genes with significantly different expression 
due to a sex-by-diet interaction, which a GO Enrichment analysis showed were enriched for 
three biological processes: epoxygenase P450 pathway (p = 2.36x10-5), oxidation-reduction 
process (p = 5.58x10-5), and response to stilbenoid (p = 5.21x10-3). This indicates that the 
difference between the male and female response to dietary fat may be mediated by sex 
differences in these pathways.  
 The GAGE pathway analysis revealed that the ribosome and oxidative phosphorylation 
pathways were upregulated in males compared to females, whereas the steroid hormone 
biosynthesis, linoleic acid metabolism, and retinol metabolism were downregulated in males. An 
HF diet changed the regulation of 7 pathways overall (Table 3.8). This included the 
downregulation of the oxidative phosphorylation pathway and upregulation of the cytokine-
cytokine pathway, indicating that the HF diet reduced mitochondrial function and increased 
inflammation (Figure 3.6). In females, there were 4 pathways upregulated by an HF diet: 
cytokine-cytokine receptor interaction, chemokine signaling, cell adhesion molecules, and the 
natural killer cell mediated cytotoxicity pathways. In males, the cytokine-cytokine receptor 
interaction pathway was also upregulated by an HF diet, while the ribosome and oxidative 
phosphorylation pathways were downregulated (Table 3.9). None of the genes in the ribosome 
pathway had differentially methylated regions, but the other two pathways in males had a 
 62
handful of such genes. Numerous GO Biological Processes were upregulated by an HF diet, and 
none were downregulated. In females, 29 processes were upregulated, nearly all of them related 
to the immune system. Even more were upregulated in males, with 61 affected processes, again 
mostly involved in the immune system (Table 3.10). 
Methylation 
 A q-value cutoff of 0.05 revealed tens of thousands of differentially methylated regions 
(DMRs) due to diet, which encompassed 0.6-0.8% of the nearly 5.3 million 500-base-pair 
windows in the genome. A cutoff of 0.01 was more discriminating, with less than 0.04% of 
windows falling below it, allowing us to focus on a few thousand genes with differential 
methylation (Supplementary Tables 3.14-3.15). The comparison of HF and LF females resulted 
in 2,356 DMRs (q < 0.01), which was more than the 1,539 DMRs between the HF and LF males 
(Table 3.5). There were even more DMRs due to sex than diet, with HF males and females 
differing at 3,831 regions and LF males and females differing at 5,632 regions (q < 0.01). A 
greater percentage of DMRs were found on the X chromosome in the between-sex comparisons 
(2.3-2.8%) than in the within-sex comparisons (0.1-0.3%, q < 0.01), consistent with the 
expectation that the X chromosome is regulated differently in males and females (Cotton et al. 
2011, El-Maarri et al. 2007).   
 In all, 7,814 genes (38.3% of genes) in the liver had at least one diet-induced DMR (q < 
0.05) in the females, as did 7,086 genes (34.7%) in the males (Table 3.7). When the DMRs were 
assigned to one of four categories, 15% fell within promoters, 25% fell within exons, 34% fell 
within introns, and 31% were in intergenic regions (Table 3.6). Not all of these categories were 
mutually exclusive, since several DMRs encompassed both exons and promoters. Many of the 
DMRs were in regulatory regions, including 10-12% in enhancers, 14-16% in promoters, 3-7% 
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in CTCF transcription factor binding sites, and 34% in promoter flanking regions. Differentially 
methylated regions were far more likely to be found in these regulatory regions than non-
regulatory regions of the genome (p < 1 x 10-10 from a χ2). Across the genome, only 4% of the 
windows overlapped enhancers, 2% overlapped CTCF binding sites, and 8% overlapped 
promoter flanking regions. Thus, a high-fat diet alters not just the methylation of gene promoters, 
but also enhancers and transcription factor binding sites.   
 Although only a small percentage of the DMRs fell in differentially expressed genes, it 
still happened more often than expected by chance (p = 2.2 x 10-8). In the females, 2,170 (5.6% 
of) DMRs fell within differentially expressed genes, whereas only 1,994 (5.1%) were expected to 
by chance. In the males, 3,209 (10.2% of) DMRs fell within differentially expressed genes, 
whereas only 2,992 (9.5%) were expected to by chance. Differential methylation thus is 
associated with differential gene expression.  
DISCUSSION 
 Both sex and diet had a statistically significant effect on body weight by 4 weeks of age. 
By 17 weeks of age, mice on a high fat (HF) diet weighed approximately 70% more than mice 
on a low fat (LF) diet. An HF diet significantly increased the following traits: all body weights 
and organ weights, baseline glucose levels, and serum levels of cholesterol, triglycerides, 
glucose, leptin, and insulin. The HF diet did not increase levels of free fatty acids in the serum, 
but Do et al. (2011) found the same trend in HF-fed C57BL/6J mice, despite elevated fatty acid 
levels in the liver. In our study, HF-fed mice had higher area under the curve (AUC) values for 
the glucose and insulin tolerance tests, indicating hyperglycemia and insulin resistance.  
 This strong obesogenic response to an HF diet was driven by changes in DNA 
methylation and gene expression. Diet significantly altered the expression of 4,356 genes and the 
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methylation of more than 7,000 genes in the mice. An HF diet had an extensive effect on 
methylation, with more than one-third of genes in the liver having at least one differentially 
methylated region (DMR), and one-fifth of genes having more than one DMR in response to 
diet. The DMRs occurred in regulatory regions such as enhancers, CTCF transcription factor 
binding sites, other transcription factor binding sites, and promoter flanking regions significantly 
more often than these regions occur in the genome, supporting the notion that methylation plays 
an important role in regulating the response to an HF diet. That role is not straightforward, 
however. The DMRs fell within differentially expressed genes significantly more often than 
expected by chance; however, 90% of the DMRs were not located in differentially expressed 
genes. In fact, 41% of the DMRs did not even occur within genes at all, although 17% of those 
contained enhancers, CTCF binding sites, or other transcription factor binding sites. This is on 
par with the findings of other studies in the field, such as Rönn et al. (2013) who found DMRs in 
7,663 genes after 6 months of exercise in men’s adipose tissue, but only 197 of those genes had 
expression changes and just 61% of those had an inverse relationship between methylation and 
expression. The effect of methylation on gene expression depends on where the methylated 
region is located in the genome (Parle-McDermott and Ozaki 2011). It will be interesting in the 
future to correlate the DNA methylation changes with histone modifications, as these two 
regulatory features work together to modulate gene expression, and we know that an HF diet 
induces chromatin remodeling (Leung et al. 2014). 
 In the females, 2,170 (5.6%) of DMRs (q < 0.05) occurred within genes that were 
differentially expressed due to diet. This was higher in males, where 3,209 (10.2%) of DMRs 
occurred within genes that were differentially expressed. The differentially expressed gene with 
the lowest q-value in the females was ADAM metallopeptidase domain 11 (Adam11) (q = 
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7.6x10-20), which also had three adjacent DMRs (q = 0.00029, q = 1.6x10-8, and q = 3.3x10-6) 
encompassing exons 14-18 of the gene. The males had the same three DMRs and exhibited the 
same pattern as the females of having higher Adam11 expression as well as higher methylation at 
the DMRs due to an HF diet (Figure 3.7A). Although the Adam11 gene is known to be expressed 
in the mouse liver (MGI Gene Expression Database), its role in obesity and diabetes has not been 
discussed. It belongs to a family of genes involved in cell signaling, migration, and adhesion, and 
mice lacking Adam11 have impaired spatial learning and motor coordination, along with a 
reduced response to inflammatory pain (Takahashi et al. 2006). Perhaps the increased 
inflammation associated with obesity leads to an increase in inflammation-related pain.  
 An HF diet also increased expression of the UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (Galnt10) gene in the females. 
There is a DMR in the first intron, which is more heavily methylated by an HF diet (Figure 
3.7B). A genome-wide association study found a SNP in the human Galnt10 gene that is 
associated with BMI (Monda et al. 2013), and another study found a SNP in it associated with 
physical activity (Ahmad et al. 2015). Galnt10 is known to be expressed in the mouse liver (MGI 
Gene Expression Database), and the Galnt10 protein participates in post-translational 
modification in the Golgi apparatus where it catalyzes the synthesis of mucin-type O-
glycosylation. Important mucin-type O-linked glycoproteins include the cytokine interluekin-2 as 
well as proteins involved in homing leukocytes to inflamed areas (Hang and Bertozzi 2005).  
 An HF diet also upregulated the expression of the ladinin 1 (Lad1) gene in the females 
and decreased methylation at two adjacent DMRs in its first intron, which is also considered to 
be a promoter region (Figure 3.7C). Lad1 is highly expressed in the kidneys and lungs, and is 
found in lower levels in the liver and spleen (Motoki et al. 1997). The protein is a part of the 
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basement membrane, a thin matrix that holds the epithelium to its connective tissue and is also 
involved in angiogenesis. In liver fibrosis, the basement membrane increases around the liver 
vessels, and basement membrane peptides increase in the serum with the severity of liver 
damage (Walsh et al. 2000). This is relevant because the HF mice had visibly fattier livers, in 
line with the increased risk of non-alcoholic fatty liver disease (NAFLD) due to obesity. 
 Further epigenetic evidence of liver distress induced by an HF diet is the upregulation of 
the collagen type I alpha 1 chain (Col1a1) gene in HF males, accompanied by increased 
methylation at a DMR spanning exons 23 and 24 of the gene (Figure 3.7D). The COL1A1 
protein is a subunit of type 1 collagen, which is found in many parts of the body such as tendons, 
bone, and scar tissue. It is the main type of collagen that accumulates in the liver during fibrosis 
and cirrhosis. When mice with advanced liver fibrosis were administered siRNA to degrade 
transcripts of Col1a1, collagen deposition decreased by half and several other profibrogenic 
genes became downregulated as well (Calvente et al. 2015). Our results support the notion that 
siRNA or other epigenetic treatments for elevated Col1a1 levels may help in obesity related liver 
fibrosis.   
 The ATP binding cassette subfamily G member 5 (Abcg5) gene lies head-to-head with 
Abcg8, and both were expressed more in HF males than in LF males. A DMR close to the start of 
both genes, located in the first intron of Abcg5, had lower methylation due to an HF diet and may 
be involved in the co-regulation of the genes (Figure 3.7E). They encode proteins forming a 
heterodimer that facilitates the excretion of cholesterol and other phytosterols into bile. 
Mutations in either gene are associated with atherosclerosis and sitosterolemia, a condition that 
leads to cardiovascular disease through the accumulation of sterols in the body (Yu et al. 2014). 
Our findings support previous studies that have identified the upregulation of Abcg5 and Abcg8 
 67
in response to insulin resistance and an HF diet (Biddinger et al. 2008, Yamazaki et al. 2011, Do 
et al. 2011, Yu et al. 2014). The upregulation of the heterodimer may have been an attempt to 
eliminate the excess cholesterol from the body, although even with the upregulation high-fat-fed 
mice still had 2-3 times as much serum cholesterol as the low-fat-fed mice. 
 Our gene expression findings mostly support those of other mouse studies, while 
highlighting differences that can be caused by a different genetic background. For instance, Do et 
al. (2011) compared liver expression of HF- and LF-fed male C57BL/6J mice and found that an 
HF diet perturbed genes that were enriched for processes involved in immune and inflammatory 
response. Like us, they found that diet altered biological processes involving the defense 
response, inflammatory response, and innate immune response. Of the 332 genes they found 
differentially expressed due to an HF diet, 120 were the same as the ones I identified in the males 
(they did not study females). These included Adam11, Abcg5, and Abcg8, which I highlighted in 
my study as being both differentially expressed and differentially methylated due to diet. I found 
28 genes in common with Kim et al. (2004), who identified 97 differentially expressed genes due 
to an HF diet in C57BL/6J males. I found more genes in common with Kim et al. (2004) and Do 
et al. (2011) than either did with each other (they had Acox1, Cyp3a11, Egfr, Nsdhl, Serpina3g, 
and Sqle in common), even though they used the same mouse strain, which shows the utility of 
RNA-seq data over microarray data when comparing across studies. Of the 309 differentially 
expressed genes that Kirpich et al. (2011) identified in male C57BL/6 mice due to an HF diet, I 
found 124 of the same genes. Kirpich et al. (2011) shared 12 genes in common with Kim et al. 
(2004) and 57 genes in common with Do et al. (2011), and the only genes found in all three 
studies were Nsdhl and Sqle (Figure 3.8). Like Inoue et al. (2005) found in C57BL/6Ncrj male 
mice, I found that Pparg and its target gene Cd36 were both upregulated in the male and female 
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HF mice, corroborating their conclusion that an HF diet induces liver steatosis by upregulating 
Pparg. Similar to other studies, I found an upregulation of genes in pathways associated with 
defense, stress, and inflammation responses (Kim et al. 2004, Do et al. 2011). 
 I compared my list of differentially expressed genes in the males and females with those 
found in 9 other strains exposed to an HF diet in the Mouse Phenome Database (MPD, The 
Jackson Laboratory) from the Shockley et al. (2009) study and found between 16 and 27 genes 
in common with the males in each study and 3 to 15 genes in common with the females 
(Supplementary Table 3.16). The varied results depending on strain underscore the importance of 
studying obesity in multiple strains of mice instead of basing conclusions off of one strain. In the 
males, 13 genes were found to be altered by an HF diet in 3 of the strains (Aplp2*, Bach2, 
Cenph*, Ercc5*, Fhdc1*, Kdm5c*, Nrxn3, Pms2*, Slc8a1*, Tmem57*, Vacn*, Zfp385b, and 
Zfp608*) and 4 genes were altered in 4 strains (Fgfr2*, Homer1*, Kcnma1, and Ptprd) (an 
asterisk indicates that our SM/J mice constituted one of the strains). In the females, 12 genes 
were found to be altered by diet in 3 strains (4933431K23Rik, Atp2a2*, Fam63a*, Gata6*, 
Hmx1, Klhl3*, Osbpl3*, Pus10, Sept8*, Slc38a2*, Spty2d1*, and Syt11*), and one gene was 
altered in 4 strains (Fgfr2*). Due to its responsiveness to an HF diet in both males and females of 
four different mouse strains, Fgfr2 could be an important therapeutic target in obesity—
especially because, along with lower expression in our HF-fed SM/Js, the gene had 2 DMRs in 
the first intron of the females and 1 DMR in the third intron of the males. Fgfr2 is important for 
liver regeneration and its expression is increased in the livers of people with NAFLD (Younossi 
et al. 2005). Additionally, Haworth et al. 2014 linked the methylation of this gene to weight 
when they found that the methylation of three CpGs in the cord blood of newborns was 
significantly associated with high birth weight.  
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 Replicating differentially methylated regions across studies can be more difficult than 
replicating gene expression, since methylation can be more variable and fewer studies have 
investigated it, especially in terms of genome-wide studies. Ge et al. (2014) found that Lep was 
less expressed and its promoter was more methylated in the livers of HF-fed female CD-1 mice. I 
also found a hypermethylated DMR in the Lep promoter of the females (q = 0.02), but there was 
no difference in expression. Ge et al. (2014) additionally found a hypomethylated Pparα 
promoter, and although I too found a DMR in Pparα, mine was hypermethylated by an HF diet, 
it was located in the second intron, and the gene was not differentially expressed. Yoon et al. 
(2017) identified hypomethylated CpG sites 1.5-kb upstream of the Casp1 gene in C57BL/6N 
male mice, but I found no DMRs in that gene. Like them, I did find lower expression of the 
Ndufb9 gene in HF-fed males along with a DMR in it, but my DMR was hypomethylated by an 
HF diet whereas theirs was hypermethylated. As exemplified by this variability across studies, 
understanding the methylation changes underlying obesity will require much more research in 
the context of multiple genetic backgrounds.  
 Males and females respond differently to an HF diet, shown by differences in 
methylation, gene expression (184 differentially expressed genes had a sex-by-diet interaction), 
and obesity phenotypes (although there was not a significant sex-by-diet interaction here, males 
clearly differed due to diet more than females in their serum biomarkers and response to glucose 
and insulin tolerance testing). The genes with a significant sex-by-diet interaction were enriched 
for the epoxygenase P450 pathway, oxidation-reduction process, and response to stilbenoid, 
suggesting sex differences in these pathways mediate the difference between the male and 
female response to dietary fat. Cytochrome P450 genes are important for homeostasis and 
encode enzymes involved in metabolizing compounds such as fatty acids and drugs, so sex 
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differences in this pathway are relevant to pharmaceutical approaches to weight loss. Likewise, a 
sex-by-diet effect on the response to stilbenoids is interesting because they have been shown to 
regulate lipids, and Lin et al. (2015) found that the stilbenoid TSG prevented non-alcoholic fatty 
liver disease in HF-fed rats, with results that hinted at a small but inconclusive difference 
between males and females (Lin et al. 2015). Although there were more differentially expressed 
genes due to diet in males than in females, the opposite was true for DMRs. However, while 
there were fewer DMRs total in males, more of their DMRs occurred within genes that were 
differentially expressed due to diet.  
 This study identified thousands of genes that were differentially expressed and 
differentially methylated due to a high-fat diet in SM/J mice. Genome-wide studies such as this 
are essential for developing a better understanding of the relevant epigenetic changes in obesity 
and identifying new targets for treatments. It is essential that these treatments take sex into 
consideration, since—from the level of methylation to expression to the obesity phenotypes—
males and females responded quite differently to an obesogenic diet.  
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TABLES AND FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1. Diet compositions. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Component High-Fat Diet Low-Fat Diet 
Energy from fat, % 42 15 
Casein, g/kg 195 197 
Sugars, g/kg 341 307 
Corn starch, g/kg 150 313 
Cellulose, g/kg 50 30 
Corn oil, g/kg 0 58 
Hydrogenated 
coconut oil, g/kg 
0 7 
Anhydrous milk fat, 
g/kg 
210 0 
Cholesterol, g/kg 1.5 0 
Kilojoules per gram 18.95 16.99 
 80
 
Trait Diet (p-value) Sex (p-value) Sex-by-diet (p-value) 
Week 1 Wt 0.898 0.629 0.555 
Week 2 Wt 0.904 0.684 0.670 
Week 3 Wt 0.866 0.543 0.447 
Week 4 Wt 1.84E-3 8.74E-3 0.298 
Week 5 Wt 4.70E-8 1.83E-8 0.284 
Week 6 Wt 1.28E-10 1.81E-6 0.537 
Week 7 Wt 1.93E-12 3.18E-6 0.484 
Week 8 Wt 6.80E-13 1.00E-5 0.180 
Week 9 Wt 1.27E-12 1.00E-4 0.494 
Week 10 Wt 1.13E-12 1.60E-4 0.497 
Week 11 Wt 6.88E-12 4.50E-4 0.446 
Week 12 Wt 1.42E-12 2.40E-4 0.358 
Week 13 Wt 1.06E-13 4.60E-4 0.651 
Week 14 Wt 1.45E-13 2.33E-3 0.501 
Week 15 Wt 7.11E-15 8.09E-3 0.848 
Week 16 Wt 1.24E-13 4.93E-3 0.786 
Week 17 Wt 2.62E-14 4.08E-3 0.702 
IPGTT Baseline glucose 9.15E-7 1.67E-2 0.654 
IPGTT AUC 2.07E-6 2.00E-5 0.194 
IPITT Baseline glucose 1.00E-5 1.80E-2 0.102 
IPITT AUC 1.21E-7 2.37E-2 0.024 
Leptin 5.31E-8 0.944 0.943 
Insulin 4.50E-4 0.00163 0.002 
Triglycerides 3.32E-3 0.885 0.247 
Cholesterol 4.93E-11 1.70E-4 0.005 
Glucose 2.00E-4 0.149 0.063 
Free Fatty Acids 0.409 0.440 0.322 
Liver (log) 8.52E-14 0.013 0.897 
Fat pad (log) 8.54E-12 0.255 0.199 
Heart (log) 1.79E-8 0.01558 0.938 
Kidney Avg (log) 1.95E-9 4.98E-16 0.635 
Spleen (log) 8.28E-8 0.110 0.056 
Brown fat (log) 2.89E-8 0.301 0.923 
Leg Muscle (log) 0.01645 0.612 0.960 
 
Table 3.2. The effect of diet and sex on weekly weights, diabetes traits, and organ weights.  
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Figure 3.1. The average weight of mice in grams (± one standard error) from 1 to 17 weeks of 
age. Diet had a statistically significant effect from 4 weeks of age and on. HF = High-fat diet, 
and LF = Low-fat diet. 
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Figure 3.2. The average organ weights for each sex and diet group in grams (± one standard 
error). All organ weights except were significantly heavier in the high fat mice than the low fat 
mice. HF = High-fat diet, and LF = Low-fat diet. 
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Figure 3.3. High-fat diet mice had an elevated response to glucose tolerance testing and 
reduced sensitivity to insulin tolerance testing. They also had higher levels of triglycerides, 
cholesterol, glucose, leptin, and insulin in their serum than low-fat diet mice. Error bars are ± 
a single standard error, HF = High-fat diet, and LF = Low-fat diet. 
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Comparison Differentially expressed genes 
All HF vs. LF 4,356 
HF vs. LF females 1,750 
HF vs. LF males 3,330 
Table 3.3. Number of differentially expressed genes due to diet. HF = High-fat diet, and LF = 
Low-fat diet. 
 
 
Figure 3.4. The multidimensional scaling plot indicates that gene expression libraries clustered 
by sex (dimension 1) and then by diet (dimension 2). HF = High-fat diet, and LF = Low-fat diet.  
 
 
Gene Forward primer Reverse primer 
Adam11 5'-TGCTGCTGTTACCGCTTCT-3' 5'-TCAGAGCCCTCTGGACTCTCT-3' 
Lad1 5'-ATGTCGGTCAGCAGAAAGGAC-3' 5'-CTGTGGTTGAACTCAGGTTGC-3' 
Galnt10 5'-TGACCGATGCCGAGAGAGT-3' 5'-AGAGAGCGATTCAGGGAGATT-3' 
Abcg8 5'-GTACGTGGGGTGTCCGGGGGTGAG-3' 5'-GCGAGGCTGGTGGAGGGAGATGAG-3' 
Col1a1 5'-GCTCCTCTTAGGGGCCACT-3' 5'-CCACGTCTCACCATTGGGG-3' 
Gapdh 5'-ACAATGAATACGGCTACAGCAACAG-3’ 5’-GGTGGTCCAGGGTTTCTTACTCC-3’ 
Table 3.4. Primers used for RT-qPCR. 
 
Comparison Group <0.05 <0.01 <0.001 DMRs in X (%) 
Different diets 
LF ♀ vs. HF ♀ 38,865 2,356 375 100 (0.3%) 
LF ♂ vs. HF ♂ 31,549 1,539 314 17 (0.1%) 
Different sexes 
HF ♀ vs. HF ♂ 36,876 3,831 1,250 1,045 (2.8%) 
LF ♀ vs. LF ♂ 44,076 5,632 1,716 994 (2.3%) 
Table 3.5. The number of differentially methylated regions (DMRs) due to diet and sex at three 
different q-value cutoffs. There were thousands of methylation differences due to diet, and even 
more due to sex. A greater proportion of the DMRs fell on the X-chromosome when comparing 
across sexes than when comparing across diet treatments. HF = High-fat diet, and LF = Low-fat 
diet. 
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Region Female DMRs Male DMRs Whole Genome 
Enhancer 237 (10.0%) 180 (11.7%) 3.5% 
CTCF Binding Site 157 (6.7%) 55 (3.6%) 1.7% 
TF binding site 33 (1.4%) 12 (0.8%) 0.3% 
Promoter Flanking Region 795 (33.8%) 522 (33.9%) 8.1% 
Promoter  370 (15.7%) 215 (14.0%) 4.5% 
Exon 598 (25.4%) 415 (27.0%) 7.5% 
Intergenic 748 (31.8%) 471 (30.6%) 58.6% 
Table 3.6. The distribution of significant differentially methylated regions (DMRs) (q < 0.01) 
across the genome due to diet. Numbers indicate how many 500 base pair windows overlap each 
genomic region, with the percent of the total significant DMRs that overlap such regions in 
parentheses for the female and male mice. The percent of windows across the entire genome that 
overlap these genomic regions is listed as a comparison, illustrating the overrepresentation of 
regulatory regions in the DMRs.   
 
 
 
  
Genes with ≥ 1 DMR 
in gene body 
Genes with > 1 DMR 
in gene body 
Genes with ≥ 1 DMR 
in promoter 
Females 7,814 (38.3%) 3,912 (19.2%) 2,146 (10.5%) 
Males 7,086 (34.7%) 3,375 (16.5%) 1,548 (7.6%) 
Table 3.7. The number of genes in the mouse liver with: at least one diet-induced differentially 
methylated region (DMR) within the gene body, more than one DMR in the gene body, and at 
least one DMR in the promoter, defined as within 2 kb upstream of the transcription start site (q 
< 0.05).  
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Comparison Pathway q-value Up- or  
Downregulated 
Males vs. females mmu03010 Ribosome 0.012 up (in males) 
mmu00190 Oxidative phosphorylation 0.024 up 
mmu00140 Steroid hormone biosynthesis 0.052 down 
mmu00591 Linoleic acid metabolism 0.052 down 
mmu00830 Retinol metabolism 0.052 down 
High fat vs. low fat  
diet 
mmu04060 Cytokine-cytokine receptor 
interaction 0.002 
up (in high fat) 
mmu04062 Chemokine signaling pathway 0.006 up 
mmu04514 Cell adhesion molecules (CAMs) 0.016 up 
mmu04640 Hematopoietic cell lineage 0.016 up 
mmu04650 Natural killer cell mediated 
cytotoxicity 
0.029 
 
up 
mmu03010 Ribosome 9.74E-06 down 
mmu00190 Oxidative phosphorylation 0.010 down 
Table 3.8. The signaling and metabolism pathways up- or downregulated by sex and diet. The 
ribosome pathway was upregulated in males compared to females, and the cytokine-cytokine and 
chemokine signaling pathways were upregulated in high-fat mice compared to low-fat mice.  
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Comparison Pathway q-value Up- or 
Down-
regulated 
Genes in 
Pathway 
Genes in the pathway with 
a DMR 
High fat vs. 
low fat 
females 
mmu04060 
Cytokine-cytokine 
receptor interaction 
0.017 up 270 Acvr1, Bmpr1b, Ccr4, Ccr7, 
Flt4, Kdr, Lifr, Ngfr, Osm, 
Pf4, Tnfrsf13b 
mmu04062 
Chemokine 
signaling pathway 
0.017 up 185 Adcy1, Adcy5, Adcy7, Ccr4, 
Ccr7, Dock2, Foxo3, Gng7, 
Grb2, Hck, Jak3, Mapk3, 
Nfkb1, Pard3, Pf4, Pik3cd, 
Pik3r2, Pxn, Stat3, Tiam1, 
Vav2 
mmu04514 Cell 
adhesion molecules 
(CAMs) 
0.049 up 145 Cadm1, Cd6, Cdh15, 
Cldn18, Cldn2, Itga9, 
Lrrc4b, Mpzl1, Nrxn3, 
Ntng1, Pecam1, Spn 
mmu04650 Natural 
killer cell mediated 
cytotoxicity 
0.049 up 133 Cd48, Fyn, Grb2, Lat, 
Mapk3, Nfatc1, Pik3cd, 
Pik3r2, Plcg2, Ppp3ca, 
Sh3bp2, Syk, Vav2, Zap70 
High fat vs. 
low fat  
males 
mmu04060 
Cytokine-cytokine 
receptor interaction 
0.039 up 270 Acvr1b, Bmp7, Csf1r, 
Cx3cr1, Flt3, Osm, Pdgfa, 
Pdgfra, Tgfbr2 
mmu03010 
Ribosome 
3.3x10-6 down 154  NA 
mmu00190 
Oxidative 
phosphorylation 
0.002 down 133 Atp6v0a1, Lhpp, Ppa1, Ppa2 
Table 3.9. The signaling and metabolism pathways up- or downregulated in female mice and 
male mice due to a high-fat diet. Any genes in these pathways that have a differentially 
methylated region are listed. Each of the five significant pathways for females was upregulated 
by a high-fat diet. In males, a high-fat diet upregulated the cytokine-cytokine pathway and 
downregulated the ribosome and oxidative phosphorylation pathways.  
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A)  B)  
Figure 3.5. (A) A high-fat diet drastically increases leptin levels in male mice, (B) but reduces 
the expression of the leptin receptor. HF = High-fat diet, and LF = Low-fat diet. Error bars 
represent ± a single standard error.    
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A)   
B)  
 
Figure 3.6. KEGG pathway diagrams, where red indicates upregulation by a high-fat diet and 
green indicates downregulation. A) The oxidative phosphorylation pathway is significantly 
downregulated due to a high-fat diet. B) The cytokine-cytokine pathway is significantly 
upregulated due to a high-fat diet.  
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A)   
 
B)   
 
C)   
 
D)    
 
E)  
Figure 3.7. Examples of differentially expressed genes that have differentially methylated 
regions within them. Epigenome Browser screenshots indicate the amount of methylation 
from MeDIP-seq. HF = High-fat diet, and LF = Low-fat diet. Error bars represent ± a single 
standard error.    
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Comparison GO_ID q-value Up or 
Down-
regulated 
Sex-by-diet 
Interaction 
GO:0009118 regulation of nucleoside metabolic process 3.75E-02 up 
GO:0030811 regulation of nucleotide catabolic process 3.75E-02 up 
GO:0033121 regulation of purine nucleotide catabolic 
process 
3.75E-02 up 
GO:0046578 regulation of Ras protein signal transduction 3.75E-02 up 
GO:0051056 regulation of small GTPase mediated signal 
transduction 
3.75E-02 up 
High-fat vs. 
low-fat diet 
GO:0002684 positive regulation of immune system process 4.95E-05 up 
GO:0043207 response to external biotic stimulus 4.95E-05 up 
GO:0045087 innate immune response 4.95E-05 up 
GO:0051707 response to other organism 4.95E-05 up 
GO:0001816 cytokine production 2.97E-04 up 
GO:0009607 response to biotic stimulus 2.97E-04 up 
GO:0031349 positive regulation of defense response 2.97E-04 up 
GO:0050776 regulation of immune response 2.97E-04 up 
GO:0009617 response to bacterium 2.98E-04 up 
GO:0001817 regulation of cytokine production 3.85E-04 up 
GO:0098542 defense response to other organism 4.12E-04 up 
GO:0002237 response to molecule of bacterial origin 6.30E-04 up 
GO:0060326 cell chemotaxis 1.78E-03 up 
GO:0050900 leukocyte migration 1.88E-03 up 
GO:0002252 immune effector process 2.47E-03 up 
GO:0006935 chemotaxis 2.47E-03 up 
GO:0006954 inflammatory response 2.47E-03 up 
GO:0031347 regulation of defense response 2.47E-03 up 
GO:0032496 response to lipopolysaccharide 2.47E-03 up 
GO:0042330 taxis 2.47E-03 up 
GO:0045088 regulation of innate immune response 2.47E-03 up 
GO:0045321 leukocyte activation 2.47E-03 up 
GO:0050663 cytokine secretion 2.47E-03 up 
GO:0050778 positive regulation of immune response 2.47E-03 up 
GO:0009306 protein secretion 3.43E-03 up 
GO:0046649 lymphocyte activation 3.69E-03 up 
GO:0030595 leukocyte chemotaxis 3.80E-03 up 
GO:0050707 regulation of cytokine secretion 4.43E-03 up 
GO:0034341 response to interferon-gamma 4.53E-03 up 
GO:0042742 defense response to bacterium 4.53E-03 up 
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GO:0000280 nuclear division 4.55E-03 up 
GO:0007067 mitosis 4.55E-03 up 
GO:0042110 T cell activation 4.55E-03 up 
GO:0097529 myeloid leukocyte migration 4.55E-03 up 
GO:0050729 positive regulation of inflammatory response 4.89E-03 up 
GO:0097530 granulocyte migration 6.56E-03 up 
GO:0002521 leukocyte differentiation 6.90E-03 up 
GO:0002757 immune response-activating signal transduction 7.14E-03 up 
GO:0071219 cellular response to molecule of bacterial origin 8.63E-03 up 
GO:0001819 positive regulation of cytokine production 9.12E-03 up 
GO:0032103 positive regulation of response to external 
stimulus 
9.97E-03 up 
GO:0051249 regulation of lymphocyte activation 1.15E-02 up 
GO:0045089 positive regulation of innate immune response 1.18E-02 up 
GO:0050708 regulation of protein secretion 1.18E-02 up 
GO:0071621 granulocyte chemotaxis 1.31E-02 up 
GO:0002764 immune response-regulating signaling pathway 1.37E-02 up 
GO:0002253 activation of immune response 1.47E-02 up 
GO:0071222 cellular response to lipopolysaccharide 1.47E-02 up 
GO:0048285 organelle fission 1.59E-02 up 
GO:0050865 regulation of cell activation 1.59E-02 up 
GO:0071216 cellular response to biotic stimulus 1.59E-02 up 
GO:0072676 lymphocyte migration 1.59E-02 up 
GO:0002696 positive regulation of leukocyte activation 1.73E-02 up 
GO:0030098 lymphocyte differentiation 1.77E-02 up 
GO:0050867 positive regulation of cell activation 1.80E-02 up 
GO:0030593 neutrophil chemotaxis 2.07E-02 up 
GO:0002694 regulation of leukocyte activation 2.08E-02 up 
GO:0071345 cellular response to cytokine stimulus 2.23E-02 up 
GO:0032101 regulation of response to external stimulus 2.34E-02 up 
GO:0050863 regulation of T cell activation 2.34E-02 up 
GO:1990266 neutrophil migration 2.41E-02 up 
GO:0071346 cellular response to interferon-gamma 2.63E-02 up 
GO:0050715 positive regulation of cytokine secretion 2.82E-02 up 
GO:0051251 positive regulation of lymphocyte activation 2.82E-02 up 
GO:0002685 regulation of leukocyte migration 4.36E-02 up 
GO:0032655 regulation of interleukin-12 production 4.36E-02 up 
GO:0050870 positive regulation of T cell activation 4.63E-02 up 
GO:0043900 regulation of multi-organism process 4.64E-02 up 
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GO:0034097 response to cytokine 5.18E-02 up 
GO:0002443 leukocyte mediated immunity 5.27E-02 up 
GO:0030217 T cell differentiation 5.27E-02 up 
GO:0002687 positive regulation of leukocyte migration 5.31E-02 up 
GO:0032615 interleukin-12 production 5.45E-02 up 
High fat vs. 
low fat 
females 
GO:0043207 response to external biotic stimulus 1.27E-03 up 
GO:0045087 innate immune response 1.27E-03 up 
GO:0051707 response to other organism 1.27E-03 up 
GO:0002684 positive regulation of immune system process 2.29E-03 up 
GO:0098542 defense response to other organism 3.95E-03 up 
GO:0009607 response to biotic stimulus 6.07E-03 up 
GO:0002252 immune effector process 6.10E-03 up 
GO:0009617 response to bacterium 6.10E-03 up 
GO:0050776 regulation of immune response 6.52E-03 up 
GO:0001816 cytokine production 7.54E-03 up 
GO:0001817 regulation of cytokine production 1.22E-02 up 
GO:0002237 response to molecule of bacterial origin 1.22E-02 up 
GO:0031349 positive regulation of defense response 1.22E-02 up 
GO:0060326 cell chemotaxis 1.35E-02 up 
GO:0042742 defense response to bacterium 1.79E-02 up 
GO:0050900 leukocyte migration 1.79E-02 up 
GO:0009306 protein secretion 1.85E-02 up 
GO:0050663 cytokine secretion 1.90E-02 up 
GO:0030595 leukocyte chemotaxis 2.11E-02 up 
GO:0006954 inflammatory response 2.35E-02 up 
GO:0034341 response to interferon-gamma 2.44E-02 up 
GO:0050778 positive regulation of immune response 2.58E-02 up 
GO:0032496 response to lipopolysaccharide 3.46E-02 up 
GO:0050729 positive regulation of inflammatory response 3.97E-02 up 
GO:0031347 regulation of defense response 4.36E-02 up 
GO:0045088 regulation of innate immune response 4.36E-02 up 
GO:0050707 regulation of cytokine secretion 4.36E-02 up 
GO:0097529 myeloid leukocyte migration 4.36E-02 up 
GO:0097530 granulocyte migration 4.36E-02 up 
High-fat vs. 
low-fat diet 
males 
GO:0002684 positive regulation of immune system process 2.03E-03 up 
GO:0045087 innate immune response 3.38E-03 up 
GO:0043207 response to external biotic stimulus 4.53E-03 up 
GO:0051707 response to other organism 4.53E-03 up 
GO:0001816 cytokine production 5.86E-03 up 
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GO:0031349 positive regulation of defense response 5.86E-03 up 
GO:0001817 regulation of cytokine production 6.70E-03 up 
GO:0009617 response to bacterium 6.70E-03 up 
GO:0002237 response to molecule of bacterial origin 6.81E-03 up 
GO:0006935 chemotaxis 6.81E-03 up 
GO:0009607 response to biotic stimulus 6.81E-03 up 
GO:0042330 taxis 6.81E-03 up 
GO:0050776 regulation of immune response 6.81E-03 up 
GO:0045321 leukocyte activation 1.15E-02 up 
GO:0007067 mitosis 1.20E-02 up 
GO:0046649 lymphocyte activation 1.23E-02 up 
GO:0042110 T cell activation 1.55E-02 up 
GO:0032496 response to lipopolysaccharide 1.64E-02 up 
GO:0098542 defense response to other organism 1.64E-02 up 
GO:0031347 regulation of defense response 1.74E-02 up 
GO:0045088 regulation of innate immune response 1.74E-02 up 
GO:0050663 cytokine secretion 1.74E-02 up 
GO:0050900 leukocyte migration 1.74E-02 up 
GO:0002521 leukocyte differentiation 2.09E-02 up 
GO:0050707 regulation of cytokine secretion 2.09E-02 up 
GO:0060326 cell chemotaxis 2.19E-02 up 
GO:0050778 positive regulation of immune response 2.27E-02 up 
GO:0034341 response to interferon-gamma 2.40E-02 up 
GO:0006954 inflammatory response 2.44E-02 up 
GO:0071345 cellular response to cytokine stimulus 2.44E-02 up 
GO:0000280 nuclear division 2.49E-02 up 
GO:0002757 immune response-activating signal transduction 2.81E-02 up 
GO:0030098 lymphocyte differentiation 2.81E-02 up 
GO:0051056 regulation of small GTPase mediated signal 
transduction 
3.30E-02 up 
GO:0051249 regulation of lymphocyte activation 3.30E-02 up 
GO:0030334 regulation of cell migration 3.34E-02 up 
GO:0071219 cellular response to molecule of bacterial origin 3.34E-02 up 
GO:0001819 positive regulation of cytokine production 3.37E-02 up 
GO:0050865 regulation of cell activation 3.37E-02 up 
GO:0097529 myeloid leukocyte migration 3.37E-02 up 
GO:0045089 positive regulation of innate immune response 3.52E-02 up 
GO:0050867 positive regulation of cell activation 3.97E-02 up 
GO:0030595 leukocyte chemotaxis 4.24E-02 up 
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GO:0046578 regulation of Ras protein signal transduction 4.36E-02 up 
GO:0071216 cellular response to biotic stimulus 4.36E-02 up 
GO:0032103 positive regulation of response to external 
stimulus 
4.51E-02 up 
GO:0032880 regulation of protein localization 4.51E-02 up 
GO:0050729 positive regulation of inflammatory response 4.51E-02 up 
GO:0071222 cellular response to lipopolysaccharide 4.51E-02 up 
GO:0072676 lymphocyte migration 4.51E-02 up 
GO:2000145 regulation of cell motility 4.51E-02 up 
GO:0097530 granulocyte migration 4.52E-02 up 
GO:0002694 regulation of leukocyte activation 4.56E-02 up 
GO:0002696 positive regulation of leukocyte activation 4.56E-02 up 
GO:0009306 protein secretion 4.56E-02 up 
GO:0002764 immune response-regulating signaling pathway 4.60E-02 up 
GO:0042742 defense response to bacterium 5.01E-02 up 
GO:0034097 response to cytokine 5.09E-02 up 
GO:0002253 activation of immune response 5.24E-02 up 
GO:0030097 hemopoiesis 5.24E-02 up 
GO:0032101 regulation of response to external stimulus 5.24E-02 up 
Table 3.10. Significant GO Biological Processes affected by sex and diet.  
 
A)  B)  
Figure 3.8. A) Venn Diagram illustrating the number of genes whose expression was found to be 
altered by a high-fat diet in my study of SM/J mice, compared to those found by other 
researchers using C57BL/6 mice. The present study replicated between 28-40% of the genes 
found in other studies. B) Only two genes were found by all three studies that used C57BL/6 
mice, illustrating the difficulty of replication in studies of how dietary fat alters gene expression.   
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  Gene Fold difference of HF vs. LF 
Females 
Adam11 6.57 ± 0.33 
Lad1 3.54 ± 0.37 
Galnt10 4.15 ± 1.80 
Males 
Adam11 7.84 ± 4.10 
Col1a1 9.90 ± 6.08 
Abcg8 11.77 ± 7.30 
 
Table 3.11. The RT-qPCR validation results. Values are presented as high-fat diet expression 
relative to low-fat diet expression levels. Fold differences were calculated with the ∆∆CT 
method and reported as a range to include the standard deviation. HF= High-fat diet, LF= Low-
fat diet.  
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Maternal Obesity Alters Offspring Gene Expression, DNA Methylation, and Obesity Risk 
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ABSTRACT 
 In this study, I investigated maternal obesity in inbred SM/J mice by assigning females to 
a high-fat diet or a low-fat diet at weaning, mating them to low-fat-fed males, then cross-
fostering the offspring to low-fat-fed SM/J nurses at birth, and weaning the offspring onto a high 
fat or low-fat diet. A maternal high-fat diet exacerbated obesity in the high-fat-fed daughters, 
causing them to weigh more, have heavier livers and reproductive fat pads, and have higher 
serum levels of leptin as adults, accompanied by gene expression and methylation changes in 
their livers and hearts (46 differentially expressed genes and 1,700 differentially methylated 
regions in the liver, 45 differentially expressed genes and 4,103 differentially methylated regions 
in the heart). RNA sequencing revealed that maternal diet changed the expression of dozens of 
genes in the liver in both sons and daughters. Maternal obesity particularly affected genes 
involved in RNA processing, immune response, and mitochondria. It also induced thousands of 
DNA methylation changes regardless of offspring diet. High-fat-fed offspring had over 7,300 
genes in the liver with at least one differentially methylated region due to maternal diet, while 
low-fat-fed offspring had 9,300 genes with differentially methylated regions. Between one-
quarter and one-third of differentially expressed genes contained a differentially methylated 
region due to maternal diet. An offspring high-fat diet reduced overall variation in DNA 
methylation, increased body weight and organ weights, increased the lengths and weights of the 
long bones, decreased insulin sensitivity, and changed the expression of 3,908 genes in the liver. 
Although the offspring were more affected by their own diet, their maternal diet had epigenetic 
effects lasting through adulthood, and in the daughters these effects were accompanied by 
phenotypic changes relevant to obesity and diabetes.  
INTRODUCTION 
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 A mother’s diet—from its fat and protein content to its richness in methyl donors while 
DNA methylation is being established in the developing fetus—can directly affect her 
offspring’s epigenome (Wolff et al. 1998, Waterland and Jirtle 2003, Dolinoy et al. 2006, 
Oestreich and Moley 2017). Maternal diet is important to study, because half of women giving 
birth in the United States have pre-pregnancy weights classifying them as overweight or obese 
(Branum et al. 2016). As obesity rates continue rising, it is crucial to investigate individuals’ 
responses to both their own nutritional environment and the environment provided by their 
mothers to take the next step towards understanding the epigenetic architecture of obesity.  
 In humans, maternal obesity poses dangers for the mother and her child. Obese women 
have higher rates of infertility, miscarriage, preeclampsia, gestational diabetes, and cesarean 
section (Poston et al. 2011, Weiss et al. 2004). Their babies have a higher risk of stillbirth (Yao 
et al. 2014, Chu et al. 2007), neural-tube defects (Poston et al. 2011, Rasmussen et al. 2008), 
being born large for gestational age (Sebire et al. 2001, Gaudet et al. 2014), and being born on 
average with a higher percentage of body fat, more leptin in their cord blood, and increased 
levels of the inflammatory cytokine interleukin-6 (Catalano et al. 2009). The detrimental health 
effects of maternal obesity can last throughout life. Maternal obesity raises the rate of childhood 
obesity (Whitaker 2004, Hillier et al. 2007, Yu et al. 2013) and is associated with higher levels 
of insulin, cholesterol, and blood pressure in children (Gaillard et al. 2014). Children of obese 
mothers have also been shown to be at risk of impaired cognitive and executive function (Pugh et 
al. 2015), and 3- to 5-year-olds whose mothers were very severely obese during pregnancy 
(Body Mass Index ≥ 40 kg/m2) had an increased risk of neuropsychiatric problems including 
hyperactivity, aggression, anxiety, and sleep difficulties (Mina et al. 2017). The effects of 
maternal obesity continue into adulthood, increasing the risk of cancer, type 2 diabetes, 
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cardiovascular disease, and high blood pressure, and raising serum levels of insulin and 
triglycerides (Hochner et al. 2012, Eriksson et al. 2014, Stirrat and Reynolds 2014, Galliard 
2015). 
 The effects of maternal obesity in mice are similar to those in humans. C57BL/6J mice 
exposed to a high-fat diet during gestation had higher levels of obesity, hyperglycemia, 
hypertension, and insulin resistance as adults, even though they were fed a standard diet after 
birth (Liang et al. 2009). Another study of C57BL/6NCrl mice found that regardless of offspring 
diet, daughters of high-fat-fed mothers weighed more, had higher cholesterol and blood pressure, 
and had fattier livers (Elahi et al. 2009). Some of the phenotypic changes induced by maternal 
obesity have been linked to epigenetics and gene expression. For instance, Wankhade et al. 
(2017) found that offspring of high-fat-fed C57BL/6J mothers had larger livers exhibiting 
inflammation and steatosis, accompanied by higher profibrogenic gene expression and 82 
differentially methylated regions. Heart structure and gene expression are also affected by 
maternal obesity, as exemplified by the findings of Fernandez-Twinn et al. (2012) where adult 
offspring of obese C57BL/6J mouse dams had larger hearts, thicker left ventricles, wider muscle 
cells, hyperinsulinemia, increased expression of molecular markers indicative of cardiac 
hypertrophy, and increased expression of genes associated with oxidative distress. Similarly, 
Blackmore et al. (2014) found cardiac dysfunction in the adult sons of obese C57BL/6J mouse 
dams, despite the sons being fed a low-fat diet. They expressed cardiac genes that normally are 
expressed only during fetal development, which is a sign of cardiac hypertrophy. 
 Previous rodent studies have shown that offspring sex affects the response to maternal 
obesity, with daughters of high-fat-fed mothers having higher blood pressure (Khan et al. 2004), 
higher plasma leptin levels (Bellisario et al. 2014), and smaller livers than sons (Miller et al. 
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2014), whereas sons have a more pronounced difference in their transcriptomes (Mischke et al. 
2013). It is thus important to take offspring sex into account when investigating the phenotypic 
and epigenetic effects of maternal obesity.  
 Maternal obesity impacts offspring disease risk through multiple mechanisms across the 
spectrum of development, from altering the glucose consumption and size of oocytes to 
disrupting the circadian rhythms and metabolic genes in the hearts and livers of offspring 
(Jungheim et al. 2010, Leary et al. 2015, Wang et al. 2015). High blood pressure in obese 
women alters blood vessels, and during pregnancy vasodilatation is impaired in uterine arteries 
(Roberts et al. 2015). On the cellular level, maternal obesity can leave lasting effects on 
offspring by changing the number, distribution, structure, and function of mitochondria in 
oocytes (Igosheva et al. 2010, Luzzo et al. 2012, Grindler and Moley 2013). At the level of the 
organ, obesity affects offspring prenatally through placental abnormalities, including heavier 
placental weight, more inflammatory lesions (43% in obese women as opposed to 3.6% in lean 
women) (Bar et al. 2012), lower rates of apoptosis, more muscular vessel walls, higher transport 
of glucose and amino acids across the placenta (Sferruzzi-Perri et al. 2013), and greater 
inflammatory cytokine expression (Roberts et al. 2011). Obesity is an inflammatory disease in 
addition to a metabolic one (André et al. 2014), and exposure to elevated inflammatory cytokines 
in the womb alters the way the fetal immune system is programmed. Wilson et al. (2015) found 
that the cord blood of infants with obese mothers had fewer CD4 helper T cells and higher levels 
of the cytokines IFN-α2 and IL-6, which could impair response to vaccination and infection. In 
rodents, offspring of obese dams have inflammation in their brains (Bilbo and Tsang 2010, Kang 
et al. 2014).  
 Although obesity can be passed on to offspring via genetic variants, there is growing 
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evidence that prenatal epigenetic programming plays a substantial role in the transmission of 
obesity across generations (Oestreich and Moley 2017). A classic example of this phenomenon is 
the Avy allele at the agouti locus in mice. Avy dams give birth to pups with ectopic agouti 
expression, which causes obesity. However when a pregnant Avy dam is fed a diet rich in methyl-
donors, her offspring are born with increased agouti methylation, restored agouti expression, and 
they do not develop obesity, thus illustrating an epigenetic route for the enduring effects of 
maternal diet (Wolff et al. 1998, Waterland and Jirtle 2003, Waterland et al. 2004). In humans, 
newborns with obese parents have methylation differences at several imprinted genes in their 
cord blood (Soubry et al. 2015). These methylation changes last at least into childhood, as 
demonstrated by Guénard et al. (2013) in their study of 20 obese mothers who underwent gastric 
bypass surgery. The children born after their mother’s surgery had lower Body Mass Indexes, 
better cardiometabolic profiles, and methylation differences in more than 5,000 genes in their 
blood compared to their siblings born before the surgery. Much remains to be learned about the 
epigenetic changes induced by maternal obesity. Due to cost limitations, most studies only 
measure methylation in one tissue—even though the epigenetic changes likely vary across tissue 
types—and methylation is often only assessed in candidate genes, which cannot give a full 
picture of the extent to which the genome is affected. It is important to uncover the epigenetic 
dysregulation that offspring experience due to maternal obesity in order to understand how 
obesity is transmitted in utero as well as to identify targets for novel epigenetic therapies. Since 
the effects of maternal obesity begin even before birth, it is crucial to know which specific 
epigenetic risk factors a baby is likely to be born with in order to make early intervention 
possible.  
 In the last few decades we have seen increasing portion sizes, the rise of the fast food 
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industry, the birth of fructose-enrichment technology, and the expansion of the food processing 
industry—which adds large quantities of saturated fats, fructose, and salt to food (Young and 
Nestle 2002). It is no surprise that obesity rates are skyrocketing, and with as many as 38% of 
pregnant women classified as obese today (McDonald 2010), it is vital to investigate the 
epigenetic mechanisms through which a mother’s diet can induce obesity in her offspring.  
 Maternal effects occur when the mother’s genotype or phenotype causally influences the 
offspring phenotype (Wolf and Wade 2009). In the present study of diet, I am concerned with the 
non-genetic aspect of maternal effects. In the context of evolution, non-genetic maternal effects 
can be good predictors of the environment that the offspring will experience and thus improve 
fitness and even help with the colonization of new niches (Maestripieri and Mateo 2009). 
However, non-genetic maternal effects can also be maladaptive, as in the case of the thrifty-
phenotype hypothesis. This posits that exposure to poor nutrition in the prenatal and early 
postnatal environment results in metabolic syndrome later in life (Hales and Barker 2001). 
 Here, I investigated the direct effects of a high-fat diet as well as the non-genetic 
maternal effects of a high-fat diet. I measured the direct effects of diet by assigning offspring to 
either a high fat or a low-fat diet. I measured the maternal effects of a high-fat diet by comparing 
groups of offspring that had the same sex and diet but had mothers on different diets (for 
instance, I investigated if high-fat-fed females who had high-fat-fed mothers were heavier than 
high-fat-fed females who had low-fat-fed mothers). It can be difficult to disentangle the effects 
of prenatal and postnatal maternal obesity in humans, so in this study I used a cross-fostering 
design in mice where offspring of high-fat-fed and low-fat-fed mothers were all fostered at birth 
to low-fat-fed nurses. Most maternal obesity research in mice focuses on the C57BL/6 strain, but 
because epigenetic response can be highly dependent on genomic background, I used the less-
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studied but highly responsive SM/J strain. While many studies use a candidate-gene approach to 
assess changes in methylation due to maternal obesity, I took a genome-wide approach in order 
to identify novel genes involved and gain a more comprehensive picture. I also investigated the 
DNA methylation in two types of tissue, liver and heart, to better understand the systemic 
epigenetic effects of maternal obesity. Finally, as another measure of body size I measured the 
weights and lengths of the long bones. It has been suggested that obesity affects bone 
metabolism through leptin and inflammatory cytokines (Ducy et al. 2000, Cao 2011), but it is not 
known if exposure to a high-fat diet in utero affects the bones of adult offspring.  
METHODS 
Animal Rearing  
 The animals used in this experiment were derived from inbred SM/J mice obtained from 
The Jackson Laboratory (Bar Harbor, Maine). This strain originated from a selective breeding 
experiment for small size at 60 days of age (MacArthur 1944), and has an extreme obesogenic 
response to dietary fat (Cheverud et al. 1999, Ehrich et al. 2003, Partridge et al. 2014). The 
parental generation was born in our facility at Loyola University Chicago and was weaned onto a 
high fat (HF) diet or a low fat (LF) diet at 3 weeks of age. The diets are nearly isocaloric, but the 
HF diet has three times as much fat. In the LF diet, fat accounted for 15% of the calories 
(Research Diets D12284), whereas 42% of the calories came from fat in the HF diet (Harlan 
Teklad diet TD.88137) (Table 4.1). Erich et al. (2003) showed that food consumption does not 
differ due to the HF or LF diet in SM/J mice. At 10 weeks of age, 12 HF diet females and 14 LF 
diet females were mated with LF diet males to create an F1 generation. Males were removed 
from the cage when abdominal palpation revealed the female to be pregnant. To control for the 
postnatal effect of maternal diet, I cross-fostered all offspring to an LF-fed SM/J nurse within 24 
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hours of birth. At three weeks of age, half of the offspring were weaned onto an LF diet and the 
other half were weaned onto an HF diet to produce 4 diet treatment groups: HF-HF, LF-HF, HF-
LF, and LF-LF (where the first diet listed is the maternal diet and the second is the offspring 
diet) (Figure 4.1). There were 10 male and 10 female offspring in each of the diet treatment 
groups, and they were housed in same-sex pairs of mice on the same diet. Each cage had a 
privacy hut (Alt Design), a cotton nestlet (Ancare), a wooden gnawing block (Bio Serve), and 
food and water provided ad libitum in a 12-h light, 12-h dark cycle. Procedures were performed 
under an approved Institutional Animal Care and Use Committee protocol (Project #1188).  
Obesity Phenotypes 
 The mice were weighed weekly for 17 weeks. They were housed in pairs until 13 weeks 
of age, after which they were housed individually. When the mice were 14 weeks old, 20 pellets 
of food were weighed and placed into their food rack. Food consumption was measured by 
weighing the food remaining in the cage 24, 48, 96, and 168 hours later. Previous research shows 
that SM/J mice initially lose weight after being moved to single housing (Ehrich et al. 2003), so I 
measured food consumption after the mice had one week to adjust to being housed singly. When 
the mice were 15 weeks old, they underwent an intraperitoneal glucose tolerance test (IPGTT). 
All IPGTTs were performed at 10:00 AM, after the mice had been fasted for 4 hours. I measured 
their baseline glucose levels with a glucometer (Ascensia Bayer Breeze 2) using blood from a 
tail snip, then intraperitoneally injected a 10% glucose solution (0.01 mL/g body weight). I 
measured the glucose levels again at 30, 60, and 120 minutes after the injection. When the mice 
were 16 weeks old, they underwent intraperitoneal insulin tolerance testing (IPITT). The IPITT 
protocol is similar to the IPGTT protocol, except rather than receiving a glucose injection, the 
mice were injected with a 0.1% insulin solution (0.75 mU/g body weight). If a mouse’s blood 
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glucose levels dropped under 25 mg/dL, it was injected with a 10% glucose solution and was not 
included in the IPITT results. After the IPGTT and IPITT, the area under the curve (AUC) was 
calculated using the blood glucose levels at the 4 different time points via the trapezoidal 
summation method for each mouse. When the mice were 17 weeks old, they were fasted for four 
hours and then sacrificed by carbon dioxide asphyxiation between 10:00 am and 2:00 pm. A 
cardiac puncture was immediately performed to draw blood, and the serum was submitted to 
Washington University in St. Louis’s Core Laboratory for Clinical Studies to measure leptin and 
insulin, and to the Diabetes Models Phenotyping Core to measure triglycerides, cholesterol, free 
fatty acids, and glucose. After the blood draw, I necropsied the mice on ice and recorded the 
weights of the liver, heart, reproductive fat pad, kidneys, spleen, brown fat, and skeletal muscle. I 
chose to weigh only the reproductive fat pad instead of all of the fat pads, since it is the largest 
and is strongly phenotypically (r = 0.67-0.82) and genetically correlated (h2 = 0.7-0.9) with the 
other fat pads (Cheverud et al. 2004, Cheverud et al. 2011). I submerged tissue from the liver, 
heart, pancreas, reproductive fat pad, and hypothalamus in RNAlater and then stored the samples 
in a -80C freezer. The mouse bones were cleaned with dermestid beetles, and then the long bones 
(radius, ulna, femur, and tibia) were weighed and their lengths were double-measured with 
calipers (Table 4.3 and Figure 4.2), based on landmarks used by Kenney-Hunt et al. (2008). 
These skeletal dimensions provide an alternate measure of body size in addition to body weight, 
which is strongly influenced by obesity. The repeatabilities of the osteological measurements 
were all above 0.92 (Table 4.3).  
 For each obesity trait, differences between the diet treatments were analyzed by running a 
general linear model in SYSTAT (Version 12, Systat Software, San Jose, CA). A full model was 
run to test for the effect of sex, maternal diet, offspring diet, nurse ID, and the two-, three-, and 
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four-way interactions of those variables. A reduced model tested only the effects of maternal 
diet, offspring diet, sex, offspring-diet-by-sex, and offspring-diet-by-maternal diet terms. 
Multivariate tests were performed on three groups of traits: weekly weights, diabetes-related 
traits (week 15 and 16 weight, baseline glucose during IPGTT, IPGTT AUC, baseline glucose 
during IPITT, IPITT AUC, and food consumption), and necropsy traits (week 17 weight, serum 
biomarkers, and organ weights), in addition to all of the associated univariate tests. Differences 
were interpreted as significant for p-values less than 0.05. 
Gene Expression 
 I used the Qiagen RNeasy Plus Mini kit to extract RNA from the liver tissue of the 80 F1 
mice, and submitted it for RNA-seq with poly-A selection at the GTAC facility at Washington 
University in St. Louis. Quality control indicated that 74 of the 80 samples were of high enough 
quality for sequencing. A total of 37 libraries were sequenced, each with two mice of the same 
sex, maternal diet, and offspring diet pooled together. One exception was a HF-HF daughter 
library, which had 3 mice pooled together due to insufficient quantities of RNA. A 1x50 single 
read sequencing run was done on an Illumina HiSeq machine. The FastQ files were aligned to 
the Ensembl release 76 assembly using STAR version 2.0.4b (Dobin et al. 2013). The transcript 
and gene counts were imported to the R package edgeR (Robinson et al. 2010), a TMM 
normalization was performed to account for differences in library size, and genes with counts of 
zero were filtered out. The voom function in the R package Limma was then used to calculate the 
weighted likelihoods based on the mean-variance relationship of each gene. Differential 
expression was then tested with generalized linear models. Any gene with an unadjusted p-value 
of less than 0.05 and a log fold change (logFC) with an absolute value greater than 2 was 
considered differentially expressed. Two of the male libraries were determined to be outliers 
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based on inspection of the MDS plots, and they were not included in the rest of the analysis. The 
remaining 35 libraries were analyzed, which were: 4 libraries of HF-HF daughters, 5 LF-HF 
daughters, 5 HF-LF daughters, 4 LF-LF daughters, 5 HF-HF sons, 4 LF-HF sons, 4 HF-LF sons, 
and 4 libraries of LF-LF sons. The R package WGCNA (Langfelder and Horvath 2008) was used 
to build a tree from the libraries and then identify modules of genes with highly correlated 
expression levels. For each module that was significantly associated with at least one diabetes 
trait, I summarized the module based on its top ten significant Gene Ontology (GO) terms. I also 
used the R package GAGE (Luo et al. 2009) to identify pathways that were perturbed in a single 
direction or generally dysregulated due to maternal diet, and visualized those pathways using the 
R package Pathview (Luo and Brouwer 2013).  
 I validated the differential expression of three genes with RT-qPCR in the HF daughters 
(Mpo, Anxa2, and Chrna4), using Gapdh as a normalizer. I extracted total RNA from the liver 
tissue of 3 HF-HF and 3 LF-HF daughters with Tri-Reagent (MRC), following the 
manufacturer’s instructions. The concentration and quality of the RNA from each sample was 
assessed twice with a NanoDrop Spectrophotometer, and I found that all samples had a 260/280 
ratio between 1.7-2.1 and a 260/230 ratio between 2.0-2.4. I used the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) to reverse transcribe the RNA to cDNA. I chose 
primers for qPCR from the literature and PrimerBank (https://pga.mgh.harvard.edu/primerbank/), 
and those primers were then synthesized by Thermo Fisher Scientific (Table 4.6). I used a 
reaction volume of 20 µL for the RT-qPCR, with 10 µL of PowerUp™ SYBR® Green Master 
Mix (Thermo Fisher), 1 µL of the forward primer, 1 µL of the reverse primer, 4 µL of 20-fold 
diluted cDNA, and 4 µL of water. For each of the 3 biological replicates, I used 3 technical 
replicates, a no-template control, and a no-reverse-transcriptase control. A StepOnePlus Real-
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Time PCR System (Applied Biosystems) was used to perform the RT-qPCR under these 
conditions: 20 seconds at 95°C and then 40 cycles of 3 seconds at 95°C and 30 seconds at 60°C. 
I then used the comparative ΔΔCt method to perform a relative quantification of each of the three 
genes compared to Gapdh (Table 4.13). 
DNA Methylation 
 I extracted DNA from the liver and heart tissue using a phenol-chloroform extraction. 
DNA methylation across the genome was then measured with Methylated DNA 
Immunoprecipitation Sequencing (MeDIP-seq) and Methylation-sensitive Restriction Enzyme 
Sequencing (MRE-seq) as previously described in detail by Li et al. (2015). MeDIP-seq reveals 
methylated sites whereas MRE-seq reveals unmethylated sites, and when used together they 
provide a genome-wide methylation map at single CpG resolution. This technique has high 
concordance with whole genome bisulfite sequencing at a fraction of the cost (Stevens et al. 
2013). For the liver tissue, 4 mice of the same sex and from the same maternal diet and offspring 
diet treatment group were pooled per library, for 2 biological replicates per group and a total of 
16 liver libraries. For the heart tissue, only the HF-HF and LF-HF daughters were analyzed, for a 
total of 4 heart libraries. I combined the MRE-seq and MeDIP-seq data using the R package 
methylMnM to find differentially methylated regions (DMRs) due to maternal diet. MethlyMnM 
works by calculating the proportion of methylated CpGs in each window, and then determining 
the probability that the methylation level is statistically different between the two diet treatment 
groups. This is accomplished by performing a hypothesis test for each window based on the 
novel M&M test statistic (Zhang et al. 2013). For this analysis, I removed blacklist sites and set 
the window size to 500 base pairs, which split the genome into 5,283,825 windows. Since there 
were two biological replicates per group and M&M can only do pairwise comparisons, I used 
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Fisher’s combined probability test to compare offspring on the same diet who had mothers on 
different diets (Fisher 1954). For example, the p-value from the M&M test comparing the HF-
HF-daughter-1 vs. LF-HF-daughter-1 libraries was combined with the p-value from the M&M 
test comparing the HF-HF-daughter-2 vs. LF-HF-daughter-2 libraries. 
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Pi is the p-value from the M&M test, and since I combined p-values from k = 2 tests, X has a chi-
squared distribution with 4 degrees of freedom. I then corrected for multiple comparisons using 
the Benjamini-Hochberg false discovery rate (FDR), and the resulting corrected combined q-
values were used to determine which windows were differentially methylated. Since setting a 
significance threshold is somewhat arbitrary, I determined how many windows had a q-value 
below 0.05, 0.01, and 0.001.  
 For each DMR, I identified the gene it was closest to, any genes or Ensembl regulatory 
elements it fell within (mouse genome assembly GRCm38.p5), if it fell within a promoter, and if 
the gene closest to it was previously known to be involved in diabetes mellitus, obesity, or 
cardiovascular diseases according to Phenopedia’s continuously updated list of genetic 
association studies (retrieved May 7, 2017) (Tables 19-23). I classified each DMR as being 
located in an intergenic region, intron, exon, or promoter by using the list of introns, exons, and 
genes in the NCBI37/mm9 assembly of the UCSC Genome Browser. If a DMR overlapped an 
exon as well as an intron, it was classified as falling within an exon. A DMR was labeled as 
being in a promoter if it was between 2,000 base pairs upstream of a transcription start site and 
600 base pairs downstream of one. To establish if the DMRs were significantly associated with 
gene expression, I randomized the location of the DMRs across the genome and determined how 
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many fell within differentially expressed genes by chance. To account for the observed 
underrepresentation of DMRs in intergenic regions, the percent of DMRs that were randomized 
into intergenic regions equaled the percent that actually exist in intergenic regions. 
RESULTS 
Obesity Phenotypes 
 When the dams were mated at 10 weeks of age to produce the F1 offspring, the LF dams 
weighed on average 15.3 grams and the HF dams weighed on average 21.7 grams. I consider this 
40% increase in weight of the HF dams to signify obesity. The general linear model showed that 
the weekly weights, diabetes-related traits, and necropsy traits were all significantly affected by 
maternal diet (p = 0.001), offspring diet (p = 4.17 x 10-16), sex (p = 2.36 x 10-13), and an 
offspring-diet-by-sex interaction (p = 3.0 x 10-5). Due to the strong offspring-diet-by-sex 
interaction, sons and daughters were analyzed separately. There was a significant offspring-diet-
by-maternal-diet interaction (p = 0.009) for the necropsy traits only. Also, there was a borderline 
significant interaction of maternal diet, offspring diet, and sex for the diabetes-related traits (p = 
0.07), and a borderline significant sex-by-maternal-diet interaction for the weekly weights (p = 
0.07). 
 Unsurprisingly, the offspring’s diet had a major effect on the obesity traits. Mice on a 
high fat (HF) diet had heavier body weights within one week of being weaned onto the diet (4 
weeks old), a greater response to glucose tolerance testing, a reduced response to insulin 
tolerance testing, heavier organs, and higher serum levels of leptin, insulin, triglycerides, 
glucose, and free fatty acids. HF mice also had longer, heavier long bones than mice on a low fat 
(LF) diet (Table 4.3 and Table 4.4), consistent with the notion that obesity alters bone 
metabolism (Cao 2011). 
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 The direct effect of diet was much more extensive than the maternal effect of diet. 
Maternal diet affected the obesity traits of the daughters, but not the sons. HF-fed daughters 
weighed more in adulthood (Figure 4.3), had higher serum levels of leptin (Figure 4.4), 
consumed more food at 14 weeks of age (Figure 4.9A), and had even heavier reproductive fat 
pads and brown fat if they had HF mothers rather than LF mothers (Figure 4.4). LF-fed 
daughters of HF mothers had the highest levels of free fatty acids in their serum, and a maternal 
HF diet actually lowered the triglyceride and glucose levels in the daughters on either diet 
(Figure 4.4). 
Gene Expression 
 The multidimensional scaling plot indicated that the gene expression libraries clustered 
by sex (dimension 1) and offspring diet (dimension 2), without any discernable patterns in 
dimensions 3 or 4 (Figure 4.5). Offspring diet caused expression differences in 3,908 genes in 
the liver. Of note is the considerable downregulation of the leptin receptor (Lepr) gene by an HF 
diet. Offspring on an HF diet had far more leptin in their serum (HF daughters had over 5 times 
more leptin than LF daughters, and HF sons had over 3 times more than LF sons) (Figure 4.6A). 
Despite having more of this satiety hormone, HF offspring actually ate more than LF offspring at 
14 weeks of age (Figure 4.6B). This resistance to leptin appears to be mediated in part by the 
substantial reduction in the expression of Lepr, which was 8 times lower in the HF daughters 
than the LF daughters and 12 times lower in the HF sons than the LF sons (Figure 4.6C). 
 Maternal diet did not have as widespread an effect on expression as offspring diet, but it 
significantly altered the expression of dozens of genes. When comparing offspring of the same 
sex and diet who differed only in maternal diet, I found that maternal diet altered 46 genes in the 
HF-fed daughters’ livers, 45 genes in the HF-fed daughters’ hearts, 70 genes in the LF-fed 
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daughters’ livers, 22 genes in the HF-fed sons’ livers, and 434 genes in the livers of the LF-fed 
sons (Table 4.5 and Tables 4.14-4.18). The GAGE pathway analysis revealed many signaling 
and metabolism pathways that were downregulated due to a maternal HF diet (Table 4.6). More 
pathways were downregulated in the LF-fed offspring, with 28 downregulated pathways in the 
LF-fed daughters and 146 in the LF-fed sons, compared to 4 in the HF daughters’ livers (and 21 
in their hearts) and 51 in the HF sons’ livers. A maternal HF diet downregulated the ribosome, 
spliceosome, oxidative phosphorylation, and RNA transport pathways in the livers of all four of 
the offspring diet-sex group comparisons. The GO Biological Processes affected by maternal diet 
showed a similar trend of more being dysregulated in the LF-fed offspring, with 284 processes 
altered in the LF-fed daughters and 2,660 in the LF-fed sons, compared to 31 in the HF-fed 
daughters’ livers (151 in their hearts) and 625 in the HF-fed sons’ livers.  
 The top GO terms affected by maternal diet in the liver involved RNA splicing and 
processing, non-coding RNA processing, immune response, and protein catabolic processes 
(Table 4.7). In the HF-fed daughters’ heart tissue, maternal HF diet downregulated biosynthetic 
and metabolic pathways (Table 4.7). An offspring HF diet significantly changed the regulation of 
28 KEGG disease pathways in the liver, including downregulating the non-alcoholic fatty liver 
disease (NAFLD) (Figure 4.7), Alzheimer’s disease (Figure 4.8), Parkinson’s disease, and 
Huntington’s disease pathways. A maternal HF diet further downregulated these four pathways 
in each of the offspring diet-sex group comparisons.  
 The weighted gene co-expression network analysis (WGCNA) provided more insight into 
the relationship of the gene expression with the obesity phenotypes (Table 4.9). The phenogram 
built from clustering the expression libraries had cophenetic correlations all above 0.85, 
indicating that it closely represented the relationships between the libraries. Setting the minimum 
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module size to 40 genes yielded 29 modules of co-expressed genes, ranging from 34 to 1,785 
genes per module. Four of these modules were significantly associated with the diabetes-related 
traits (week 15 and week 16 weight, glucose tolerance, insulin tolerance, serum glucose and 
insulin levels, and food consumption) (Figure 4.8). The black module was negatively correlated 
with the diabetes traits and contained 637 genes, which were significantly enriched for immune 
system function. The yellow module was also negatively correlated with the diabetes traits, and it 
contained 932 genes that were enriched for terms involving oxidation reduction and arachidonic 
acid (which is an inflammatory intermediate and a vasodilator). The magenta module was 
positively correlated with the diabetes traits and contained 312 genes that were enriched for 
mitochondrial and ribosomal processes, suggesting that the genes in this module were regulating 
the diet-induced changes in metabolism and gene expression. The turquoise module had 1,785 
genes and was positively correlated with the diabetes traits, with enrichment for respiratory chain 
and mitochondrial processes. Overall, the GO term enrichment showed that the modules tended 
to involve the immune system and mitochondria, indicating that the disruption of these processes 
lead to the development of the diabetes traits I measured. 
 Maternal HF diet disrupted gene expression not only in the offspring’s livers, but in their 
hearts as well. Comparing the HF-fed daughters of HF mothers with HF-fed daughters of LF 
mothers revealed 45 differentially expressed genes due to maternal diet (Table 4.15). The gene 
expression libraries clustered by maternal diet, and the cophenetic correlations of the phenogram 
were all above 0.93 (Figure 4.10). The 21 upregulated genes due to maternal HF diet were 
primarily pseudogenes and non-coding RNAs. Most of the 24 downregulated genes were ones 
previously reported to be involved in obesity and cardiovascular diseases, in addition to 6 
cytochrome P450 genes.  
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Methylation 
 There were tens of thousands of differentially methylated regions (DMRs) due to 
maternal diet that fell below a q-value cutoff of 0.05 (0.7-1.1% of the 5.3 million windows) 
(Table 4.10). A q-value cutoff of 0.01 encompassed less than 0.2% of the windows, and 
highlighted several thousand regions affected by maternal diet (Supplementary Tables 4.19-
4.23). Less than 300 windows fell below the q-value cutoff of 0.001 in the HF-fed offspring, 
whereas 10 times as many windows did in the LF-fed offspring. A higher percentage of DMRs 
were found on the X-chromosome for between-sex comparisons (1.9-3.0%) than within-sex 
comparisons (0.1-0.5%). The daughters had a greater proportion of DMRs on the X-chromosome 
(0.2% and 0.5%) due to maternal diet than the sons (0.1%).  
 An offspring HF diet reduced the overall variation in methylation. When comparing 
offspring that had the same diet but different maternal diets, the LF-fed offspring had more 
maternal diet DMRs than the HF-fed offspring. For instance, when HF-fed daughters of HF 
mothers were compared to HF-fed daughters of LF mothers, they had 1,701 DMRs (q < 0.01) 
due to maternal diet. However, when LF-fed daughters with different maternal diets were 
compared, they had 9,550 DMRs—far more than the HF-fed daughters had. The same trend was 
seen in the sons, where the HF-fed sons had 2,262 DMRs due to maternal diet and the LF-fed 
sons had 8,737 DMRs. The pattern continued when comparing mice of the same maternal diet 
and offspring diet who were different sexes. HF-fed sons of HF mothers compared to HF-fed 
daughters of HF mothers had 5,031 DMRs, and similarly HF-fed sons and daughters of LF 
mothers had 5,610 DMRs. This was far fewer than the LF-fed offspring; when LF-fed sons of 
HF mothers were compared to LF-fed daughters of HF mothers, they had 14,571 DMRs, and LF-
fed sons and daughters of LF mothers had 10,201 DMRs. Thus, methylation patterns of males 
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and females were more similar to each other if they were both on an HF diet than both on an LF 
diet. Overall, being on an HF diet reduced the number of DMRs in comparisons of mice of 
different sexes and also in comparisons of mice with different maternal diets. This indicates that 
an offspring HF diet constrains variation in methylation patterns in the liver.  
 In the HF offspring, over 7,300 genes (36% of genes) in the liver had at least one DMR 
due to maternal diet (q < 0.05), whereas LF offspring had 9,300 genes (46% of genes) with a 
DMR (Table 4.11). About 14% of the maternal diet DMRs fell within promoters, 23% within 
exons, 35% in intergenic regions, and the rest in introns (Table 4.12). When Ensembl regulatory 
elements were included in the classification scheme, it became clear that the DMRs were 
disproportionately found in regulatory regions. Between 10 and 20% of DMRs overlapped 
enhancers (whereas only 3.5% of the 5.3 million windows genome-wide overlapped enhancers). 
Similarly, 5-10% of DMRs overlapped CTCF Binding sites (compared to 1.7% of windows 
genome-wide), 0.6-1.3% overlapped other transcription factor binding sites (compared to 0.3% 
of windows genome-wide), and 31-50% overlapped promoter flanking regions (compared to 
8.1% of windows genome-wide). Clearly, a maternal HF diet preferentially disrupted the 
methylation of promoters and other regulatory elements across the entire genome.  
 In HF-fed daughters, 23 (0.067%) of the maternal obesity DMRs (q < 0.05) were located 
in differentially expressed genes, although 45 DMRs (0.13%) would have been expected to fall 
in differentially expressed genes due to chance. In the LF-fed daughters, 80 (0.15% of) DMRs 
fell within differentially expressed genes, whereas 97 (0.18%) would have been expected due to 
chance. Thus, in the daughters, DMRs fell within differentially expressed genes less often than 
expected due to chance (p = 0.0002). The opposite was true in the sons. The HF-fed sons had 22 
(0.05%) of their DMRs in differentially expressed genes, while 17 (0.04%) were expected to be 
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there by chance. The LF-fed sons had 297 (0.52%) of their DMRs in differentially expressed 
genes, while 208 (0.36%) would have been expected to be there by chance. In the sons, DMRs 
fell within differentially expressed genes more often than expected (p = 3.2 x 10-10). To look at it 
another way, 23.9% of differentially expressed genes in the HF-fed daughters had a DMR, as did 
37% of genes in the LF-fed daughters, 36.4% of genes in the HF-fed sons, and 23.2% of genes in 
the LF-fed sons. Thus, one-quarter to one-third of differentially expressed genes contained a 
DMR due to maternal diet.  
DISCUSSION 
  Independent of maternal diet, an offspring high fat (HF) diet induced a vast array of 
changes in the SM/J mice: it increased body and organ weights; reduced sensitivity to insulin; 
increased the serum levels of leptin, insulin, triglycerides, glucose, and free fatty acids; increased 
the lengths and weights of the long bones; and changed the expression of 3,908 genes in the 
liver. An HF diet drastically reduced the expression of the leptin receptor (Lepr) gene, which 
may explain why the HF offspring consumed more food despite having 3-5 times more of the 
satiety hormone leptin in their serum. An HF diet had a larger effect on the males than the 
females in terms of inducing even more differences in gene expression (1,662 differentially 
expressed genes in males, 1,224 in females), causing a greater response to intraperitoneal glucose 
tolerance testing and a more severely impaired response to intraperitoneal insulin tolerance 
testing, and even further increasing the weights of the liver and kidneys. Meanwhile, an HF diet 
had a larger effect on the reproductive fat pad weight in the females. There were 1,062 genes 
differentially expressed in the males that were not differentially expressed in the females, and 
602 genes differentially expressed in the females but not the males (637 genes were differentially 
expressed in both sexes). These sex differences underscore the importance of including both 
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males and females in obesity studies.  
 A maternal HF diet changed the expression of dozens of genes in the offspring’s livers, 
induced methylation differences in thousands of genes (36-46% of genes in the liver had at least 
one differentially methylated region due to maternal diet), and in the daughters it affected the 
adult body weights, organ weights, and serum biomarkers. Compared to HF-fed daughters of LF 
mothers, HF-fed daughters of HF mothers weighed more, had heavier fat pads and livers, and 
had higher levels of leptin in their serum in adulthood. LF-fed daughters were also affected by 
maternal diet. Compared to LF-fed daughters of LF mothers, LF-fed daughters of HF mothers 
had significantly higher levels of free fatty acids in their serum. Interestingly, a maternal HF diet 
actually lowered the triglyceride and glucose levels in the daughters on either diet. This is similar 
to the finding of Ashino et al. (2012) that adult male Swiss mice had higher levels of 
triglycerides in the liver but lower levels in the serum due to maternal HF diet, possibly due to 
inadequate export of triglycerides from the liver.  
 The effect of maternal diet depended on the sex of the offspring. When males and 
females were analyzed together, there was a significant maternal-diet-by-offspring diet-
interaction for the necropsy traits, but not for the weekly weights or diabetes-related traits. When 
the sexes were analyzed separately, there was no maternal-diet-by-offspring-diet interaction in 
the sons, however in the daughters there was a significant interaction effect for the weekly 
weights and necropsy traits. On a univariate level, the interaction significantly affected: the 
serum levels of leptin, insulin, free fatty acids, and glucose; weight after 10 weeks of age; and 
the weights of the liver, reproductive fat pad, kidney, and brown fat. The genes that were 
differentially expressed due to maternal diet were almost entirely different in the sons and 
daughters (only 6 genes overlapped). Three genes that were disrupted in the same direction in the 
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LF-fed sons and daughters due to a maternal HF diet were cyclin B2 (Ccnb2), cytokine-like 1 
(Cytl1), and small nucleolar RNA, H/ACA box 78 (Snora78). Ccnb2 was downregulated by a 
maternal HF diet and regulates the cell cycle, with elevated levels associated with various 
cancers (Park et al. 2007, Soria et al. 2000, Shubbar et al. 2013). Cytl1 was upregulated by a 
maternal HF diet and is a cytokine-like protein involved in chondrogenesis and cartilage 
homeostasis (Kim et al. 2007, Jeon et al. 2011), and it has been linked to neuroblastoma (Wen et 
al. 2012). Snora78 was also upregulated by a maternal HF diet and may be linked to 
tumorigenesis, since increased expression of this gene has been linked to lower survival rates 
from lung cancer (Gao et al. 2015). Although only the daughters showed phenotypic differences 
in the obesity and diabetes traits due to maternal diet, gene expression and methylation were 
affected in all offspring.  
 The non-alcoholic fatty liver disease (NAFLD) pathway was downregulated by an 
offspring HF diet and also downregulated by a maternal HF diet. The parts of the pathway that 
were especially downregulated by a maternal HF diet were the mitochondrial respiratory chain 
complexes. Reduced activity of the respiratory chain complexes are one of the mitochondrial 
abnormalities associated with NAFLD, in addition to impaired mitochondrial β-oxidation, 
lesions, increased mitochondrial size, and decreased mitochondrial number (Pessayre and 
Fromenty 2005, Wei et al. 2008). These results support findings in other mouse studies that 
maternal obesity can program NALFD in offspring. For instance, C57BL/6J mice fed an 
obesogenic diet had more severe liver injury if their mothers had also been on obesogenic diets, 
and this appeared to be mediated by immune dysfunction (Mouralidarane et al. 2013) and 
disrupted circadian rhythms (Mouralidarane et al. 2015). This was accompanied by differential 
expression and promoter hypermethylation of the biological clock genes Bmal-1 and Per2 in the 
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liver (Mouralidarane et al. 2015). Our LF-fed sons had a DMR in an intron of the Per2 gene, but 
the expression was not altered. Bruce et al. (2009) also found that an HF maternal diet led to 
NAFLD regardless of offspring diet, along with impaired mitochondrial metabolism in the liver 
and upregulation of pathways involved in lipogenesis, oxidative stress, and inflammation. 
 It has been demonstrated that NAFLD is associated with Alzheimer’s disease in mice 
(Kim et al. 2016), and thus it is not surprising that the Alzheimer’s disease pathway was also 
downregulated by both an offspring and a maternal HF diet in this study. The parts of the 
pathway particularly downregulated by a maternal HF diet were the mitochondrial respiratory 
chain complexes and the SERCA Ca(2+)-ATPase intracellular pumps. Disrupted SERCA 
activity and calcium homeostasis can lead to Alzheimer’s disease (Satoh et al. 2011). There was 
also a modest change in the amyloid precursor protein (App) gene. APP is cleaved to produce 
amyloid beta (Aβ) peptides, which can form plaques in the brain in Alzheimer’s disease. Aβ is 
not only produced in the brain, but also in the liver, and it can be transported into the brain by 
low-density lipoprotein receptors (Sutcliffe et al. 2011, Wildsmith et al. 2013). It has been 
shown that treating mice with a drug that cannot cross the blood-brain barrier lowered Aβ in both 
the blood and the brain (Sutcliffe et al. 2011), indicating that Alzheimer’s disease may start with 
a peripheral excess of Aβ that enters the brain. In our study, App was slightly overexpressed in 
the daughters due to a maternal HF diet (1.21 times higher in LF-fed daughters, p = 0.015, and 
1.15 times higher in HF-fed daughters, p = 0.062). It would be interesting in the future to 
determine if this increase in App by maternal obesity raises levels of Aβ in the blood, 
predisposing the offspring to developing amyloid plaques. Reduced levels of the important 
antioxidant glutathione have been implicated as a cause for the oxidative stress in Alzheimer’s 
disease (Saharan and Mandal 2014), and it has been suggested that therapeutically increasing 
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glutathione levels could treat the disease (Pocernich and Butterfield 2012). A maternal HF diet 
significantly downregulated glutathione metabolism in our mice, which may have been an early 
indicator of a reduced ability to respond to oxidative stress and could have predisposed the 
offspring to neurological impairment. It is known that obesity raises the risk of Alzheimer’s 
disease (Kivipelto et al. 2005, Profenno et al. 2010, Moser and Pike 2016, Pugazhenthi et al. 
2017), but the results in our study suggest that a maternal HF diet may also elevate that risk. This 
is plausible given that a maternal HF diet has already been shown to alter the brains of offspring 
(Ross et al. 2007, Bilbo and Tsang 2010, Kang et al. 2014). 
 In all offspring, a maternal HF diet downregulated the ribosome, spliceosome, oxidative 
phosphorylation, and RNA transport pathways, indicating that maternal diet has an extensive 
effect on the offspring transcriptome. Other studies have found that a high maternal BMI 
downregulates genes involved in mitochondrial and lipid metabolism in the cord blood of infants 
(Costa et al. 2011), maternal obesity in sheep downregulates AMPK signaling pathways in 
offspring skeletal muscle (Zhu et al. 2016), and maternal obesity downregulates mitochondrial 
pathways in the skeletal muscle of male rat offspring, including the oxidative-phosphorylation 
and electron transport pathways (Latouche et al. 2014). In our LF-fed offspring, a maternal HF 
diet also downregulated mitochondrial pathways such as oxidative-phosphorylation, in addition 
to several key metabolic pathways. In the daughters, these included the pyruvate, pyrimidine, 
purine, carbon, glyoxylate and dicarboxylate, and glutathione metabolism pathways. In the sons, 
these same pathways were downregulated by a maternal HF diet, in addition to the inositol 
phosphate, starch and sucrose, fatty acid, cysteine and methionine, ascorbate and aldarate, 
sphingolipid, and fructose and mannose metabolism pathways. The LF-fed sons also had 
numerous signaling pathways downregulated by a maternal HF diet, including insulin, 
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adipocytokine, prolactin, p53, PPAR, toll-like receptor, Wnt, AMPK, and TGF-beta. The TGF-
beta signaling pathway is an important regulator of glucose and energy homeostasis (Yadav et al. 
2011), and the AMPK signaling pathway is associated with insulin resistance and lipogenesis in 
the liver (Zeng et al. 2014). Wnt signaling modulates liver metabolism, particularly through the 
β-catenin (Ctnnb1) gene (Liu et al. 2011), which had a maternal diet DMR 2.5 kb upstream of 
the transcription start site in the LF-fed sons in this study. Maternal diet altered the expression 
and methylation of genes across the genome in the sons, and although these did not translate to 
changes in the obesity and diabetes traits I measured, it is certainly possible that it affected other 
traits or that differences would have been detectable after 17 weeks of age.  
 The weighted gene co-expression network analysis revealed several modules of highly 
co-expressed genes that were directly linked to the diabetes-related traits in the offspring. The 
two modules that were negatively associated with the diabetes-related traits contained genes that 
were significantly enriched for immune system function, oxidation reduction, and arachidonic 
acid metabolism. The two modules that were positively correlated with the diabetes traits were 
enriched for mitochondrial, respiratory, and ribosomal processes. Together, these modules 
indicate that the diabetes-related traits were being regulated by diet-induced changes in the 
expression of genes involved in inflammation and mitochondria.  
 In addition to its effects in the liver, a maternal HF diet had an even larger effect on the 
methylation and gene expression in the hearts of HF-fed daughters. There were 4,103 
differentially methylated regions in the heart and 45 differentially expressed genes due to 
maternal diet in the daughters, including 6 cytochrome P450 genes. Cytochrome P450 genes are 
important for homeostasis, and encode enzymes involved in metabolizing endogenous 
compounds such as fatty acids, steroids, and drugs. A strong link between cytochrome P450 
 123
enzymes and heart failure has been reported (Zordoky and El-Kadi 2008). Many cytochrome 
P450 enzymes have been found in the heart, with altered levels during cardiac hypertrophy and 
heart failure. None of the P450 genes identified in the present study are on Phenopedia’s list of 
genes associated with cardiovascular diseases, but one (Cyp2c44) was identified as protective 
against pulmonary hypertension in female mice. Joshi et al. (2016) found that Cyp2c44-knockout 
mice exposed to hypoxia had more ventricular hypertrophy and higher left ventricular and 
arterial stiffness in their hearts. Due to the role that cytochrome P450 genes play in homeostasis 
and drug metabolism, the genes I identified (Cyp4a12a, Cyp2c67, Cyp2c54, Cyp2c50, Cyp2c44, 
and Cyp2f2) should be further investigated in the context of maternal obesity and response to 
pharmaceutical treatments for metabolic syndrome and heart disease. 
 The set of genes differentially expressed in the heart and the liver did not overlap at all, 
underscoring the importance of investigating multiple tissues to understand the full scope of the 
effects of a maternal high-fat diet. Three of the 46 differentially expressed genes in the livers of 
the HF daughters (Mpo, Ltf, Erbb4) had been previously identified by genetic association studies 
in humans to be associated with obesity, diabetes, and cardiovascular diseases. The other genes 
included 13 predicted genes, 3 sulfotransferase genes (Sult2a3, Sult3a2, Sult3a1), 2 genes 
involved in antimicrobial activity and the inflammation pathway (Camp, Ltf), 2 transcriptional 
regulators (Lmo1, Mybl2), and 2 glycoproteins involved in the immune system (Cd177, Igkv4-
74). 
 More DMRs were found on the X-chromosome in between-sex comparisons than within-
sex comparisons, which was to be expected because sex has a substantial effect on X-
chromosome methylation (El-Maarri et al. 2007, Cotton et al. 2011, Pai et al. 2011, Li et al. 
2012, Numata et al. 2012). More DMRs were located on the X-chromosome in the daughters 
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than in the sons, which may be a result of X-chromosome inactivation, as this is known to be 
maintained by DNA methylation (Goto and Monk 1998, Sharp et al. 2011). The LF-fed offspring 
had more genes and pathways disrupted by maternal diet than HF-fed offspring. Likewise, the 
LF-fed offspring had tens of thousands more methylation differences due to maternal diet than 
HF-fed offspring, including on the X-chromosome. These trends indicate that the direct effect of 
an offspring HF diet may be so strong that it dampens the effect that a maternal HF diet has on 
gene expression and methylation. 
 Many of the genes that were differentially expressed did not have DMRs (63-77%), and 
many of the DMRs were located within genes that were not differentially expressed (90%). In 
the sons, maternal diet DMRs were found in differentially expressed genes more often than 
expected by chance, but in the daughters the trend was reversed. These results indicate that—
while DNA methylation is linked to differential expression in some genes—overall, DNA 
methylation within genes is likely not the primary driver of differential expression in response to 
a maternal HF diet. Instead, the DMRs located outside of the gene bodies are likely to play a 
larger role. The maternal diet DMRs fell within regulatory regions far more often than expected 
by chance, with 10-20% overlapping enhancers, 5-10% overlapping CTCF Binding sites, and 31-
50% overlapping promoter flanking regions. 
 Nevertheless, there were a handful of genes that exhibited both differential methylation 
and differential expression that are relevant to the obesity traits measured in this study. For 
instance, compared to HF-fed daughters of LF mothers, HF-fed daughters of HF mothers had a 
more highly methylated region in the promoter of the apelin (Apln) gene in the liver, which 
corresponded to higher expression of the gene (Figure 4.11A).  Apln activates signaling 
pathways involved in angiogenesis, insulin, and cardiovascular function (Castan-Laurell et al. 
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2011). Altered expression levels of Apln in the placenta have been linked to preeclampsia 
(Inuzuka et al. 2013, Liang et al. 2016), and SNPs in Apln are associated with Body Mass Index 
in Chinese women (Liao et al. 2011) as well as obesity and insulin resistance in Egyptian women 
(Aboouf et al. 2015). Apln is secreted by adipocytes and its expression is increased by the 
inflammatory cytokine TNFα (Castan-Laurell et al. 2011), which may cause the increased 
angiogenesis that occurs in adipose tissue in obesity (Hu et al. 2016). Although Apln expression 
in the liver is understudied, Yokomori et al. (2012) found that the Apln gene and protein were 
over-expressed in human cirrhotic liver tissue—and the expression increased with the 
progression of the cirrhosis. Thus, the overexpression of Apln due to maternal diet in the HF-fed 
daughters may indicate that liver damage is worsened by a maternal HF diet. 
 Another gene that was both differentially methylated and differentially expressed due to 
maternal diet in the HF daughters was myeloperoxidase (Mpo), which is a hemoprotein released 
by white blood cells during inflammation. Its products can create oxidative stress, and Mpo 
knockout mice are protected from HF diet-induced weight gain and insulin resistance (Wang et 
al. 2014). It has been suggested that Mpo links inflammation, oxidative stress, and 
cardiovascular disease (Stenvinkel et al. 2006). Mpo activity is higher in the livers of obese 
patients suffering from nonalcoholic steatohepatitis (Rensen et al. 2009) and in the leukocytes of 
people with chronic kidney disease (Sela et al. 2005). In the present study, there was also a direct 
effect of diet on Mpo expression, with HF-fed offspring having much higher Mpo expression in 
their livers that LF-fed offspring (Figure 4.12A). In the daughters, this was exacerbated by a 
maternal HF diet. Compared to HF-fed daughters of LF mothers, HF-fed daughters of HF 
mothers had lower methylation in the eighth exon of the Mpo gene (q = 0.02), which may have 
contributed to the difference in expression (Figure 4.11B). The high Mpo expression in the HF-
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fed offspring increased even further with a maternal HF diet in females, indicating that they were 
under more severe oxidative stress.  
 In addition to increasing oxidative stress, obesity raises the levels of inflammatory 
cytokines (Keaney et al. 2003, Furukawa et al. 2004, Fain 2006, Fernández-Sánchez et al. 2011). 
It is thought that the exposure to inflammatory cytokines in the womb can predispose offspring 
to metabolic disease (Hauguel-de Mouzon and Guerre-Millo 2006, Madan et al. 2009, Zhu et al. 
2010, Bilbo and Tsang 2010). Elevated cytokines are known to activate the signal transducer and 
activator of transcription 1 (Stat1) gene (Gao 2005). There was a direct effect of offspring diet on 
Stat1 in the present study, with the HF-fed sons and daughters having higher Stat1 expression 
than the LF-fed mice (Figure 4.12B). This is important because higher levels of Stat1 are 
associated with liver injury and inflammation as well as the suppression of liver regeneration 
(Gao 2005). Maternal diet also affected Stat1 in HF-fed sons, but in a protective way by 
decreasing Stat1 expression. Compared to HF-fed sons of LF mothers, HF-fed sons of HF 
mothers had decreased methylation at a DMR less than 2 kb from the Stat1 transcription start 
site, in an Ensembl-defined promoter flanking region (Figure 4.12C). A maternal HF diet 
somewhat offset the increase in Stat1 expression caused by an HF diet in the sons, which 
illustrates that the gene expression changes caused by maternal obesity are not always the same 
as those caused by an individual’s obesity. Examples such as this show that it is important to 
study the effects of maternal obesity separately from offspring obesity. 
 One advantage to taking a whole-genome approach versus a candidate-gene approach in 
this study is that it enabled us to identify genes that were not well known to be involved in 
maternal obesity but that were nonetheless important. For instance, I found that in HF-fed 
daughters, a maternal HF diet decreased methylation and upregulated the expression of the 
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cholinergic receptor nicotinic alpha 4 subunit (Chrna4) gene, a nicotinic acetylcholine receptor 
well known for its involvement in nicotine sensitivity and epilepsy but not obesity. However, 
Chrna4 has been shown to be downregulated in rat livers during liver regeneration (Xu et al. 
2009), and in a study of the effect of nicotine metabolic genetic variants on obesity, Zhu et al. 
(2014) found that SNPs in the Chrna gene family were associated with abdominal obesity in 
American Indians. Our finding that Chrna4 was differentially expressed and differentially 
methylated in the HF-fed daughters due to a maternal diet suggests that the Chrna gene family 
should be studied further in the context of obesity, as epigenetic variation in addition to genetic 
variation may mediate its health effects across generations.   
 Our study highlighted another gene meriting further investigation of its role in obesity, 
annexin A2 (Anxa2). This gene is a phospholipid-binding protein that is over-expressed in some 
tumors and in the blood of people with osteoporosis (Deng et al. 2011). Anxa2 is also involved in 
cholesterol uptake in the intestine, and although it is unclear what this gene does in the liver, its 
expression is known to be higher in the livers of diabetic sand rats (Levy et al. 2010) and the 
livers of HF-fed C57BL/6J mice (Do et al. 2011). In the present study, a maternal HF diet led to 
over-expression of Anxa2 in the HF-fed daughters, as well as hypermethylation of a DMR in its 
first intron (Figure 4.11D). Further research is required to understand the implications of Anxa2 
overexpression resulting from an HF diet.  
 In the LF-fed daughters, a maternal HF diet altered the levels of triglycerides, glucose, 
and free fatty acids in the serum. However, their differential expression of the alkaline 
phosphatase, liver/bone/kidney (Alpl) gene suggests that another useful serum maker to measure 
could have been alkaline phosphatase levels. Bone-specific alkaline phosphatase promotes bone 
mineralization, and increased methylation of the gene in cord blood at birth is associated with 
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shorter stature in childhood (Relton et al. 2012). Higher serum levels of the bone or the liver 
isoform can indicate obstructive liver disease (Saraç and Saygili 2007). Furthermore, higher 
serum levels of bone-specific alkaline phosphatase are associated with reduced insulin sensitivity 
and higher levels of insulin and high-density lipoprotein cholesterol (Cheung et al. 2013), and 
elevated levels increase the risk of heart attack and mortality in patients with stents (Park et al. 
2013). A maternal HF diet decreased the methylation at a DMR in the first intron of Alpl and 
increased its expression in the LF-fed daughters (Figure 4.11E). The elevated Alpl expression 
suggests that in the future it may be useful to measure serum levels of alkaline phosphatase when 
studying the effects of maternal obesity.  
 In this study, I identified dozens of genes that were differentially expressed due to 
maternal diet, along with thousands of differentially methylated regions. Many of the 
differentially expressed genes have been found by previous studies, while many others are novel 
in their involvement in obesity. In the future, it will be important to incorporate other epigenetic 
factors such as histone modification into the analysis in order to gain a fuller understanding of 
the epigenetic changes induced by maternal obesity.  
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Figure 4.2. Diagram of the long bone lengths that were measured with calipers. A description of 
the measurements can be found in Table 4.2.  
Table 4.1. Diet Content 
Component High-fat diet Low-fat diet 
Energy from fat, % 42 15 
Casein, g/kg 195 197 
Sugars, g/kg 341 307 
Corn starch, g/kg 150 313 
Cellulose, g/kg 50 30 
Corn oil, g/kg 0 58 
Hydrogenated 
coconut oil, g/kg 
0 7 
Anhydrous milk fat, 
g/kg 
210 0 
Cholesterol, g/kg 1.5 0 
Kilojoules per gram 18.95 16.99 
Figure 4.1. Experiment Overview 
           Diet treatment group 
Generation     1         2         3         4 
        F0          HF      LF       LF       HF 
                                                 
        F1          HF      HF      LF       LF 
                                                                                                                       
HF = High-fat diet    LF = Low-fat diet 
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Trait HF-HF ♀ avg LF-HF ♀ avg HF-LF♀ avg LF-LF ♀ avg 
Mat Diet 
p-value 
Mat 
Diet*Off 
Diet  
p-value 
Week 9 weight (g) 17.44 ± 0.40 15.91 ± 0.55 12.05 ± 0.34 10.88 ± 1.02 0.041 0.781 
Week 11 weight (g) 21.86±1.09 18.41±0.68 13.01±0.35 12.84±0.52 0.016 0.028 
Week 12 weight (g) 23.69±1.32 19.86±0.91 12.25±0.97 13.19±0.37 0.138 0.017 
Week 13 weight (g) 25.96±1.45 19.38±1.12 13.66±0.39 13.67±0.47 0.002 0.002 
Week 14 weight (g) 27.11±1.58 22.33±1.09 13.85±0.35 14.02±0.46 0.028 0.019 
Week 15 weight (g) 29.63±1.67 23.32±1.12 14.35±0.46 14.58±0.45 0.007 0.004 
Week 17 weight (g) 30.73 ± 1.64 25.66 ± 1.11 14.53 ± 0.43 15.62 ± 0.37 0.062 0.005 
Liver weight (g) 1.38 ± 0.22 0.87 ± 0.13 0.40 ± 0.03 0.53 ± 0.02 0.231 0.034 
Fat pad weight (g) 1.42 ± 0.15 0.91 ± 0.12 0.10 ± 0.02 0.15 ± 0.03 0.018 0.005 
Kidney weight (g) 0.19 ± 0.02 0.18 ± 0.01 0.11 ± 0.01 0.14 ± 0.01 0.606 0.042 
Brown fat weight 
(g) 0.66 ± 0.08 0.32 ± 0.04 0.10 ± 0.01 0.11 ± 0.02 0.001 0.001 
Serum leptin 
(ng/mL) 26.82 ± 5.57 12.94 ± 1.30 0.84 ± 0.18 2.82 ± 0.64 0.050 0.011 
Serum insulin 
(pg/mL) 2184.30 ± 488.34 1120.67 ± 225.60 177.50 ± 31.77 348.10 ± 55.51 0.111 0.030 
Serum glucose 
(mg/dL) 288.44 ± 15.84 361.44 ± 20.41 144.60 ± 18.06 301.77 ± 17.17 1.99E-07 0.024 
Serum free fatty 
acids (mM) 1.42 ± 0.08 1.47 ± 0.09 2.06 ± 0.25 1.41 ± 0.05 0.045 0.019 
Serum triglycerides 
(mg/dL) 121.48 ± 7.62 206.02 ± 31.48 97.76 ± 5.23 145.26 ± 12.08 3.00E-04 0.268 
 
Table 4.2. The effect of maternal diet and a maternal-diet-by-offspring-diet interaction on high-
fat-fed daughters. A high-fat maternal diet increased the body weights of high-fat-fed daughters 
in adulthood, led to heavier reproductive fat pads and brown fat, and increased serum levels of 
leptin. However, a high-fat maternal diet actually decreased levels of free glucose and 
triglycerides in the daughters. HF = High-fat diet, LF = Low-fat diet, Mat = Maternal, Off = 
Offspring.  
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Measurement 
 
Description 
 
Repeatability 
 
Sex 
 
Offspring 
diet 
Humerus Length 1 
Humeral head to outermost edge of 
the trochlea 
0.9984 
2.42E-13 4.37E-07 
Humerus Length 2 
Humeral head to outermost edge of 
the capitulum 
0.9995 
1.32E-13 1.16E-07 
Humerus Weight Weight of humerus 0.9861 8.07E-10 2.85E-10 
Ulna Length 
Topmost edge of olecranon to tip of 
styloid process 
0.9954 
2.63E-14 8.06E-07 
Ulna Weight Weight of ulna 0.9861 0.06 0.98 
Femur Length 1 Head of femur to median condyle 0.9993 2.90E-04 3.76E-07 
Femur Length 2 
Tip of the greater trochanter to tip 
of lateral condyle 
0.9992 
7.00E-05 1.74E-07 
Femur Condyle 
Width 
Tip of medial condyle to tip of 
lateral condyle 
0.9202 
6.70E-07 0.42 
Femur Weight  Weight of femur 0.9963 2.07E-07 2.51E-12 
Tibia Length 
Tip of medial condyle to the lateral 
edge of the medial malleolus 
0.9988 
2.42E-07 7.30E-09 
Tibia and Fibula 
Weight Weight of tibia and fibula 
0.9907 
1.96E-09 2.42E-12 
Table 4.3. Description of bone length measurements. Maternal diet did not affect the long-bone 
lengths or weights, but offspring diet and sex had a significant effect. All repeatabilities were 
above 0.92. HF = High-fat diet, LF = Low-fat diet. 
 
 
 
Diet 
Humerus 
Length 1 
Humerus 
Length 2 
Humerus 
Weight Ulna Length Ulna Weight 
Femur 
Length 1 
HF ♀ 10.697 ± 1.04 10.778 ± 1.13 0.015 ± 0.79 12.497 ± 0.98 0.011 ± 0.14 13.911 ± 1.63 
LF ♀ 10.394 ± 1.04 10.463 ± 1.13 0.014 ± 0.79 12.249 ± 0.98 0.010 ± 0.14 13.253 ± 1.63 
HF ♂ 11.465 ± 1.74 11.521 ± 1.81 0.018 ± 2.37 13.197 ± 1.71 0.013 ± 0.14 14.196 ± 1.16 
LF ♂ 10.957 ± 1.74 11.013 ± 1.81 0.015 ± 2.37 12.766 ± 1.71 0.014 ± 0.14 13.729 ± 1.16 
 
Diet 
Femur 
Length 2 
Femur 
Condyle Width 
Femur 
Weight  
Tibia Length 
Tibia and 
Fibula Weight 
Sample 
Size 
HF ♀ 14.260 ± 1.67 2.275 ± 0.07 0.030 ± 1.58 15.657 ± 1.64 0.026 ± 1.92 16 
LF ♀ 13.536 ± 1.67 2.271 ± 0.07 0.025 ± 1.58 15.045 ± 1.64 0.022 ± 1.92 19 
HF ♂ 14.615 ± 1.22 2.363 ± 0.38 0.035 ± 2.21 16.187 ± 1.64 0.030 ± 2.41 14 
LF ♂ 14.086 ± 1.22 2.344 ± 0.38 0.028 ± 2.21 15.576 ± 1.64 0.025 ± 2.41 18 
Table 4.4. High-fat mice had longer, heavier bones than low-fat mice, and males had longer, 
heavier bones than females. Maternal diet did not affect the bone measurements. HF = High-fat 
diet, LF = Low-fat diet, averages are reported ± one standard deviation unit.   
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Figure 4.3. Weekly weights of offspring. High-fat diet offspring weigh more than low-fat diet 
offspring by 4 weeks of age (1 week after being weaned onto the diet). Maternal diet does not 
affect the sons, but it does affect the daughters. High fat daughters weigh even more if their 
mothers were also on a high-fat diet. HF = High-fat diet, LF = Low-fat diet.  
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Figure 4.4. Traits in female offspring affected by maternal diet (± SE). Each bar represents 
the average of 10 offspring.  HF = High-fat diet, LF = Low-fat diet. 
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A)  
B)  
Figure 4.5. (A) The multidimensional scaling plot indicates that gene expression libraries 
clustered by sex (dimension 1) and offspring diet (dimension 2), but not maternal diet. (B) There 
were no discernable patterns in dimensions 3 or 4. HF = High-fat diet, and LF = Low-fat diet. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 148
Diet Group 
Differentially 
Expressed Genes 
All HF vs. LF 3,908 
HF vs. LF daughters 1,224 
HF vs. LF sons 1,662 
HF-HF vs. LF-HF daughters 46 
HF-HF vs. LF-HF sons 22 
HF-LF vs. LF-LF daughters 70 
HF-LF vs. LF-LF sons 434 
Table 4.5. Number of differentially expressed genes due to offspring diet and maternal diet, p < 
0.05, absolute value of the logFC > 2. Maternal diet affected the expression of dozens of genes in 
the offspring, especially the sons. HF = High-fat diet, LF = Low-fat diet. 
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A)   
B)        
 
C)    
 
Figure 4.6. (A) A high fat offspring diet increased the amount of serum leptin, but (B) high 
fat mice still consumed more food as adults. (C) This could be in part due to the drastically 
reduced expression of the leptin receptor. Maternal high-fat diet further increased the serum 
leptin levels in high-fat-fed daughters.   
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Diet 
Comparison KEGG_ID Mean LogFC FDR 
HF-HF ♀ 
vs. 
LF-HF ♀ 
liver 
mmu03010 Ribosome -6.12 3.85E-07 
mmu03040 Spliceosome -5.45 8.20E-06 
mmu00190 Oxidative phosphorylation -3.90 4.36E-03 
mmu03013 RNA transport -3.22 3.81E-02 
HF-HF ♂ 
vs. 
LF-HF ♂ 
mmu03010 Ribosome -6.16 3.71E-07 
mmu03040 Spliceosome -5.33 1.25E-05 
mmu00190 Oxidative phosphorylation -5.27 1.25E-05 
mmu04210 Apoptosis -5.01 2.82E-05 
mmu04145 Phagosome -4.92 2.82E-05 
mmu04144 Endocytosis -4.80 3.63E-05 
mmu04141 Protein processing in endoplasmic 
reticulum -4.69 6.72E-05 
mmu04612 Antigen processing and presentation -4.26 4.70E-04 
mmu03050 Proteasome -4.29 7.68E-04 
mmu03008 Ribosome biogenesis in eukaryotes -3.88 1.76E-03 
mmu04623 Cytosolic DNA-sensing pathway -3.74 2.96E-03 
mmu04668 TNF signaling pathway -3.63 2.96E-03 
mmu00230 Purine metabolism -3.58 2.96E-03 
mmu00240 Pyrimidine metabolism -3.60 2.96E-03 
mmu04062 Chemokine signaling pathway -3.56 2.96E-03 
mmu03013 RNA transport -3.33 5.56E-03 
mmu04620 Toll-like receptor signaling pathway -3.34 5.56E-03 
mmu04622 RIG-I-like receptor signaling pathway -3.36 5.56E-03 
mmu04060 Cytokine-cytokine receptor interaction -3.29 5.56E-03 
mmu04120 Ubiquitin mediated proteolysis -3.31 5.56E-03 
mmu04650 Natural killer cell mediated cytotoxicity -3.31 5.56E-03 
mmu04064 NF-kappa B signaling pathway -3.30 5.67E-03 
mmu04380 Osteoclast differentiation -3.21 6.79E-03 
mmu04722 Neurotrophin signaling pathway -3.00 1.29E-02 
mmu04666 Fc gamma R-mediated phagocytosis -2.93 1.69E-02 
mmu04540 Gap junction -2.88 1.83E-02 
mmu04142 Lysosome -2.86 1.83E-02 
mmu03030 DNA replication -2.94 1.86E-02 
mmu04662 B cell receptor signaling pathway -2.85 1.91E-02 
mmu04915 Estrogen signaling pathway -2.72 2.45E-02 
mmu04110 Cell cycle -2.71 2.45E-02 
mmu00051 Fructose and mannose metabolism -2.69 3.00E-02 
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mmu04514 Cell adhesion molecules (CAMs) -2.60 3.00E-02 
mmu04151 PI3K-Akt signaling pathway -2.58 3.00E-02 
mmu00520 Amino sugar and nucleotide sugar 
metabolism -2.64 3.00E-02 
mmu04621 NOD-like receptor signaling pathway -2.58 3.21E-02 
mmu00010 Glycolysis / Gluconeogenesis -2.55 3.38E-02 
mmu01200 Carbon metabolism -2.52 3.38E-02 
mmu04390 Hippo signaling pathway -2.50 3.43E-02 
mmu04130 SNARE interactions in vesicular transport -2.53 3.73E-02 
mmu03015 mRNA surveillance pathway -2.45 3.73E-02 
mmu04360 Axon guidance -2.44 3.73E-02 
mmu04071 Sphingolipid signaling pathway -2.44 3.73E-02 
mmu03420 Nucleotide excision repair -2.47 3.95E-02 
mmu03410 Base excision repair -2.46 4.06E-02 
mmu03020 RNA polymerase -2.47 4.15E-02 
mmu04066 HIF-1 signaling pathway -2.36 4.34E-02 
mmu04510 Focal adhesion -2.31 4.61E-02 
mmu04910 Insulin signaling pathway -2.31 4.65E-02 
mmu04015 Rap1 signaling pathway -2.29 4.67E-02 
mmu04611 Platelet activation -2.28 4.76E-02 
HF-LF ♀ 
vs. 
LF-LF ♀ 
 
mmu04110 Cell cycle -4.55 5.58E-04 
mmu00190 Oxidative phosphorylation -4.53 5.58E-04 
mmu03040 Spliceosome -4.32 8.71E-04 
mmu04120 Ubiquitin mediated proteolysis -4.10 1.38E-03 
mmu03030 DNA replication -4.26 1.38E-03 
mmu00240 Pyrimidine metabolism -4.04 1.38E-03 
mmu03050 Proteasome -4.12 1.92E-03 
mmu04141 Protein processing in endoplasmic 
reticulum -3.82 2.14E-03 
mmu01200 Carbon metabolism -3.62 4.16E-03 
mmu00480 Glutathione metabolism -3.43 8.85E-03 
mmu03420 Nucleotide excision repair -3.47 8.94E-03 
mmu04623 Cytosolic DNA-sensing pathway -3.39 8.94E-03 
mmu04144 Endocytosis -3.06 1.79E-02 
mmu03010 Ribosome -3.04 1.79E-02 
mmu00630 Glyoxylate and dicarboxylate metabolism -3.17 1.79E-02 
mmu00970 Aminoacyl-tRNA biosynthesis -3.10 1.79E-02 
mmu03460 Fanconi anemia pathway -2.98 2.27E-02 
mmu00620 Pyruvate metabolism -2.93 2.49E-02 
mmu03013 RNA transport -2.85 2.49E-02 
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mmu03410 Base excision repair -2.92 2.49E-02 
mmu00230 Purine metabolism -2.76 2.98E-02 
mmu03440 Homologous recombination -2.81 3.32E-02 
mmu04130 SNARE interactions in vesicular transport -2.76 3.85E-02 
mmu04114 Oocyte meiosis -2.57 4.65E-02 
mmu04210 Apoptosis -2.52 4.94E-02 
mmu03060 Protein export -2.63 4.94E-02 
mmu03008 Ribosome biogenesis in eukaryotes -2.53 4.94E-02 
mmu00520 Amino sugar and nucleotide sugar 
metabolism -2.51 5.07E-02 
HF-LF ♂ 
vs. 
LF-LF ♂ 
mmu04144 Endocytosis -7.17 3.07E-10 
mmu04151 PI3K-Akt signaling pathway -7.03 3.07E-10 
mmu04110 Cell cycle -7.00 1.30E-09 
mmu04120 Ubiquitin mediated proteolysis -6.27 6.91E-08 
mmu04380 Osteoclast differentiation -6.01 1.48E-07 
mmu04210 Apoptosis -5.99 1.48E-07 
mmu04062 Chemokine signaling pathway -5.86 1.66E-07 
mmu04015 Rap1 signaling pathway -5.81 1.66E-07 
mmu04662 B cell receptor signaling pathway -5.79 8.33E-07 
mmu04360 Axon guidance -5.47 9.57E-07 
mmu03010 Ribosome -5.36 2.44E-06 
mmu04620 Toll-like receptor signaling pathway -5.40 2.44E-06 
mmu03460 Fanconi anemia pathway -5.63 2.62E-06 
mmu04722 Neurotrophin signaling pathway -5.28 2.62E-06 
mmu04510 Focal adhesion -5.16 2.78E-06 
mmu03040 Spliceosome -5.24 3.02E-06 
mmu04010 MAPK signaling pathway -5.06 3.68E-06 
mmu04141 Protein processing in endoplasmic 
reticulum -5.14 3.68E-06 
mmu04666 Fc gamma R-mediated phagocytosis -5.13 6.51E-06 
mmu00230 Purine metabolism -4.95 6.59E-06 
mmu04650 Natural killer cell mediated cytotoxicity -4.93 9.13E-06 
mmu04145 Phagosome -4.79 1.17E-05 
mmu04064 NF-kappa B signaling pathway -4.88 1.17E-05 
mmu04150 mTOR signaling pathway -4.70 1.90E-05 
mmu04060 Cytokine-cytokine receptor interaction -4.63 2.03E-05 
mmu00240 Pyrimidine metabolism -4.73 2.07E-05 
mmu04152 AMPK signaling pathway -4.67 2.17E-05 
mmu04068 FoxO signaling pathway -4.63 2.22E-05 
mmu03013 RNA transport -4.56 2.81E-05 
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mmu04910 Insulin signaling pathway -4.57 2.81E-05 
mmu04668 TNF signaling pathway -4.58 2.81E-05 
mmu04142 Lysosome -4.53 3.49E-05 
mmu04070 Phosphatidylinositol signaling system -4.55 3.49E-05 
mmu04014 Ras signaling pathway -4.44 3.51E-05 
mmu04623 Cytosolic DNA-sensing pathway -4.76 3.51E-05 
mmu04066 HIF-1 signaling pathway -4.49 3.67E-05 
mmu03008 Ribosome biogenesis in eukaryotes -4.56 3.67E-05 
mmu04610 Complement and coagulation cascades -4.49 4.27E-05 
mmu04390 Hippo signaling pathway -4.39 4.31E-05 
mmu04114 Oocyte meiosis -4.40 4.40E-05 
mmu04611 Platelet activation -4.24 8.45E-05 
mmu04919 Thyroid hormone signaling pathway -4.20 9.90E-05 
mmu04071 Sphingolipid signaling pathway -4.19 1.02E-04 
mmu04660 T cell receptor signaling pathway -4.17 1.13E-04 
mmu00562 Inositol phosphate metabolism -4.25 1.13E-04 
mmu04810 Regulation of actin cytoskeleton -4.10 1.13E-04 
mmu03410 Base excision repair -4.43 1.14E-04 
mmu04115 p53 signaling pathway -4.14 1.34E-04 
mmu04514 Cell adhesion molecules (CAMs) -4.04 1.45E-04 
mmu03030 DNA replication -4.42 1.53E-04 
mmu04310 Wnt signaling pathway -4.01 1.63E-04 
mmu04012 ErbB signaling pathway -4.06 1.63E-04 
mmu04914 Progesterone-mediated oocyte maturation -4.03 1.65E-04 
mmu03420 Nucleotide excision repair -4.27 1.73E-04 
mmu00310 Lysine degradation -4.18 1.90E-04 
mmu04146 Peroxisome -3.98 2.14E-04 
mmu04550 Signaling pathways regulating 
pluripotency of stem cells -3.77 3.73E-04 
mmu04640 Hematopoietic cell lineage -3.78 4.02E-04 
mmu04740 Olfactory transduction 4.74 4.08E-04 
mmu04915 Estrogen signaling pathway -3.77 4.11E-04 
mmu03018 RNA degradation -3.78 4.36E-04 
mmu01200 Carbon metabolism -3.74 4.36E-04 
mmu03440 Homologous recombination -3.91 4.82E-04 
mmu04340 Hedgehog signaling pathway -3.80 5.54E-04 
mmu04922 Glucagon signaling pathway -3.61 6.85E-04 
mmu00480 Glutathione metabolism -3.63 8.52E-04 
mmu04350 TGF-beta signaling pathway -3.49 1.01E-03 
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mmu00860 Porphyrin and chlorophyll metabolism -3.60 1.06E-03 
mmu04540 Gap junction -3.47 1.06E-03 
mmu00510 N-Glycan biosynthesis -3.62 1.08E-03 
mmu04520 Adherens junction -3.44 1.16E-03 
mmu00071 Fatty acid degradation -3.45 1.35E-03 
mmu04512 ECM-receptor interaction -3.36 1.41E-03 
mmu04621 NOD-like receptor signaling pathway -3.38 1.42E-03 
mmu00983 Drug metabolism - other enzymes -3.43 1.42E-03 
mmu04130 SNARE interactions in vesicular transport -3.56 1.46E-03 
mmu00190 Oxidative phosphorylation -3.26 1.74E-03 
mmu03050 Proteasome -3.35 2.17E-03 
mmu00532 Glycosaminoglycan biosynthesis - 
chondroitin sulfate / dermatan sulfate -3.46 2.22E-03 
mmu04330 Notch signaling pathway -3.21 2.50E-03 
mmu00970 Aminoacyl-tRNA biosynthesis -3.26 2.60E-03 
mmu00500 Starch and sucrose metabolism -3.18 2.77E-03 
mmu04670 Leukocyte transendothelial migration -3.09 2.88E-03 
mmu00980 Metabolism of xenobiotics by cytochrome 
P450 -3.12 2.88E-03 
mmu04370 VEGF signaling pathway -3.10 3.14E-03 
mmu03015 mRNA surveillance pathway -3.06 3.22E-03 
mmu04622 RIG-I-like receptor signaling pathway -3.08 3.39E-03 
mmu03430 Mismatch repair -3.29 3.76E-03 
mmu01212 Fatty acid metabolism -2.98 4.47E-03 
mmu03320 PPAR signaling pathway -2.94 4.47E-03 
mmu03020 RNA polymerase -3.11 4.65E-03 
mmu00563 Glycosylphosphatidylinositol(GPI)-anchor 
biosynthesis -3.14 4.67E-03 
mmu04022 cGMP-PKG signaling pathway -2.82 5.74E-03 
mmu03022 Basal transcription factors -2.90 5.74E-03 
mmu04270 Vascular smooth muscle contraction -2.80 6.09E-03 
mmu04728 Dopaminergic synapse -2.74 7.17E-03 
mmu04630 Jak-STAT signaling pathway -2.72 7.41E-03 
mmu04912 GnRH signaling pathway -2.74 7.41E-03 
mmu04916 Melanogenesis -2.72 7.51E-03 
mmu00010 Glycolysis / Gluconeogenesis -2.74 7.60E-03 
mmu04974 Protein digestion and absorption -2.69 8.15E-03 
mmu04612 Antigen processing and presentation -2.67 8.65E-03 
mmu04024 cAMP signaling pathway -2.64 8.86E-03 
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mmu00620 Pyruvate metabolism -2.73 9.20E-03 
mmu00564 Glycerophospholipid metabolism -2.61 9.86E-03 
mmu00040 Pentose and glucuronate interconversions -2.66 1.01E-02 
mmu01230 Biosynthesis of amino acids -2.61 1.01E-02 
mmu00640 Propanoate metabolism -2.67 1.13E-02 
mmu04921 Oxytocin signaling pathway -2.52 1.18E-02 
mmu00270 Cysteine and methionine metabolism -2.55 1.24E-02 
mmu04725 Cholinergic synapse -2.49 1.29E-02 
mmu00280 Valine, leucine and isoleucine degradation -2.47 1.41E-02 
mmu04020 Calcium signaling pathway -2.43 1.43E-02 
mmu04710 Circadian rhythm -2.49 1.47E-02 
mmu04976 Bile secretion -2.44 1.47E-02 
mmu04920 Adipocytokine signaling pathway -2.42 1.51E-02 
mmu00520 Amino sugar and nucleotide sugar 
metabolism -2.43 1.56E-02 
mmu04962 Vasopressin-regulated water reabsorption -2.40 1.68E-02 
mmu00053 Ascorbate and aldarate metabolism -2.44 1.69E-02 
mmu00982 Drug metabolism - cytochrome P450 -2.35 1.77E-02 
mmu04750 Inflammatory mediator regulation of TRP 
channels -2.30 1.91E-02 
mmu00514 Other types of O-glycan biosynthesis -2.35 1.97E-02 
mmu00600 Sphingolipid metabolism -2.32 1.97E-02 
mmu04917 Prolactin signaling pathway -2.28 2.03E-02 
mmu04672 Intestinal immune network for IgA 
production -2.27 2.15E-02 
mmu00900 Terpenoid backbone biosynthesis -2.28 2.48E-02 
mmu03450 Non-homologous end-joining -2.40 2.51E-02 
mmu04664 Fc epsilon RI signaling pathway -2.18 2.54E-02 
mmu00051 Fructose and mannose metabolism -2.19 2.61E-02 
mmu04970 Salivary secretion -2.16 2.61E-02 
mmu00100 Steroid biosynthesis -2.24 2.76E-02 
mmu00770 Pantothenate and CoA biosynthesis -2.27 2.80E-02 
mmu00260 Glycine, serine and threonine metabolism -2.13 2.92E-02 
mmu04730 Long-term depression -2.05 3.30E-02 
mmu00561 Glycerolipid metabolism -2.05 3.30E-02 
mmu00450 Selenocompound metabolism -2.17 3.32E-02 
mmu00630 Glyoxylate and dicarboxylate metabolism -2.09 3.32E-02 
mmu02010 ABC transporters -2.05 3.33E-02 
mmu00830 Retinol metabolism -2.03 3.33E-02 
mmu04140 Regulation of autophagy -2.08 3.33E-02 
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mmu00020 Citrate cycle (TCA cycle) -2.06 3.46E-02 
mmu04918 Thyroid hormone synthesis -1.98 3.65E-02 
mmu01040 Biosynthesis of unsaturated fatty acids -1.99 3.94E-02 
mmu00670 One carbon pool by folate -2.03 3.94E-02 
mmu04713 Circadian entrainment -1.85 4.73E-02 
mmu04961 Endocrine and other factor-regulated 
calcium reabsorption -1.86 4.80E-02 
HF-HF ♀ 
vs. 
LF-HF ♀ 
heart 
mmu04610 Complement and coagulation cascades -6.80 3.61E-08 
mmu00830 Retinol metabolism -6.39 1.96E-07 
mmu00140 Steroid hormone biosynthesis -5.98 1.08E-06 
mmu03320 PPAR signaling pathway -4.54 3.16E-04 
mmu00983 Drug metabolism - other enzymes -4.12 1.93E-03 
mmu01230 Biosynthesis of amino acids -3.80 3.67E-03 
mmu00590 Arachidonic acid metabolism -3.76 3.93E-03 
mmu00053 Ascorbate and aldarate metabolism -3.95 4.48E-03 
mmu00591 Linoleic acid metabolism -3.51 9.72E-03 
mmu00260 Glycine, serine and threonine metabolism -3.37 1.21E-02 
mmu00980 Metabolism of xenobiotics by cytochrome 
P450 -3.31 1.21E-02 
mmu01200 Carbon metabolism -3.24 1.21E-02 
mmu00010 Glycolysis / Gluconeogenesis -3.24 1.21E-02 
mmu04151 PI3K-Akt signaling pathway -3.04 1.63E-02 
mmu00040 Pentose and glucuronate interconversions -3.17 1.63E-02 
mmu00982 Drug metabolism - cytochrome P450 -3.07 1.68E-02 
mmu00860 Porphyrin and chlorophyll metabolism -2.99 2.25E-02 
mmu00360 Phenylalanine metabolism -2.91 3.41E-02 
mmu04918 Thyroid hormone synthesis -2.62 5.04E-02 
mmu00120 Primary bile acid biosynthesis -2.76 5.04E-02 
 
Table 4.6. Significantly downregulated signaling and metabolism pathways due to maternal diet. 
A negative logFC value indicates the pathway was downregulated in mice with high-fat-fed 
mothers.  
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Comparison GO Term Mean LogFC FDR 
HF-HF ♀ 
vs. 
LF-HF ♀ 
GO:0022613 ribonucleoprotein complex biogenesis -6.83 7.68E-08 
GO:0016071 mRNA metabolic process -6.57 8.43E-08 
GO:0008380 RNA splicing -6.62 8.43E-08 
GO:0034470 ncRNA processing -6.47 2.19E-07 
GO:0006397 mRNA processing -6.13 8.27E-07 
GO:0034660 ncRNA metabolic process -6.11 8.50E-07 
GO:0042254 ribosome biogenesis -5.58 2.28E-05 
GO:0006412 translation -5.37 3.55E-05 
GO:0000377 RNA splicing, via transesterification 
reactions with bulged adenosine as nucleophile 
-5.27 6.72E-05 
GO:0000398 mRNA splicing, via spliceosome -5.27 6.72E-05 
HF-HF ♂ 
vs. 
LF-HF ♂ 
GO:0045087 innate immune response -7.39 9.16E-10 
GO:0050776 regulation of immune response -6.98 7.56E-09 
GO:0022613 ribonucleoprotein complex biogenesis -6.88 1.76E-08 
GO:0098542 defense response to other organism -6.72 1.85E-08 
GO:0043043 peptide biosynthetic process -6.72 1.85E-08 
GO:0043900 regulation of multi-organism process -6.67 2.17E-08 
GO:0034660 ncRNA metabolic process -6.69 2.17E-08 
GO:0006412 translation -6.57 2.97E-08 
GO:0050778 positive regulation of immune response -6.57 2.97E-08 
GO:0034470 ncRNA processing -6.59 4.22E-08 
HF-LF ♀ 
vs. 
LF-LF ♀ 
GO:0007067 mitotic nuclear division -8.65 9.02E-14 
GO:0000280 nuclear division -7.93 7.91E-12 
GO:0043632 modification-dependent macromolecule 
catabolic process 
-6.90 8.47E-09 
GO:0019941 modification-dependent protein catabolic 
process 
-6.78 1.48E-08 
GO:0006511 ubiquitin-dependent protein catabolic 
process 
-6.72 1.76E-08 
GO:0006281 DNA repair -6.69 1.90E-08 
GO:0007059 chromosome segregation -6.73 1.97E-08 
GO:0034660 ncRNA metabolic process -5.72 5.72E-06 
GO:0010498 proteasomal protein catabolic process -5.66 5.95E-06 
GO:0034470 ncRNA processing -5.72 5.95E-06 
HF-LF ♂ 
vs. 
LF-LF ♂ 
GO:0006281 DNA repair -11.77 1.80E-25 
GO:0007067 mitotic nuclear division -11.62 2.50E-25 
GO:0051345 positive regulation of hydrolase activity -11.19 7.00E-24 
GO:0000280 nuclear division -10.62 4.22E-22 
GO:0043632 modification-dependent macromolecule 
catabolic process 
-10.66 6.32E-22 
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GO:0019941 modification-dependent protein catabolic 
process 
-10.55 1.46E-21 
GO:0006511 ubiquitin-dependent protein catabolic 
process 
-10.46 3.04E-21 
GO:0050776 regulation of immune response -10.16 1.64E-20 
GO:0031329 regulation of cellular catabolic process -10.18 2.17E-20 
GO:0034109 homotypic cell-cell adhesion -9.95 1.24E-19 
HF-HF ♀ 
vs. 
LF-HF ♀ 
heart 
GO:0006631 fatty acid metabolic process -6.18 3.11E-06 
GO:0044283 small molecule biosynthetic process -5.81 1.18E-05 
GO:0016053 organic acid biosynthetic process -5.61 2.32E-05 
GO:0046394 carboxylic acid biosynthetic process -5.61 2.32E-05 
GO:0042738 exogenous drug catabolic process -6.06 3.97E-05 
GO:0006520 cellular amino acid metabolic process -5.42 3.97E-05 
GO:0042737 drug catabolic process -5.85 6.30E-05 
GO:0008202 steroid metabolic process -5.24 7.91E-05 
GO:1901605 alpha-amino acid metabolic process -5.24 7.91E-05 
GO:0071466 cellular response to xenobiotic stimulus -5.40 8.12E-05 
Table 4.7. Top 10 significant GO Biological Processes affected by maternal diet. A negative 
logFC value indicates that the process was downregulated in mice with high-fat-fed mothers.  
 
 
 
 
 
 
 
 
 
 
Gene Forward primer Reverse primer 
Mpo 5'-GGCCTCCCAGGATACAATGC-3' 5'-ACACCGCCCATCCAGATGTC-3' 
Chrna4 5'-CTAGCAGCCACATAGAGACCC-3' 5'-GACAAGCCAAAGCGGACAAG-3' 
Anxa2 5'-ATGTCTACTGTCCACGAAATCCT-3' 5'-CGAAGTTGGTGTAGGGTTTGACT-3' 
Gapdh 5'-ACAATGAATACGGCTACAGCAACAG-3’ 5’-GGTGGTCCAGGGTTTCTTACTCC-3’ 
Table 4.8. Primers used for RT-qPCR. 
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A) 
 
B) 
   
 
 
Figure 4.7. Non-alcoholic fatty liver disease (NAFLD) pathway diagrams, where orange 
indicates upregulation by a high-fat diet and blue indicates downregulation. (A) The NAFLD 
pathway is significantly downregulated due to an offspring high-fat diet. (B) It is also 
downregulated by a maternal high-fat diet. HF = High-fat diet, LF = Low-fat diet.  
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Figure 4.8. Alzheimer’s disease pathway diagrams, where orange indicates upregulation by a 
high-fat diet and blue indicates downregulation. (A) The Alzheimer’s disease pathway is 
significantly downregulated due to an offspring high-fat diet. (B) It is also downregulated by 
maternal high-fat diet. HF = High-fat diet, LF = Low-fat diet.  
 
 
 
 
 
 
Figure 4.9. The WGCNA analysis revealed 29 modules of co-expressed genes in the offspring. 
Four of these modules (black, yellow, turquoise, and magenta) were significantly correlated with 
the diabetes-related traits: week 15 weight, week 16 weight, baseline glucose at week 15, area 
under the curve for the intraperitoneal glucose tolerance test, baseline glucose at week 16, area 
under the curve for the intraperitoneal insulin tolerance test, serum insulin and glucose, and 
average food consumed per day at 14 weeks of age.  
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Module 
(# genes) 
Enrichment 
p-value 
# Module 
Genes in 
GO Term 
GO ID 
GO 
Ont 
GO Name 
Black 
(637) 
3.29E-19 145 GO:0002376 BP immune system process 
9.95E-17 93 GO:0006955 BP immune response 
2.83E-11 88 GO:0002682 BP 
regulation of immune system 
process 
7.04E-09 83 GO:0006952 BP defense response 
4.02E-08 59 GO:0016337 BP 
single organismal cell-cell 
adhesion 
4.24E-07 53 GO:0046649 BP lymphocyte activation 
5.17E-07 60 GO:0098609 BP cell-cell adhesion 
7.73E-07 34 GO:0009897 CC external side of plasma membrane 
1.26E-06 63 GO:0001775 BP cell activation 
1.51E-06 58 GO:0009986 CC cell surface 
Magenta 
(312) 
1.39E-05 16 GO:0005840 CC ribosome 
1.75E-05 13 GO:0005761 CC mitochondrial ribosome 
3.00E-04 12 GO:0044391 CC ribosomal subunit 
0.003 17 GO:0005759 CC mitochondrial matrix 
0.045 26 GO:0030529 CC 
intracellular ribonucleoprotein 
complex 
0.046 12 GO:0003735 MF structural constituent of ribosome 
0.355 6 GO:0005763 CC 
mitochondrial small ribosomal 
subunit 
0.691 6 GO:0005762 CC 
mitochondrial large ribosomal 
subunit 
0.691 6 GO:0015935 CC small ribosomal subunit 
1 20 GO:0006412 BP translation 
Turquoise 
(1,785) 
2.16E-12 33 GO:0070469 CC respiratory chain 
1.02E-11 31 GO:0005746 CC mitochondrial respiratory chain 
3.73E-08 41 GO:0005840 CC ribosome 
1.31E-06 20 GO:0005747 CC 
mitochondrial respiratory chain 
complex I 
1.31E-06 20 GO:0045271 CC respiratory chain complex I 
7.96E-06 28 GO:0005761 CC mitochondrial ribosome 
1.10E-04 14 GO:0003954 MF NADH dehydrogenase activity 
1.47E-04 213 GO:0005739 CC mitochondrion 
1.49E-04 16 GO:0005763 CC 
mitochondrial small ribosomal 
subunit 
2.25E-04 35 GO:0003735 MF structural constituent of ribosome 
4.41E-04 12 GO:0070330 MF aromatase activity 
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Yellow 
(932) 
8.36E-04 16 GO:0008395 MF steroid hydroxylase activity 
0.001 22 GO:0004497 MF monooxygenase activity 
0.001 12 GO:0016712 MF 
oxidoreductase activity, acting on 
paired donors, with incorporation 
or reduction of molecular oxygen, 
reduced flavin or flavoprotein as 
one donor, and incorporation of 
one atom of oxygen 
0.002 12 GO:0008392 MF 
arachidonic acid epoxygenase 
activity 
0.002 10 GO:0019373 BP epoxygenase P450 pathway 
0.005 12 GO:0008391 MF 
arachidonic acid monooxygenase 
activity 
0.010 13 GO:0019369 BP arachidonic acid metabolic process 
0.032 26 GO:0016705 MF 
oxidoreductase activity, acting on 
paired donors, with incorporation 
or reduction of molecular oxygen 
0.108 20 GO:0004866 MF endopeptidase inhibitor activity 
Table 4.9. Modules from WGCNA. 
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Figure 4.10. Clustering diagram of the heart gene expression libraries in the high-fat diet 
daughters. The 21 upregulated genes due to a maternal high-fat diet are mostly pseudogenes and 
non-coding RNAs. The 24 downregulated genes due to a maternal high-fat diet are primarily 
p450 cytochromes and genes already known to be involved in obesity and cardiovascular 
diseases. HF= High-fat diet, LF = Low-fat diet, first diet listed is maternal diet and second diet 
(after the hyphen) is the offspring diet. 
 
 
 
Comparison Group p<0.05 p<0.01 p<0.001 DMRs in X (%) 
Different diets 
HF-HF ♀ vs. LF-HF ♀ 34,844 1,701 232 79 (0.2%) 
HF-LF ♀ vs. LF-LF ♀ 55,014 9,550 2,566 284 (0.5%) 
HF-HF ♂ vs. LF-HF ♂ 40,437 2,262 258 28 (0.1%) 
HF-LF ♂ vs. LF-LF ♂ 57,374 8,737 1,505 75 (0.1%) 
Different sexes 
HF-HF ♀ vs. HF-HF ♂ 41,340 5,031 1,679 1,219 (3.0%) 
HF-LF ♀ vs. HF-LF ♂ 66,447 14,571 4,533 1,278 (1.9%) 
LF-HF ♀ vs. LF-HF ♂ 40,766 5,610 1,728 1,074 (2.6%) 
LF-LF ♀ vs. LF-LF ♂ 54,304 10,201 3,048 1,185 (2.2%) 
Table 4.10. Distribution of DMRs. Thousands of DMRs in the liver were associated with 
maternal diet. Low-fat offspring had more DMRs than high-fat offspring. There were more than 
twice as many DMRs on the X-chromosome when comparing between sexes than within sexes. 
HF= High-fat diet, LF = Low-fat diet, first diet listed is maternal diet and second diet (after the 
hyphen) is the offspring diet. 
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Genes with ≥1 DMR 
in gene body 
Genes with >1 DMR 
in gene body 
Genes with ≥1 
DMR in promoter 
HF-HF ♀ vs. LF-HF ♀ 7,367 (36.1%) 3,554 (17.4%) 1,878 (9.2%) 
HF-LF ♀ vs. LF-LF ♀ 9,358 (45.8%) 5,347 (26.2%) 2,724 (13.4%) 
HF-HF ♂ vs. LF-HF ♂ 7,980 (39.1%) 4,031 (19.8%) 2,213 (10.8%) 
HF-LF ♂ vs. LF-LF ♂ 9,369 (45.9%) 5,260 (25.8%) 3,254 (16.0%) 
Table 4.11. Number of genes in the mouse liver with at least one differentially methylated region 
(DMR) due to maternal diet within the gene body, more than one DMR in the gene body, and at 
least one DMR in the promoter region (within 2 kb upstream of the transcription start site (p < 
0.05). HF = High-fat diet, LF = Low-fat diet, first diet listed is maternal diet and second diet 
(after the hyphen) is the offspring diet.  
 
Region 
High Fat 
Daughters 
High Fat 
Sons 
Low Fat 
Daughters 
Low Fat 
Sons 
Whole 
Genome 
Enhancer 180 (10.6%) 259 (20.3%) 1,038 (10.9%) 1,024 (11.7%) 3.5% 
CTCF Binding Site 102 (6.0%) 129 (10.1%) 450 (4.7%) 614 (7.0%) 1.7% 
TF binding site 16 (0.9%) 16 (1.3%) 62 (0.6%) 93 (1.1%) 0.3% 
Promoter Flanking Region 549 (32.3%) 637 (49.9%) 3,625 (38.0%) 2,729 (31.2%) 8.1% 
Promoter  251 (14.7%) 311 (13.8%) 1,366 (14.3%) 1,393 (15.9%) 4.5% 
Exon 395 (23.2%) 528 (23.4%) 2,651 (27.8%) 1,958 (22.4%) 7.5% 
Intergenic 616 (36.2%) 807 (35.7%) 2,870 (30.0%) 3,037 (34.8%) 58.6% 
Table 4.12. Distribution of significant differentially methylated regions (DMRs) (p < 0.01) 
across the genome due to maternal diet. Values indicate the number of 500 base-pair windows 
overlapping each genomic region, with the percent of the total significant DMRs overlapping 
these regions in parentheses for the sons and daughters. As a comparison, the percentage of 
windows across the whole genome that overlap these genomic regions is listed, demonstrating 
how overrepresented these regulatory regions are in the DMRs.   
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A)   
 
B)   
C)   
D)   
 
E)   
 
 
Figure 4.11. Examples of differentially expressed genes that have differentially methylated 
regions within them due to maternal diet. The WashU Epigenome Browser screenshots 
indicate amount of methylation from MeDIP-seq. HF = High-fat diet, LF = Low-fat diet, and 
error bars represent ± the standard error.    
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A)  
B)   
 
 
  
 
 
 
   
 
 
 
C) 
 
Figure 4.12. (A) Expression of the Mpo gene is much higher in high fat offspring than in low fat 
offspring. (B) Stat1 expression is also higher in offspring on a high-fat diet than those on a low-fat 
diet. (C) Compared to high fat sons of low fat mothers, high fat sons of high fat mothers have 
reduced methylation of the Stat1 gene. HF = High-fat diet, LF = Low-fat diet, and error bars 
represent ± the standard error. 
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Gene Fold Difference of HF-HF vs. LF-HF daughters 
Anxa2 2.85 ± 1.21 
Chrna4 5.84 ± 2.09 
Mpo 12.96 ± 4.70 
Table 4.13. RT-qPCR validation results. Values are presented as HF-HF expression relative to 
LF-HF expression levels. Fold differences were calculated with the ∆∆CT method and reported 
as a range to include the standard deviation. HF= High Fat, LF= Low Fat. 
 
Gene Name logFC P-value 
Expression 
HF-HF 
Expression 
LF-HF 
SE          
HF-HF 
SE             
LF-HF 
Known Disease 
Involvement 
Lmo1 3.065 3.24E-04 -0.34 -3.38 0.86 0.77   
Mpo 2.790 2.47E-04 -0.65 -3.41 0.62 1.01 Obesity, Diabetes, CVD 
Sult2a3 2.783 8.23E-03 1.78 -1.21 1.03 0.74   
Lgr6 2.739 3.05E-04 -2.79 -5.56 0.41 0.53   
Ngp 2.686 5.02E-03 0.19 -2.42 0.88 0.94   
Sult3a2 2.655 4.99E-05 4.07 1.29 0.73 0.30   
Gm5210 2.504 2.80E-04 -2.95 -5.39 0.33 0.27   
Srpk3 -2.482 6.75E-05 -4.61 -2.14 0.53 0.29   
A4gnt 2.471 1.79E-02 -0.20 -2.55 0.70 0.69   
Slc9b1 2.457 3.54E-04 -3.51 -6.03 0.30 0.20   
Camp 2.455 7.65E-03 -2.57 -4.89 1.05 0.83   
Gm15540 -2.355 4.87E-04 -5.19 -2.93 0.22 0.21   
Gm17022 -2.344 3.16E-04 -5.00 -2.69 0.40 0.28   
Aplnr 2.329 2.17E-04 -1.81 -4.07 0.17 0.66   
Ltf 2.329 2.54E-02 -1.05 -3.30 0.76 0.95 Obesity, Diabetes, CVD 
Gm26937 2.312 2.15E-03 -3.42 -5.71 0.78 0.17   
Adam1a -2.292 6.94E-05 -5.00 -2.71 0.40 0.32   
Kat6b-ps2 2.288 1.01E-04 -2.09 -4.46 0.43 0.48   
Gm17229 2.274 2.64E-03 -3.32 -5.71 0.30 0.39   
Sult3a1 2.269 2.39E-05 6.69 4.32 0.55 0.43   
Cd177 2.251 1.12E-03 -1.91 -4.09 0.42 0.69   
Gm16731 -2.244 8.13E-04 -4.61 -2.28 0.68 0.11   
Il13ra2 -2.242 2.14E-04 -5.19 -3.06 0.22 0.41   
Igkv4-74 2.236 4.11E-03 -2.29 -4.61 0.67 0.58   
2610507I01Rik -2.229 7.10E-04 -4.79 -2.52 0.36 0.21   
Gm23388 2.210 1.22E-03 -2.41 -4.61 0.18 0.51   
Pla2g4f 2.196 5.01E-03 -0.94 -3.12 0.93 0.78   
Hao2 2.143 1.05E-04 3.06 0.81 0.60 0.28   
Gm23935 2.141 3.89E-04 9.02 6.85 0.13 0.19   
Ltk -2.140 2.18E-04 -4.79 -2.50 0.59 0.14   
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Gm15344 -2.135 3.30E-03 -5.19 -2.76 0.48 0.62   
Mcmdc2 2.110 2.42E-03 -1.98 -3.99 0.14 0.72   
Pcdh11x 2.107 1.71E-03 -1.91 -4.05 0.25 0.55   
Cap2 2.107 8.12E-03 -3.46 -5.71 0.93 0.40   
5430416N02Rik -2.103 3.30E-04 -3.90 -1.82 0.86 0.21   
Gm4956 -2.102 4.36E-04 -2.32 -0.12 0.28 0.42   
Gm4419 -2.081 3.13E-03 -5.58 -3.43 0.18 0.31   
Mybl2 -2.070 2.61E-04 -4.61 -2.60 0.45 0.35   
mt-Rnr2 2.054 3.45E-04 11.83 9.75 0.18 0.34   
Tmem167-ps1 2.043 1.81E-03 -1.62 -3.72 0.65 0.51   
Gm20125 2.038 2.44E-03 -2.93 -4.83 0.32 0.38   
Mir6236 2.035 1.04E-03 10.84 8.78 0.14 0.26   
Gm28323 -2.030 1.65E-03 -5.19 -3.17 0.22 0.37   
Gm16172 -2.027 4.64E-03 -4.61 -2.62 0.45 0.37   
Chrna4 2.027 2.33E-02 -0.84 -2.73 0.21 0.75   
Erbb4 2.006 6.11E-06 0.52 -1.49 0.46 0.15 Obesity, Diabetes, CVD 
 
Table 4.14. Differentially expressed genes due to maternal diet for high-fat-fed daughters (liver). 
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Gene Name logFC P-value 
Expression 
HF-HF 
Expression 
LF-HF 
SE         
HF-HF 
SE             
LF-HF 
Known Disease 
Involvement 
Hmgb1-rs16 2.510 2.38E-06 -2.89 -5.40 0.17 0.06    
Rassf6 -2.807 3.17E-06 -5.48 -2.67 0.04 0.33    
Mab21l3 -2.106 2.30E-05 -5.48 -3.37 0.04 0.20    
Prok1 -2.106 2.55E-05 -5.48 -3.37 0.04 0.21 Diabetes, CVD 
Paqr5 2.436 3.70E-05 -1.54 -3.98 0.18 0.41    
Gm25363 2.292 4.23E-05 -2.79 -5.08 0.14 0.31    
Gm16206 2.190 1.05E-04 -2.89 -5.08 0.19 0.32    
4930533K18Rik 2.029 1.52E-04 -3.37 -5.40 0.35 0.06    
Gm8145 2.371 2.49E-04 -2.25 -4.62 0.18 0.52    
B430305J03Rik 1.974 2.96E-04 -3.11 -5.08 0.22 0.31    
Mal2 -2.699 3.38E-04 -4.03 -1.32 0.76 0.19    
Rec114 2.483 3.40E-04 -2.13 -4.62 0.35 0.51    
4930563E18Rik 2.101 3.89E-04 -2.98 -5.08 0.33 0.32    
Gm8428 2.132 4.43E-04 -2.64 -4.77 0.33 0.36    
Gm20517 2.438 7.29E-04 -1.21 -3.64 0.21 0.75    
Gm28379 2.240 7.67E-04 -2.60 -4.84 0.26 0.53    
Slc17a4 -2.333 8.04E-04 -4.06 -1.74 0.67 0.21 CVD 
Gm16192 1.973 8.09E-04 -2.35 -4.30 0.24 0.43    
Tjp3 -1.984 8.43E-04 -3.75 -1.76 0.55 0.09    
Cyct 3.146 1.16E-03 -0.75 -3.89 0.26 1.15    
Gm11737 2.112 1.25E-03 -2.18 -4.30 0.34 0.50    
Plin1 -2.198 1.32E-03 -4.14 -1.95 0.58 0.33 Obesity, Diabetes  
Cyp2c54 -2.332 1.40E-03 -2.55 -0.25 0.83 0.21    
Gm12396 -1.959 1.47E-03 -5.48 -3.52 0.04 0.56    
Kynu -2.334 1.47E-03 -3.26 -0.94 0.67 0.36 CVD 
Cyp2c67 -2.077 1.59E-03 -2.61 -0.58 0.47 0.39    
Cyp2f2 -1.983 1.62E-03 -0.25 1.66 0.57 0.36    
Fgfr4 -2.121 1.67E-03 -3.49 -1.37 0.62 0.30 CVD 
Gm14212 1.971 1.93E-03 -2.48 -4.45 0.44 0.38    
Cyp2c44 -2.494 2.09E-03 -1.83 0.61 0.48 0.52    
Gm28809 1.984 2.36E-03 -2.21 -4.20 0.23 0.59    
Gm15869 1.977 2.37E-03 -2.78 -4.77 0.43 0.42    
Tulp2 1.962 2.52E-03 -2.51 -4.47 0.22 0.57    
F11 -2.163 3.06E-03 -3.72 -1.58 0.76 0.27 Diabetes, CVD 
Inhbc -1.986 3.81E-03 -3.32 -1.34 0.69 0.29 Obesity,  CVD 
Prss35 -2.715 3.87E-03 -5.48 -2.76 0.04 1.04    
Asmt 2.037 5.86E-03 -1.48 -3.50 0.21 0.83    
Gm4952 -1.961 6.47E-03 -3.02 -1.06 0.77 0.30    
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Prdm6 -2.170 6.66E-03 -4.79 -2.61 0.71 0.45 CVD 
Cd5l -1.972 1.34E-02 -2.81 -0.87 0.86 0.40 CVD 
Clec3a -2.255 1.41E-02 -5.48 -3.22 0.04 1.07    
Gm16270 2.006 1.46E-02 -2.54 -4.52 0.73 0.54    
Cyp4a12a -2.099 1.62E-02 -4.38 -2.26 0.50 0.82    
Cyp2c50 -2.063 1.65E-02 -1.62 0.36 0.97 0.44    
Sln -3.061 2.38E-02 -4.15 -1.05 0.78 1.21 Diabetes, CVD 
 
 
Table 4.15. Differentially expressed genes due to maternal diet for high-fat-fed daughters (heart). 
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Gene Name logFC P-value 
Expression 
HF-LF 
Expressio
n LF-LF 
SE        
HF-LF 
SE       
LF-LF 
Known Disease 
Involvement 
Dmbt1 3.529 4.21E-02 1.04 -2.09 0.97 0.96    
Gm11454 -3.475 2.98E-07 -4.41 -0.96 0.44 0.53 Obesity, Diabetes, CVD 
Sftpa1 3.256 8.08E-05 -1.42 -4.54 0.67 0.51    
Gucy2e 3.108 1.10E-05 -1.83 -5.15 0.21 0.58    
Hmmr -3.081 2.36E-04 -4.04 -0.82 0.63 0.54    
Cdc20 -3.054 4.90E-05 -2.94 0.14 0.52 0.23    
Pdk4 3.023 3.63E-05 5.37 2.40 0.53 0.18    
Rpl3l 2.940 1.57E-05 -2.54 -5.55 0.52 0.35    
Arhgap8 2.920 2.60E-06 -2.90 -5.95 0.37 0.31    
Zfp811 2.835 4.81E-05 -3.01 -5.95 0.34 0.31    
Lockd -2.772 4.49E-06 -5.20 -2.34 0.23 0.36    
Trpv3 2.768 1.11E-04 -3.12 -5.95 0.25 0.31    
Ppp1r3g 2.720 2.84E-04 5.68 3.03 0.55 0.76    
Vpreb3 2.707 2.22E-05 1.18 -1.54 0.29 0.56 Obesity, CVD 
Cytl1 2.706 3.66E-04 -2.33 -5.15 0.25 0.54 Obesity, Diabetes, CVD 
Gm28644 2.659 3.76E-04 -3.17 -5.95 0.33 0.31    
Dsg1a 2.633 6.76E-06 -2.28 -4.97 0.17 0.57    
Cdkn3 -2.617 7.59E-06 -4.73 -2.08 0.47 0.39    
Gcsam 2.614 4.63E-05 -3.24 -5.95 0.22 0.31    
Ccnb2 -2.611 3.54E-03 -3.32 -0.48 0.73 0.64    
Gngt1 -2.608 1.90E-05 -4.24 -1.62 0.31 0.27    
Cenpf -2.575 2.30E-04 -3.63 -0.98 0.56 0.33    
Gm10032 2.571 6.68E-04 -3.29 -5.95 0.58 0.31 CVD 
Kifc1 -2.559 5.06E-05 -4.88 -2.28 0.41 0.39    
Rapgef4os2 2.465 2.52E-04 -0.77 -3.02 0.12 0.67    
Gm10787 2.414 2.94E-04 -2.53 -5.15 0.51 0.58    
Fam69b 2.362 9.33E-05 -2.67 -4.97 0.27 0.31 Diabetes, CVD 
Mmrn1 2.361 3.67E-04 -2.48 -4.97 0.47 0.64    
Gm11832 -2.309 3.48E-06 -2.66 -0.38 0.39 0.42    
Egfros 2.306 2.35E-02 -1.39 -3.39 0.58 1.38    
Hapln1 -2.294 2.15E-03 -1.43 0.60 0.18 0.82    
Gm26744 2.271 9.07E-04 -2.77 -5.37 0.30 0.78    
Ppbp 2.256 1.88E-03 -1.75 -4.06 0.31 0.87    
Pnpla5 -2.246 2.55E-06 -1.56 0.71 0.48 0.34    
Ckap2 -2.244 1.12E-03 -3.57 -1.13 0.66 0.55    
Sytl3 2.239 1.31E-03 -3.63 -5.95 0.16 0.31    
Spdye4c 2.223 4.18E-04 -3.63 -5.95 0.50 0.31    
Rmi2 -2.210 1.67E-03 -4.73 -2.61 0.39 0.25    
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Rasd1 2.206 4.73E-04 -0.95 -3.18 0.47 0.25    
Osbpl3 2.202 3.70E-03 1.95 -0.08 0.44 0.64    
Snora78 2.202 2.48E-03 -2.84 -4.97 0.38 0.29    
A530013C23Rik 2.201 6.79E-04 -1.05 -3.37 0.57 0.73    
Atp2b2 -2.194 4.42E-06 0.47 2.71 0.34 0.27 Obesity, CVD 
Gm12186 2.194 1.19E-03 -3.68 -5.95 0.30 0.31 Obesity, Diabetes, CVD 
Meox1 -2.193 1.76E-04 -3.80 -1.57 0.47 0.11    
4930509G22Rik 2.185 5.85E-04 -2.91 -4.97 0.19 0.29    
Dgki 2.179 2.28E-04 -3.68 -5.95 0.24 0.31    
Gm11914 2.125 1.95E-03 -3.17 -5.24 0.24 0.56    
Klhl32 2.124 1.36E-03 -3.01 -5.02 0.26 0.77    
Gm12353 2.119 3.98E-03 -3.39 -5.55 0.29 0.35    
Gm20404 2.110 4.73E-03 -3.17 -5.55 0.34 0.61    
Gm12735 2.103 1.87E-03 -2.99 -4.97 0.34 0.31    
Acot5 2.100 2.16E-04 1.55 -0.55 0.19 0.50    
Gm17597 2.095 6.66E-04 -2.80 -4.79 0.33 0.37    
Gm15785 2.091 5.56E-04 -3.78 -5.95 0.16 0.31    
Arntl -2.076 3.40E-04 -0.31 1.82 0.36 0.49    
Pnpla3 -2.067 3.22E-04 1.98 4.04 0.17 0.59    
Ighv3-1 2.066 9.25E-04 -3.85 -5.95 0.57 0.31    
Gm13855 -2.062 8.22E-06 -2.02 -0.03 0.33 0.24    
Apitd1 -2.058 4.20E-04 -3.56 -1.42 0.46 0.21    
Gm16291 2.043 6.41E-04 -0.45 -2.31 0.12 0.69    
2310040G07Rik 2.031 6.28E-03 -3.49 -5.55 0.25 0.32    
Arhgef39 -2.029 8.15E-04 -4.24 -2.08 0.63 0.38    
Lrrtm3 2.028 2.18E-03 -3.49 -5.55 0.21 0.35    
Sag 2.023 4.54E-04 -3.85 -5.95 0.47 0.31    
Gm11205 2.018 3.84E-03 -3.49 -5.55 0.25 0.35    
Ephx4 2.014 2.63E-03 -3.85 -5.95 0.45 0.31    
Gm6114 -2.006 2.40E-03 -5.20 -3.11 0.40 0.21    
Scn3b 2.005 4.95E-03 -3.39 -5.37 0.15 0.46    
Unc79 2.005 2.39E-04 1.97 -0.06 0.30 0.65    
 
Table 4.16. Differentially expressed genes due to maternal diet for low-fat-fed daughters. 
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Gene Name logFC P-value 
Expression 
HF-HF 
Expression 
LF-HF 
SE      
HF-HF 
SE       
LF-HF 
Known Disease 
Involvement 
Myh6 2.679 0.0420 -3.23 -6.05 1.37 0.32 Diabetes, CVD 
Unc79 2.590 0.0166 -1.38 -3.79 0.41 1.04    
BC043934 2.468 0.0004 -3.00 -5.34 0.28 0.47    
Scarna13 2.450 0.0009 -2.77 -5.07 0.22 0.73    
Hsd17b1 2.445 0.0002 -1.86 -4.20 0.29 0.79 Obesity, Diabetes  
Mb 2.336 0.0200 -3.63 -6.05 1.13 0.32    
D830044D21Rik 2.327 0.0014 -3.33 -5.65 0.24 0.22    
E230001N04Rik 2.309 0.0025 -1.98 -4.20 0.41 0.55    
Slc22a29 -2.225 0.0007 -5.45 -3.35 0.10 0.71    
Myl2 2.191 0.0073 -3.78 -6.05 1.04 0.32 Obesity, Diabetes, CVD 
Ryr2 2.161 0.0048 -3.49 -5.65 0.67 0.22 Diabetes, CVD 
Slc22a27 -2.153 0.0463 -3.72 -1.74 0.86 0.66    
Kcne3 -2.136 0.0013 -4.82 -2.56 0.71 0.15 Diabetes, CVD 
Tssk4 2.128 0.0023 -2.29 -4.39 0.27 0.43    
Gm12168 -2.114 0.0002 -4.35 -2.25 0.45 0.19    
A430093F15Rik 2.098 0.0112 -2.81 -4.76 0.29 0.50    
4933406C10Rik 2.092 0.0025 -3.34 -5.34 0.46 0.47    
Gprasp2 -2.092 0.0009 -4.99 -2.91 0.42 0.34    
Wfdc3 2.083 0.0021 -3.08 -5.07 0.24 0.28    
Pnck 2.054 0.0081 -3.11 -5.07 0.27 0.28    
Rcor2 2.046 0.0062 -2.99 -5.25 0.35 0.65    
Omp -2.034 0.0001 -4.99 -2.91 0.44 0.32 Diabetes, CVD 
 
Table 4.17. Differentially expressed genes due to maternal diet for high-fat-fed sons. 
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Gene Name logFC P-value 
Expression 
HF-LF 
Expression 
LF-LF 
SE       
HF-LF 
SE     
LF-LF 
Known Disease 
Involvement 
Mb 5.527 2.72E-07 -1.33 -6.56 1.50 0.26    
Myh6 4.375 2.53E-03 -1.30 -5.19 1.95 0.38 Diabetes, CVD 
Myl2 4.082 1.39E-05 -2.61 -6.56 1.19 0.26 Obesity, Diabetes, CVD 
Tnni3 3.769 3.51E-05 -2.47 -6.16 0.89 0.43 Obesity, Diabetes, CVD 
Xirp2 3.560 2.10E-06 -2.95 -6.56 1.02 0.26    
Ckmt2 3.364 5.83E-07 -3.08 -6.56 1.00 0.26    
Actn2 3.297 2.53E-06 -2.85 -6.16 1.05 0.43 Obesity, CVD 
Eef1a2 3.225 1.72E-04 -2.85 -5.98 1.05 0.42    
Myh7 3.201 6.17E-05 -3.21 -6.56 0.86 0.26 CVD 
Gm15473 3.097 1.08E-07 -3.42 -6.56 0.52 0.26    
Mybpc3 3.042 2.22E-03 -2.41 -5.19 1.30 0.38 Diabetes, CVD 
Gm11991 3.007 4.05E-06 -3.21 -6.16 0.31 0.26    
Tcap 2.984 4.07E-04 -2.87 -5.77 1.05 0.29 CVD 
Cox8b 2.963 3.96E-05 -3.21 -6.16 0.61 0.26    
Myoz2 2.856 6.74E-06 -3.53 -6.56 0.70 0.26 CVD 
Actc1 2.856 4.72E-02 -1.57 -3.99 1.79 0.21 Diabetes, CVD 
Gm6881 2.838 9.48E-05 -3.42 -6.16 0.65 0.26    
Mfap5 2.819 6.85E-04 -3.32 -6.16 0.61 0.26 CVD 
Ckm 2.758 1.01E-04 -3.30 -6.16 0.82 0.26 Diabetes, CVD 
Dlk2 2.751 4.33E-05 -3.02 -5.77 0.27 0.38    
Gm24187 2.746 1.10E-03 -3.30 -6.16 0.58 0.50    
Dpysl5 2.741 3.87E-04 -3.48 -6.16 0.72 0.43    
Rad54l -2.741 1.00E-06 -4.97 -2.08 0.18 0.41 CVD 
Gm25381 2.724 8.85E-07 -3.79 -6.56 0.35 0.26    
Gm7719 2.724 8.47E-05 -3.79 -6.56 0.35 0.26    
Gm5533 2.705 7.00E-07 -4.00 -6.56 0.76 0.26    
Adprhl1 2.698 1.60E-05 -3.69 -6.56 0.57 0.26    
Gm29155 2.693 5.24E-04 -3.39 -6.16 0.18 0.50    
BC100451 2.686 3.09E-04 -3.48 -6.16 0.72 0.50    
Fabp3 2.685 1.11E-03 -3.01 -5.77 0.62 0.51 Obesity, Diabetes, CVD 
Gm9167 2.683 1.89E-03 -2.72 -5.37 0.30 0.23    
Nppb 2.678 8.22E-07 -3.71 -6.56 0.67 0.26 Obesity, Diabetes, CVD 
Hsd11b2 2.675 1.80E-03 -2.99 -5.50 0.53 0.88 Diabetes, CVD 
Ryr2 2.669 2.09E-03 -2.89 -5.58 1.05 0.63 Diabetes, CVD 
Gm23628 2.625 1.27E-04 -3.88 -6.56 0.65 0.26    
Aox4 2.601 3.48E-07 -4.00 -6.56 0.65 0.26    
Krt222 2.595 1.16E-03 -2.90 -5.40 0.39 0.48    
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Gm17059 2.585 5.81E-05 -3.81 -6.56 0.49 0.26    
Gm12717 2.582 2.63E-04 -3.39 -5.86 0.18 0.54    
Gm7803 2.569 9.97E-06 -4.00 -6.56 0.63 0.26    
Cox6a2 2.565 3.00E-03 -1.94 -4.39 0.70 0.62    
Gm6430 2.542 9.61E-05 -4.00 -6.56 0.59 0.26    
Slc9b1 2.542 9.96E-05 -4.00 -6.56 0.59 0.26    
Gm14276 -2.530 1.98E-06 -4.97 -2.36 0.18 0.31    
Sgcg 2.527 2.13E-05 -3.88 -6.56 0.52 0.26 Diabetes  
Platr9 2.521 1.26E-04 -4.00 -6.56 0.57 0.26    
Gm11127 2.504 1.97E-03 -3.48 -5.86 0.62 0.54    
Gm11954 2.502 2.79E-07 -4.18 -6.56 0.64 0.26    
Gm13773 2.502 2.80E-07 -4.18 -6.56 0.64 0.26    
4933402J07Rik 2.502 2.08E-06 -4.18 -6.56 0.64 0.26    
Gm28155 2.502 1.56E-05 -4.18 -6.56 0.64 0.26    
Adcy8 2.502 2.59E-05 -4.18 -6.56 0.64 0.26    
Kcnb2 2.502 1.43E-04 -4.18 -6.56 0.64 0.26 CVD 
Trim63 2.496 1.12E-04 -3.39 -5.86 0.53 0.54 CVD 
Gm13094 2.483 6.88E-04 -3.60 -6.16 0.41 0.43    
4930451E10Rik 2.483 2.96E-04 -3.60 -6.16 0.41 0.43    
Sult6b2 2.479 9.28E-06 -4.18 -6.56 0.89 0.26    
Ankrd1 2.467 2.23E-04 -1.28 -3.70 0.51 0.38 CVD 
H2-Ob -2.463 3.74E-05 -4.58 -2.26 0.33 0.45    
Figf -2.456 1.30E-04 -4.27 -1.96 0.62 0.45 Obesity, Diabetes  
Gm13472 2.423 1.23E-04 -3.81 -6.16 0.71 0.26    
Ppp1r14c 2.417 2.11E-05 -4.00 -6.56 0.42 0.26 CVD 
Tlx2 2.417 7.77E-05 -4.00 -6.56 0.42 0.26    
Gm13827 2.417 1.02E-04 -4.00 -6.56 0.42 0.26    
Gm2541 2.417 5.45E-06 -4.00 -6.56 0.42 0.26    
Abra 2.417 1.03E-04 -4.00 -6.56 0.42 0.26    
Gramd2 2.417 5.66E-04 -4.00 -6.56 0.42 0.26    
Fbxo15 2.414 2.54E-03 -3.21 -5.77 0.17 0.54    
Hist1h2ba 2.406 1.10E-04 -3.88 -6.16 0.76 0.26    
Chst4 2.401 2.26E-03 -3.60 -5.86 0.56 0.54    
Ccnb2 -2.392 8.32E-03 -3.60 -1.06 0.79 0.57    
Gm15946 2.390 5.81E-07 -4.18 -6.56 0.50 0.26    
Rps29-ps 2.390 4.26E-06 -4.18 -6.56 0.50 0.26    
Csmd2 2.390 1.97E-05 -4.18 -6.56 0.50 0.26 Diabetes, CVD 
Tmem198 2.390 7.97E-05 -4.18 -6.56 0.50 0.26    
Gm11295 2.390 2.62E-04 -4.18 -6.56 0.50 0.26    
Mcpt8 2.389 3.47E-06 -4.18 -6.56 0.50 0.26    
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Gm14323 2.389 4.31E-06 -4.18 -6.56 0.50 0.26    
Sh2d6 2.389 5.51E-05 -4.18 -6.56 0.50 0.26    
1700105P06Rik 2.389 6.03E-05 -4.18 -6.56 0.50 0.26    
4930578C19Rik 2.389 1.03E-04 -4.18 -6.56 0.50 0.26    
Gm7363 2.389 2.91E-04 -4.18 -6.56 0.50 0.26    
Btn1a1 2.366 1.15E-05 -4.18 -6.56 0.48 0.26    
Gm15157 2.366 2.07E-05 -4.18 -6.56 0.48 0.26    
Gm26448 2.366 3.57E-05 -4.18 -6.56 0.48 0.26    
Gm13842 2.366 9.15E-05 -4.18 -6.56 0.48 0.26    
Gm11646 2.366 1.01E-04 -4.18 -6.56 0.48 0.26    
Gm15992 2.366 1.63E-04 -4.18 -6.56 0.48 0.26    
Scarna3b 2.366 1.67E-04 -4.18 -6.56 0.48 0.26    
Gm13000 2.366 1.72E-06 -4.18 -6.56 0.48 0.26    
Gm12321 2.366 2.53E-06 -4.18 -6.56 0.48 0.26    
Muc5b 2.366 1.80E-05 -4.18 -6.56 0.48 0.26    
Gm13809 2.366 2.10E-05 -4.18 -6.56 0.48 0.26    
Cfap52 2.366 3.39E-05 -4.18 -6.56 0.48 0.26    
Gm11760 2.358 1.19E-04 -3.79 -6.16 0.52 0.50    
Hist1h2bb 2.358 3.38E-04 -3.79 -6.16 0.52 0.50    
Gm10284 2.349 2.91E-03 -3.08 -5.46 0.42 0.73    
Pcdhb6 2.341 1.17E-03 -3.79 -5.98 0.52 0.42    
Gm18284 2.336 4.10E-03 -3.21 -5.46 0.17 0.53    
Rpl21-ps12 2.310 4.80E-03 -3.21 -5.77 0.17 0.69    
Gm5871 2.299 5.61E-05 -3.79 -6.16 0.31 0.43    
Cdh19 2.294 1.43E-02 -2.74 -5.19 0.59 0.82    
Trbv13-1 2.292 4.62E-03 -3.71 -5.98 0.77 0.42    
1700034E13Rik 2.288 2.99E-06 -4.39 -6.56 0.71 0.26    
4930570D08Rik 2.288 2.99E-06 -4.39 -6.56 0.71 0.26    
1700018B08Rik 2.288 7.61E-06 -4.39 -6.56 0.71 0.26    
Fscn3 2.288 3.71E-05 -4.39 -6.56 0.71 0.26    
Ighv1-18 2.288 9.48E-05 -4.39 -6.56 0.71 0.26    
1700013G24Rik 2.288 1.11E-04 -4.39 -6.56 0.71 0.26    
Sftpc 2.288 1.28E-04 -4.39 -6.56 0.71 0.26    
Malrd1 2.288 2.10E-04 -4.39 -6.56 0.71 0.26    
Hrc 2.285 5.98E-03 -3.02 -5.58 0.95 0.78 CVD 
Gm9144 2.279 1.12E-02 -3.23 -5.40 0.70 0.57    
Frmpd4 2.277 5.45E-05 -3.81 -5.98 0.71 0.42 Diabetes, CVD 
Gm13620 2.270 1.86E-03 -4.00 -6.16 0.65 0.26    
1700048M11Rik 2.265 3.16E-03 -3.79 -6.16 0.73 0.50    
Txlnb 2.258 2.19E-03 -2.16 -4.30 0.36 0.43    
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Tnni3k 2.253 1.89E-07 -4.18 -6.56 0.28 0.26 Obesity, Diabetes, CVD 
Foxd3 2.253 1.89E-07 -4.18 -6.56 0.28 0.26 Diabetes, CVD 
Gm15812 2.253 1.89E-07 -4.18 -6.56 0.28 0.26    
Nppa 2.253 2.61E-07 -4.18 -6.56 0.28 0.26 Obesity, Diabetes, CVD 
Gm12400 2.253 2.34E-06 -4.18 -6.56 0.28 0.26    
Gm22980 2.253 2.44E-06 -4.18 -6.56 0.28 0.26    
Olfr520 2.253 5.02E-06 -4.18 -6.56 0.28 0.26    
C230012O17Rik 2.253 1.35E-05 -4.18 -6.56 0.28 0.26    
Gm25732 2.253 1.55E-05 -4.18 -6.56 0.28 0.26    
Hist1h2ad 2.253 1.86E-05 -4.18 -6.56 0.28 0.26    
Gm14051 2.253 2.13E-05 -4.18 -6.56 0.28 0.26    
Gm13937 2.253 3.58E-05 -4.18 -6.56 0.28 0.26    
Psd2 2.253 3.83E-05 -4.18 -6.56 0.28 0.26    
Gm11639 2.253 4.02E-05 -4.18 -6.56 0.28 0.26    
Gm12098 2.253 4.83E-05 -4.18 -6.56 0.28 0.26    
Scube2 2.253 7.91E-05 -4.18 -6.56 0.28 0.26 CVD 
Gm26517 2.253 2.12E-04 -4.18 -6.56 0.28 0.26    
Gm22455 2.253 2.60E-04 -4.18 -6.56 0.28 0.26    
Ccdc85a 2.253 3.38E-04 -4.18 -6.56 0.28 0.26 Obesity   
Mir1960 2.253 3.48E-04 -4.18 -6.56 0.28 0.26    
Gm13816 2.253 3.51E-04 -4.18 -6.56 0.28 0.26    
H2-Ke6 2.250 3.77E-03 -3.88 -5.86 0.84 0.54    
Enthd1 2.250 2.80E-06 -4.39 -6.56 0.69 0.26    
1700042G07Rik 2.250 2.80E-06 -4.39 -6.56 0.69 0.26    
C1ql2 2.250 9.63E-06 -4.39 -6.56 0.69 0.26    
Rps19-ps9 2.250 3.80E-05 -4.39 -6.56 0.69 0.26    
Gm22311 2.250 3.98E-05 -4.39 -6.56 0.69 0.26    
Gm9378 2.250 1.30E-04 -4.39 -6.56 0.69 0.26    
Myl3 2.249 1.51E-02 -2.45 -4.48 1.29 0.23 Diabetes, CVD 
Gm3086 2.247 3.99E-04 -3.81 -5.98 0.68 0.42    
Gm12356 2.238 3.80E-04 -4.00 -6.16 0.63 0.26    
Cd200r3 2.238 1.22E-03 -4.00 -6.16 0.63 0.26    
Lrrc2 2.234 4.33E-03 -3.39 -5.77 0.55 0.86    
Camp 2.233 2.26E-02 -3.48 -5.58 0.62 0.38    
Acod1 -2.232 1.07E-02 -4.27 -2.25 0.62 0.59    
Gm16365 2.213 2.90E-03 -3.39 -5.46 0.18 0.47    
En2 2.212 1.25E-04 -4.00 -6.16 0.59 0.26    
Ms4a4c -2.211 8.98E-04 -3.60 -1.63 0.64 0.37    
Serpina3a 2.211 6.98E-03 -2.59 -4.88 0.29 0.65    
E530011L22Rik 2.210 5.26E-03 -3.60 -5.86 0.56 0.77    
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Gm3809 2.197 7.25E-03 -3.21 -5.28 0.17 0.54    
Gm13612 2.191 3.13E-03 -3.21 -5.37 0.31 0.76    
Igf2os 2.189 9.25E-04 -4.00 -6.16 0.57 0.26    
Fgf13 2.177 1.99E-03 -3.60 -5.58 0.63 0.38 Diabetes, CVD 
Gm13511 2.175 9.99E-05 -4.27 -6.56 0.62 0.26    
Gm13009 2.175 1.44E-04 -4.27 -6.56 0.62 0.26    
Gm14425 2.175 8.54E-04 -4.27 -6.56 0.62 0.26    
Fmr1nb 2.175 1.40E-03 -4.27 -6.56 0.62 0.26    
Bmp8b 2.174 7.19E-03 -3.48 -5.58 0.57 0.44 Obesity   
Gm23130 2.164 1.50E-03 -4.00 -6.16 0.63 0.43    
Wdr72 2.164 4.44E-03 -3.60 -5.77 0.46 0.38 Diabetes  
Syngr4 2.156 1.65E-03 -3.08 -5.19 0.25 0.34    
Gm8508 2.152 3.32E-03 -2.55 -4.72 0.53 0.47    
Gm13181 2.150 7.90E-03 -3.08 -5.19 0.58 0.25    
A530020G20Rik -2.148 8.59E-03 -4.27 -2.13 0.62 0.36    
Ttn 2.147 2.85E-02 -1.55 -3.39 1.28 0.44 Diabetes, CVD 
Gm14017 2.142 4.39E-04 -4.00 -6.16 0.65 0.50    
Gm7221 -2.141 4.43E-05 -4.39 -2.28 0.50 0.20    
Gm11951 2.138 5.50E-04 -4.00 -6.16 0.59 0.43    
Rps2-ps13 2.138 6.50E-04 -4.00 -6.16 0.59 0.43    
Shcbp1 -2.137 1.17E-03 -3.32 -1.20 0.59 0.26    
Mirlet7c-2 2.135 1.93E-03 -4.00 -5.86 0.76 0.54    
Gm8444 2.125 8.81E-04 -3.81 -6.16 0.49 0.50    
Gm12525 2.125 8.23E-05 -4.00 -5.98 0.65 0.42    
Akap3 2.122 7.43E-03 -3.60 -5.46 0.98 0.53    
Olfr726 2.119 1.65E-03 -3.79 -5.77 0.52 0.29    
Fabp5l2 2.117 9.43E-04 -3.57 -5.77 0.63 0.29    
Gm15353 2.116 4.32E-03 -4.00 -6.16 0.57 0.43    
Tmem40 2.116 9.02E-03 -2.90 -5.19 0.32 0.65    
Gm15798 2.110 2.32E-03 -4.00 -6.16 0.63 0.50    
Gm17276 2.098 8.77E-03 -2.34 -4.39 0.41 0.60    
Adam24 2.098 5.06E-04 -4.18 -6.16 0.64 0.43    
Gm9009 2.098 5.33E-04 -4.18 -6.16 0.64 0.43    
Pcdha11 2.098 8.48E-04 -4.18 -6.16 0.64 0.43    
Gm8392 2.098 9.47E-04 -4.18 -6.16 0.64 0.43    
Iqgap3 -2.092 8.80E-03 -3.71 -1.68 0.77 0.29    
Gm6793 2.091 1.01E-02 -3.60 -5.58 0.63 0.53    
Traf3ip3 -2.087 3.77E-04 -4.27 -2.28 0.62 0.18    
Smpx 2.086 3.43E-05 -4.00 -6.16 0.42 0.26    
Gm11620 2.086 3.13E-03 -4.00 -6.16 0.42 0.26    
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Myom2 2.086 3.72E-04 -4.00 -6.16 0.42 0.26    
Cytl1 2.084 2.20E-02 -2.54 -4.70 0.78 1.00    
Dnah5 -2.083 1.42E-03 -4.27 -2.34 0.62 0.47 CVD 
Slc6a19 2.083 3.00E-03 -4.00 -6.16 0.59 0.50 CVD 
Gm24407 2.077 3.27E-03 -3.88 -5.77 0.84 0.38    
Gm8773 2.076 2.01E-06 -4.58 -6.56 0.53 0.26    
Emx1 2.076 2.33E-06 -4.58 -6.56 0.53 0.26    
Gm16351 2.076 2.33E-06 -4.58 -6.56 0.53 0.26    
Prss21 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Padi1 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Piwil1 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Tgif2-ps2 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Spag16 2.076 2.35E-06 -4.58 -6.56 0.53 0.26 Obesity, Diabetes  
Zdhhc25 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Ap3b2 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Rnu12 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm15067 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm13126 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm13050 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Rps19-ps14 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm5942 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm4991 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm13715 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm15873 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
4933406K04Rik 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Ccdc42os 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Gm22518 2.076 2.35E-06 -4.58 -6.56 0.53 0.26    
Cdk19os 2.076 3.67E-06 -4.58 -6.56 0.53 0.26    
Gm16229 2.076 4.96E-06 -4.58 -6.56 0.53 0.26    
Gm22092 2.076 6.44E-06 -4.58 -6.56 0.53 0.26    
Gm8419 2.076 6.91E-06 -4.58 -6.56 0.53 0.26    
Gm13915 2.076 7.74E-06 -4.58 -6.56 0.53 0.26    
Gm26004 2.076 8.54E-06 -4.58 -6.56 0.53 0.26    
Mir7659 2.076 8.87E-06 -4.58 -6.56 0.53 0.26    
Gm17752 2.076 9.43E-06 -4.58 -6.56 0.53 0.26    
Gdap1l1 2.076 9.71E-06 -4.58 -6.56 0.53 0.26    
Gm17189 2.076 9.76E-06 -4.58 -6.56 0.53 0.26    
2900072N19Rik 2.076 1.01E-05 -4.58 -6.56 0.53 0.26    
Gm16578 2.076 1.01E-05 -4.58 -6.56 0.53 0.26    
Cfap44 2.076 1.02E-05 -4.58 -6.56 0.53 0.26    
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Gm3943 2.076 1.07E-05 -4.58 -6.56 0.53 0.26    
Slfn5os 2.076 1.27E-05 -4.58 -6.56 0.53 0.26    
Gm22613 2.076 1.30E-05 -4.58 -6.56 0.53 0.26    
1700030M09Rik 2.076 1.47E-05 -4.58 -6.56 0.53 0.26    
Gm12269 2.076 1.51E-05 -4.58 -6.56 0.53 0.26    
Slc5a5 2.076 1.60E-05 -4.58 -6.56 0.53 0.26    
Gm3617 2.076 1.68E-05 -4.58 -6.56 0.53 0.26    
Gm11479 2.076 1.80E-05 -4.58 -6.56 0.53 0.26    
Gm15432 2.076 1.80E-05 -4.58 -6.56 0.53 0.26    
Gm10689 2.076 2.17E-05 -4.58 -6.56 0.53 0.26    
Gm26465 2.076 2.71E-05 -4.58 -6.56 0.53 0.26    
Gm24693 2.076 3.04E-05 -4.58 -6.56 0.53 0.26    
Gm13703 2.076 3.08E-05 -4.58 -6.56 0.53 0.26    
Il5ra 2.076 4.17E-05 -4.58 -6.56 0.53 0.26 Obesity, Diabetes, CVD 
Ighv1-59 2.076 4.31E-05 -4.58 -6.56 0.53 0.26    
Zfp92 2.076 4.87E-05 -4.58 -6.56 0.53 0.26    
Gm27514 2.076 4.98E-05 -4.58 -6.56 0.53 0.26    
Clec2l 2.076 4.99E-05 -4.58 -6.56 0.53 0.26    
Gm6181 2.076 5.21E-05 -4.58 -6.56 0.53 0.26    
Gm5321 2.076 5.80E-05 -4.58 -6.56 0.53 0.26    
Gm14094 2.076 6.74E-05 -4.58 -6.56 0.53 0.26    
Ighv1-80 2.076 6.83E-05 -4.58 -6.56 0.53 0.26    
Aire 2.076 8.50E-05 -4.58 -6.56 0.53 0.26 Obesity, Diabetes  
Gm17199 2.076 1.49E-04 -4.58 -6.56 0.53 0.26    
Sox5os5 2.076 1.61E-04 -4.58 -6.56 0.53 0.26    
Hmgb1-ps6 2.076 1.92E-04 -4.58 -6.56 0.53 0.26    
Gm12407 2.076 2.01E-04 -4.58 -6.56 0.53 0.26    
Ces2f 2.076 2.06E-04 -4.58 -6.56 0.53 0.26    
Vwa5b2 2.076 2.65E-04 -4.58 -6.56 0.53 0.26    
Tspan1 2.076 3.00E-04 -4.58 -6.56 0.53 0.26 Diabetes  
Mir6921 2.076 3.59E-04 -4.58 -6.56 0.53 0.26    
Gm4943 2.076 5.01E-04 -4.58 -6.56 0.53 0.26    
Stac 2.076 4.78E-03 -4.58 -6.56 0.53 0.26    
Gm23851 2.074 1.67E-03 -3.79 -5.77 0.52 0.38    
Ccdc13 2.071 1.68E-06 -4.39 -6.56 0.50 0.26    
Gm1335 2.071 1.72E-06 -4.39 -6.56 0.50 0.26    
Gm23640 2.071 1.72E-06 -4.39 -6.56 0.50 0.26    
Gm12998 2.071 4.25E-06 -4.39 -6.56 0.50 0.26    
Gal3st3 2.071 1.64E-05 -4.39 -6.56 0.50 0.26    
Gm14226 2.071 1.64E-05 -4.39 -6.56 0.50 0.26    
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Gm29200 2.071 2.13E-05 -4.39 -6.56 0.50 0.26    
Gm2976 2.071 3.45E-05 -4.39 -6.56 0.50 0.26    
Gm15763 2.071 4.53E-05 -4.39 -6.56 0.50 0.26    
Tecrl 2.071 5.21E-05 -4.39 -6.56 0.50 0.26 Diabetes, CVD 
Gm13523 2.071 6.44E-05 -4.39 -6.56 0.50 0.26    
Gm26685 2.071 7.37E-05 -4.39 -6.56 0.50 0.26    
Gm15483 2.071 1.95E-04 -4.39 -6.56 0.50 0.26    
Fscn2 2.071 2.44E-04 -4.39 -6.56 0.50 0.26    
Gm24714 2.071 2.58E-04 -4.39 -6.56 0.50 0.26    
Gm26706 2.071 4.01E-04 -4.39 -6.56 0.50 0.26    
Gm16725 2.071 4.32E-04 -4.39 -6.56 0.50 0.26    
1700061E17Rik 2.071 4.45E-04 -4.39 -6.56 0.50 0.26    
Gm15965 2.071 7.07E-04 -4.39 -6.56 0.50 0.26    
Gm26477 2.071 1.72E-06 -4.39 -6.56 0.50 0.26    
Gm8597 2.071 1.72E-06 -4.39 -6.56 0.50 0.26    
Plppr4 2.071 9.26E-06 -4.39 -6.56 0.50 0.26    
Gja3 2.071 1.14E-05 -4.39 -6.56 0.50 0.26    
Gm25057 2.071 1.31E-05 -4.39 -6.56 0.50 0.26    
Gm24146 2.071 1.86E-05 -4.39 -6.56 0.50 0.26    
Mir6392 2.071 2.35E-04 -4.39 -6.56 0.50 0.26    
Eya1 2.071 2.54E-04 -4.39 -6.56 0.50 0.26    
Igkv5-45 2.071 2.80E-04 -4.39 -6.56 0.50 0.26 CVD 
Btnl10 2.071 4.78E-04 -4.39 -6.56 0.50 0.26    
Igkv3-7 2.067 3.61E-03 -3.88 -6.16 0.52 0.50    
Gm24105 2.066 8.59E-03 -3.39 -5.40 0.65 0.57    
C4bp-ps1 2.065 2.40E-02 -2.62 -4.79 0.47 0.70    
Arxes2 2.062 5.74E-03 -4.00 -6.16 0.65 0.63    
Gm12470 2.059 1.85E-05 -4.18 -6.16 0.50 0.26    
Ccdc113 2.059 5.62E-05 -4.18 -6.16 0.50 0.26    
Gm11682 2.059 1.40E-04 -4.18 -6.16 0.50 0.26    
Gm6564 2.059 1.46E-04 -4.18 -6.16 0.50 0.26    
Gm17798 2.059 5.81E-04 -4.18 -6.16 0.50 0.26    
Gm5445 2.059 2.22E-03 -4.18 -6.16 0.50 0.26    
Gm5575 2.058 1.64E-04 -4.18 -6.16 0.50 0.26    
Mypn 2.058 1.53E-02 -2.90 -4.88 0.39 0.36    
Atg4a-ps 2.058 1.81E-03 -3.79 -5.98 0.31 0.66    
Gm2735 2.048 1.57E-06 -4.58 -6.56 0.51 0.26    
Gm25881 2.048 1.58E-06 -4.58 -6.56 0.51 0.26    
Gm15714 2.048 2.16E-06 -4.58 -6.56 0.51 0.26    
Dmrtc2 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
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Tmbim7 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Vsx2 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Odf3l1 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Cypt3 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Hdhd1a 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
4930469G21Rik 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Grm5 2.048 2.19E-06 -4.58 -6.56 0.51 0.26 Diabetes, CVD 
Mrgprg 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Olfr1029 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Nkx6-3 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm22772 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm15176 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm5395 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm15580 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
H2af-ps 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm15168 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm16330 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
4930557F10Rik 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm15721 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm15668 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
4930401O12Rik 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm9719 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm15849 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Tmem207 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Vmn2r-ps19 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm26783 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
1700034K08Rik 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
1700025F24Rik 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Gm29395 2.048 2.19E-06 -4.58 -6.56 0.51 0.26    
Rps13-ps5 2.048 2.48E-06 -4.58 -6.56 0.51 0.26    
Gm11774 2.048 2.74E-06 -4.58 -6.56 0.51 0.26    
Gm13921 2.048 3.23E-06 -4.58 -6.56 0.51 0.26    
Gm8659 2.048 3.95E-06 -4.58 -6.56 0.51 0.26    
Gm13414 2.048 3.95E-06 -4.58 -6.56 0.51 0.26    
Vmn1r79 2.048 3.95E-06 -4.58 -6.56 0.51 0.26    
Gm14106 2.048 4.25E-06 -4.58 -6.56 0.51 0.26    
Gm13294 2.048 6.22E-06 -4.58 -6.56 0.51 0.26    
Mir6939 2.048 6.68E-06 -4.58 -6.56 0.51 0.26    
Haglr 2.048 6.80E-06 -4.58 -6.56 0.51 0.26    
Gssos1 2.048 6.95E-06 -4.58 -6.56 0.51 0.26    
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Gm10087 2.048 8.28E-06 -4.58 -6.56 0.51 0.26    
Hmgb1-rs18 2.048 9.94E-06 -4.58 -6.56 0.51 0.26    
Gm5105 2.048 1.05E-05 -4.58 -6.56 0.51 0.26    
Gm26928 2.048 1.10E-05 -4.58 -6.56 0.51 0.26    
Rsph14 2.048 1.12E-05 -4.58 -6.56 0.51 0.26    
Fbxo39 2.048 1.12E-05 -4.58 -6.56 0.51 0.26    
Slc16a14 2.048 1.21E-05 -4.58 -6.56 0.51 0.26    
Slco6c1 2.048 1.28E-05 -4.58 -6.56 0.51 0.26    
Gm25687 2.048 1.28E-05 -4.58 -6.56 0.51 0.26    
A430108G06Rik 2.048 1.35E-05 -4.58 -6.56 0.51 0.26    
Gm136 2.048 1.41E-05 -4.58 -6.56 0.51 0.26    
Gm26614 2.048 1.47E-05 -4.58 -6.56 0.51 0.26    
Gm14769 2.048 1.51E-05 -4.58 -6.56 0.51 0.26    
Synpr 2.048 1.59E-05 -4.58 -6.56 0.51 0.26    
Slc36a3os 2.048 1.66E-05 -4.58 -6.56 0.51 0.26    
Gm5451 2.048 1.67E-05 -4.58 -6.56 0.51 0.26    
Gm10800 2.048 1.72E-05 -4.58 -6.56 0.51 0.26    
Apobec4 2.048 2.23E-05 -4.58 -6.56 0.51 0.26    
Gm14170 2.048 2.32E-05 -4.58 -6.56 0.51 0.26    
Gm8129 2.048 3.12E-05 -4.58 -6.56 0.51 0.26    
Gm13584 2.048 3.13E-05 -4.58 -6.56 0.51 0.26    
Tnnt3 2.048 3.31E-05 -4.58 -6.56 0.51 0.26 Diabetes, CVD 
Snord111 2.048 3.83E-05 -4.58 -6.56 0.51 0.26    
BC016579 2.048 4.92E-05 -4.58 -6.56 0.51 0.26    
Gm8338 2.048 4.97E-05 -4.58 -6.56 0.51 0.26    
Gm27193 2.048 6.33E-05 -4.58 -6.56 0.51 0.26    
Gm16265 2.048 7.46E-05 -4.58 -6.56 0.51 0.26    
Gm12808 2.048 7.67E-05 -4.58 -6.56 0.51 0.26    
Gm5396 2.048 7.97E-05 -4.58 -6.56 0.51 0.26    
Olfr755-ps1 2.048 9.73E-05 -4.58 -6.56 0.51 0.26    
Gm25235 2.048 9.84E-05 -4.58 -6.56 0.51 0.26    
Gm22067 2.048 1.01E-04 -4.58 -6.56 0.51 0.26    
Gm11438 2.048 1.12E-04 -4.58 -6.56 0.51 0.26    
Ctsj 2.048 1.25E-04 -4.58 -6.56 0.51 0.26    
Gm17828 2.048 1.60E-04 -4.58 -6.56 0.51 0.26    
Gm28586 2.048 1.65E-04 -4.58 -6.56 0.51 0.26    
Dhx58os 2.048 1.88E-04 -4.58 -6.56 0.51 0.26    
Zfp385c 2.048 1.92E-04 -4.58 -6.56 0.51 0.26    
Ptchd4 2.048 2.06E-04 -4.58 -6.56 0.51 0.26    
Gm12260 2.048 2.19E-04 -4.58 -6.56 0.51 0.26    
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Gm5759 2.048 2.46E-04 -4.58 -6.56 0.51 0.26    
Gm2670 2.048 2.94E-04 -4.58 -6.56 0.51 0.26    
Tarm1 2.048 3.70E-04 -4.58 -6.56 0.51 0.26    
Gm5844 2.048 3.80E-04 -4.58 -6.56 0.51 0.26    
Atp5k-ps2 2.048 4.47E-04 -4.58 -6.56 0.51 0.26    
E330017L17Rik 2.048 4.51E-04 -4.58 -6.56 0.51 0.26    
Mir7212 2.048 8.00E-04 -4.58 -6.56 0.51 0.26    
Gm17039 2.048 8.06E-04 -4.58 -6.56 0.51 0.26    
Crybb1 2.048 8.98E-04 -4.58 -6.56 0.51 0.26    
Col28a1 2.048 9.34E-04 -4.58 -6.56 0.51 0.26 Diabetes, CVD 
Gm12774 2.048 1.37E-03 -4.58 -6.56 0.51 0.26    
4930520O04Rik 2.048 1.39E-03 -4.58 -6.56 0.51 0.26    
Gm29375 2.048 2.43E-03 -4.58 -6.56 0.51 0.26    
Gm8822 -2.048 5.42E-05 -4.97 -2.82 0.18 0.29    
Trdn 2.046 1.23E-03 -3.81 -6.16 0.49 0.63 Diabetes, CVD 
Tg 2.044 2.41E-03 -4.00 -5.98 0.57 0.42 Obesity, Diabetes  
1700021N21Rik 2.044 3.58E-03 -4.00 -5.98 0.57 0.42    
Snora78 2.044 1.44E-02 -2.62 -4.72 0.49 0.68    
Gm11945 2.043 1.22E-03 -4.18 -6.16 0.64 0.50    
Slc28a3 2.035 7.05E-04 -4.18 -6.16 0.48 0.26 CVD 
Gm6139 2.035 2.23E-03 -4.18 -6.16 0.48 0.26    
Gm26669 2.035 4.38E-03 -4.18 -6.16 0.48 0.26    
Gm9294 2.035 7.20E-04 -4.18 -6.16 0.48 0.26    
Rsph4a 2.035 4.07E-03 -4.18 -6.16 0.48 0.26 CVD 
Gm13449 -2.033 7.05E-04 -4.39 -2.32 0.50 0.32    
Spata31d1b 2.026 1.37E-04 -4.18 -5.98 0.64 0.42    
4933400F21Rik 2.026 3.45E-03 -4.18 -5.98 0.64 0.42    
Gm8151 2.025 7.59E-05 -3.79 -5.77 0.35 0.29    
Ap3s1-ps2 2.025 2.51E-02 -2.79 -4.76 0.82 0.49    
Gm15372 2.015 2.99E-02 -2.74 -4.64 0.41 1.17    
Gm13784 2.012 1.44E-03 -4.00 -6.16 0.42 0.43    
Gm13680 2.011 8.69E-03 -3.39 -5.40 0.18 0.70    
Gm20695 2.008 8.58E-03 -3.60 -5.58 0.56 0.61    
Gm29488 2.005 4.86E-03 -3.79 -5.77 0.31 0.29    
Gm14848 2.003 2.13E-03 -4.00 -6.16 0.59 0.63    
Acta1 2.003 5.14E-03 -3.48 -5.77 0.69 0.54 Diabetes, CVD 
 
Table 4.18. Differentially expressed genes due to maternal diet for low-fat-fed sons. 
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 The principal goal of this research was to uncover the gene expression and methylation 
changes that drive the physiological response to dietary fat in two generations of mice. I assigned 
inbred SM/J mice to a low-fat diet or a high-fat diet and measured their body and organ weights, 
their glucose and insulin tolerance, and biomarkers in their serum. I studied the effect of prenatal 
maternal diet by mating SM/J females on either diet with low-fat-fed males, fostering all of their 
offspring to low-fat-fed SM/J nurses, and weaning their offspring onto low fat or high-fat diets at 
three weeks of age. I measured the same traits in the offspring as in the parents, as well as 
additional behavior and bone phenotypes. To quantify expression and epigenetic profiles, I 
extracted RNA from the liver tissue for RNA-sequencing and DNA for MeDIP- and MRE-
sequencing. I then identified the changes that maternal obesity induced in gene expression and 
methylation, which has helped to provide a better understanding of the epigenetic architecture of 
obesity. I found that although offspring diet had a more substantial effect on obesity, gene 
expression, and methylation patterns in SM/J mice, maternal diet affected all three of these trait 
categories as well. Based on genes that had differences in both expression and methylation, I also 
discussed numerous candidate loci for researchers to follow-up on in other strains of mice and in 
humans in studies of epigenetic therapies for obesity.  
 One mechanism through which non-genetic maternal effects can persist in offspring is via 
epigenetics. The epigenetic factor I chose to investigate here was DNA methylation, because it is 
sensitive to prenatal programming and has been shown to affect offspring behavior and health. In 
a ground-breaking study, Meaney and Szyf (2005) showed that differences in maternal care in 
rats changed the methylation of the offspring glucocorticoid receptor promoter in the 
hippocampus. The altered methylation state lasted for life, as did the altered stress response. 
DNA methylation has also been shown to be responsive to maternal diet, as exemplified by the 
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research revealing that supplementing dietary folate—an important methyl donor—reduced 
offspring obesity and methylation of the Avy locus in mice (Wolff et al. 1998, Waterland and 
Jirtle 2003, Waterland et al. 2004). 
In Chapter 4, I found that a maternal high-fat diet altered the methylation of more than 
7,300 genes in the liver tissue of the offspring. Although fewer than 1% of the differentially 
methylated regions fell within differentially expressed genes, they did occur within gene 
regulatory regions far more often than expected by chance alone, in line with previous 
knowledge of methylation’s role in gene regulation. The offspring were more affected by the 
direct effect of their own diets than the effect of maternal diet. While maternal diet induced 
changes in dozens of genes, offspring diet induced changes in thousands of genes. On a 
phenotypic level, maternal diet induced changes in some of the traits of only the female 
offspring, whereas offspring diet induced changes in virtually every trait measured in both sexes. 
The results of Chapter 2 supported this trend, where the only behavioral trait that maternal diet 
affected was where the offspring built their nests, as opposed to the wide range of traits affected 
by offspring diet: a high-fat diet reduced nest quality, reduced activity levels, and increased 
anxiety. Other studies have revealed that a maternal high-fat diet increases anxiety in mice, so 
the fact that I found no effect in Chapter 2 suggests that the lactation environment rather than the 
prenatal environment mediates this phenomenon. Another noteworthy finding in Chapter 2 was 
that the significant weight gain induced by the high-fat diet was evident several weeks before the 
reduction in activity levels was observed. This suggests that weight gain can lead to inactivity, 
not only that inactivity leads to obesity. The lower activity levels may have exacerbated the 
weight gain from the high-fat diet.  
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 In Chapter 3, I found that a high-fat diet altered the expression of 4,356 genes in the liver 
and dysregulated several pathways. The genes in the cytokine-cytokine receptor interaction 
pathway were more highly expressed due to a high-fat diet, and 11 of those genes also had 
differentially methylated regions in the females, as did 9 genes in the males. The upregulation of 
the cytokine pathway is one of many lines of evidence that a high-fat diet increased 
inflammation. Of the dozens of GO Biological Processes that were upregulated by a high-fat 
diet, nearly all of them involved the immune system. Galnt10 was upregulated by a high-fat diet 
in females, which may indicate that more mucin-type O-glycosylation was occurring due to 
increased production of inflammatory proteins. The Adam11 gene, not previously discussed with 
regard to obesity, was strongly upregulated in mice on a high-fat diet. The gene also had 3 
consecutive DMRs spanning 5 exons that were more methylated in high-fat-fed mice. Since 
knocking out this gene in mice reduces the response to inflammatory pain, my findings indicate 
that further studies of the role Adam11 plays in obesity-associated inflammation are merited.   
Diet-induced obesity is a state of chronic inflammation, which can cause liver fibrosis 
(Calvente et al. 2015). The livers of the high fat mice were 2.8 times heavier than the low-fat 
mice, and they had a yellow discoloration from fat buildup. This was accompanied by altered 
methylation and increased expression of genes such as Col1a1—which encodes the type of 
collagen that comprises scar tissue and accumulates in the liver during fibrosis—and Lad1, a 
component of the basement membrane, which overgrows in the liver during fibrosis. The livers 
of high-fat mice showed an epigenetic response to the high cholesterol induced by the diet by 
reducing the methylation and raising the expression of the Abcg5 and Abcg8 genes, which 
encode a heterodimer responsible for eliminating cholesterol from the body. Despite this 
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upregulation, the high-fat-fed mice still had 2-3 times more serum cholesterol than the low-fat-
fed mice.  
When I compared my gene expression results to those of other high-fat diet studies, I 
found that the Fgfr2 gene was differentially expressed in the males and females of three other 
strains in addition to SM/J. Fgfr2 is upregulated in the livers of people with non-alcoholic fatty 
liver disease (NAFLD) (Younossi et al. 2005), and its methylation in cord blood has been linked 
to birth weight in newborns (Haworth et al. 2014). Due to these previous studies, as well as the 
sensitivity of Fgfr2 to a high-fat diet in both sexes of multiple mouse strains, and the fact that I 
found DMRs in both sexes of the gene, Fgfr2 could be an important therapeutic target in obesity. 
In Chapter 4, I showed that a maternal high-fat diet downregulated the ribosome, 
spliceosome, oxidative phosphorylation, and RNA transport pathways regardless of offspring 
diet. Notable disease pathways downregulated by a maternal high-fat diet included the NAFLD 
and Alzheimer’s disease pathways. Although by 17 weeks of age, changes in the obesity traits 
were detected only in the daughters, it would be interesting in the future to test the memories and 
cognitive function of older mice, knowing that the Alzheimer’s pathway was downregulated in 
both sexes by a maternal high-fat diet. The weighted gene co-expression network analysis 
revealed several modules of highly co-expressed genes that were directly associated with the 
diabetes-related traits in the offspring. The two modules that were negatively associated with the 
traits were enriched for genes involved in immune system function, oxidation reduction, and 
arachidonic acid, whereas the two modules that were positively associated with the diabetes traits 
were enriched for mitochondrial, respiratory, and ribosomal processes. This indicates that the 
diabetes-related traits were associated with an altered metabolism and immune response. A 
maternal high-fat diet appeared to exacerbate the liver distress caused by an offspring high-fat 
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diet, since genes such as Apln and Mpo were upregulated by a maternal high-fat diet in the high 
fat daughters. However, Stat1, a gene that was upregulated by an offspring high-fat diet and is 
associated with liver injury, was actually decreased by a maternal high-fat diet in sons. This 
indicates that the gene expression changes induced by maternal obesity are not always the same 
as those induced by an individual’s obesity. By examining the gene expression in both the liver 
and heart tissue in the high fat daughters, I found that each tissue had a completely different set 
of differentially expressed genes, highlighting the importance of studying multiple tissues to 
grasp the full extent of the effects of maternal obesity. Six of the genes that were differentially 
expressed in the heart were cytochrome P450 genes, which, due to their role in drug metabolism 
and the involvement of other cytochrome P450 genes in heart disease, should be studied further 
as possible targets for treating metabolic syndrome.  
 When considering Chapters 3 and 4 together, their results are highly consistent and 
several epigenetic trends emerge. First of all, more DMRs were located on the X-chromosome in 
between-sex comparisons than within-sex comparisons. Only 1% of DMRs were on the X-
chromosome in the F0 males, 1.1% in the F1 high fat males, and 1.0% in the F1 low fat males. 
Females had more DMRs on the X-chromosome than males, with 3.5% of DMRs located on the 
X chromosome in the F0 females, 3.9% in the F1 high fat females, and 3.4% in the F1 low fat 
females. Thus, it was clear in both generations is that females have more than 3 times as many 
DMRs on the X-chromosome as males, potentially due to the X-chromosome inactivation that 
happens in females. Comparing differences between sexes revealed that 5.7-7.0% of DMRs fell 
on the X-chromosome in the F0 mice, and 4.3-6.5% of DMRs did in the F1 mice, showing 
unsurprisingly that X-chromosome methylation patterns are more different between males and 
females than within sexes. Another interesting trend that arose in both generations of mice was 
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that comparisons of high fat mice with each other yielded 1.4 times fewer DMRs than 
comparisons of low fat mice with each other. This indicates that a high-fat diet reduced variation 
in methylation. In light of the behavioral results from Chapter 2, where high fat mice spent more 
time sleeping and less time walking and climbing, it is possible that the reduction in methylation 
variation was caused by the overall reduction in activity levels caused by a high-fat diet. 
 In Chapter 3, I compared my gene expression findings with those of other dietary fat 
studies in mice. I found between 28-40% of the same genes in my study as researchers did in 
C57BL/6 mice. When comparing my results from Chapters 3 and 4, 50% of the same genes were 
differentially expressed due to diet in both sets of mice. Although there was a higher 
repeatability of differential expression in the two generations of mice I studied, this also 
highlights the wide variability in gene expression even in mice of the same strain housed in the 
same facility exposed to the same diets. Replication of experimental results is always important 
in science, but it is especially important to keep this in mind when interpreting results from gene 
expression and epigenetic studies.   
 In addition to contributing to the field of obesity research, my findings also have 
implications for the field of evolutionary biology. Epigenetics is involved in phenotypic 
plasticity by mediating the response to different environments through regulating pathways and 
stabilizing phenotypic variation in certain directions. Although I know that epigenetics is 
involved in phenotypic plasticity, in most cases we have not elucidated the mechanism yet. In 
my study system, it is clear that DNA methylation changes substantially in response to different 
dietary environments. The phenotypic plasticity I observed in the genetically identical SM/Js was 
mediated by changes in methylation and gene expression. Epigenetics is important to the field of 
evolution beyond just its role in phenotypic plasticity. For instance, epigenetic inheritance may 
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facilitate or enhance the processes of genetic assimilation and genetic accommodation (Jablonka 
and Raz 2009). Additionally, a few heritable epialleles have been discovered, such as 
paramutation in maize and the AxinFu allele in mice, where the epigenetic state of the allele gets 
faithfully passed on across generations. Epigenetic variation can also help populations adapt and 
diverge even in the absence of sufficient genetic variation (Flatscher et al. 2012). Small 
populations tend to have much lower genetic variation and are at a higher risk of extinction if the 
environment changes suddenly. However, if they have heritable epialleles that confer phenotypic 
variation, small populations may be better equipped to adapt to changing environmental 
conditions—even without genetic variation.  
 Epigenetics may further affect evolution through its impact on mutation and 
recombination rates. In condensed chromatin, the rates of mutation, transposition, and 
recombination are lower compared to those in open chromatin (Belyaev and Borodin 1982; 
Jablonka and Lamb 1995). Additionally, methylated cytosines spontaneously deaminate to 
thymines over evolutionary time. The CpG-to-TpG mutation rate is 50 times higher than any 
other transitional change, which causes CpGs to occur at only 21% of the expected frequency in 
the genome (Xia et al. 2012). Gene promoters that stay hypermethylated persistently across 
generations due to epigenetic inheritance or a consistent environmental effect may have higher 
mutation rates, which could drive faster evolutionary change by accelerating the decay of a 
gene’s promoter region. Hypothetically, if a gene that protects against obesity is turned off due to 
hypermethylation from a maternal high-fat diet over many generations, the CpGs may deaminate 
to TpGs and the promoter could eventually decay. Furthermore, epigenetics may be involved in 
establishing and maintaining reproductive isolation, as in the case of Peromyscus polionotus and 
P. maniculatus, where reproductive isolation between these two species has been shown to be 
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driven by epigenetic mechanisms (Vrana et al. 2000). However, before we fully understand the 
extent of the effect that epigenetics has on evolution, more research must be conducted on the 
epigenetic changes that accompany environmental changes. My dissertation research on the 
DNA methylation changes that accompany a high-fat diet and a prenatal environment of 
maternal obesity contribute in a small way to that knowledge.  
 Overall, this dissertation has identified thousands of genes and methylated genomic 
regions in the liver that are altered by a high-fat diet. It supports the fetal origins of adult disease 
hypothesis, which posits that the environment that an individual experiences during early 
development affects adult risk of type 2 diabetes, cardiac disease, and hypertension (Hales et al. 
1991, Barker et al. 2002). A prenatal maternal high-fat diet altered the gene expression and 
methylation patterns in the offspring, and increased the body weights, leptin levels, and weights 
of the liver and fat pad in the high-fat-fed daughters. Knowing that these particular traits are 
affected in females, along with the accompanying changes in gene expression and methylation, 
will inform health interventions and treatments in the future.  
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